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Abstract
• Over the last few decades, the epidemiology of diseases of the 
proximal gastrointestinal tract has been changing. The incidence of 
gastric adenocarcinoma in the United Kingdom has decreased, with 
squamous carcinoma of the oesophagus remaining relatively static. 
Adenocarcinoma of both the oesophagus and gastro-oesophageai 
junction (including the cardia) have increased greatly.
• The risk of oesophageal adenocarcinoma has been linked with gastro- 
oesophageai reflux disease. Short-segment reflux at the cardia has 
also been postulated as a risk factor for cancers at this site.
• The factors that predispose a particular person to more severe reflux 
or put them at an increased risk of mucosal damage are poorly 
understood. Inherent physiological and anatomical parameters will 
play their roles, with the role of environmental factors often being 
overlooked.
• The increase in dietary nitrate consumption, following the post-war 
intensive farming practices with nitrogenous fertilizers, has been 
proposed as a risk factor for the increase in several human cancers.
• The entero-salivary recirculation of dietary nitrate has been examined 
by several groups. It has demonstrated the generation of high 
quantities of nitrite in swallowed human saliva. The subsequent 
luminal chemistry will cause nitrous acid (NA) to be formed in a 
healthy acid secreting stomach. In the additional presence of ascorbic 
acid, instantaneous formation of luminal nitric oxide (NO) at the gastric
cardia takes place. Nitrous acid is also capable of forming long acting 
NO-donor compounds, by reacting with ingested dietary thiols.
• Nitric oxide is a ubiquitous smooth muscle relaxant. It is involved in 
oesophageal peristalsis, lower oesophageal sphincter (LOS) and 
gastric relaxation and also the co-ordination of transient lower 
oesophageal sphincter relaxations (TLOSRs).
• A series of pilot studies, in healthy volunteers, were designed to 
investigate the physiological effects on gastro-oesophageai motility.
• A standard water perfused manometry system was adapted, and 
validated, to deliver a test solution containing NO, whilst also 
recording pressure data from the proximal gastro-intestinal tract.
• The profile of distribution of the delivered NO solutions was 
characterised by a series of silastic tube experiments. A segmented 
silastic tube was taped to the manometry catheters used for each 
experiment. The NO was delivered as it would be in each experiment.
» The segments trapped NO as nitrite, which were then analysed. They 
showed a pattern of NO distribution similar to the fasting data seen 
with a luminal NO probe. The post-prandial model showed evidence of 
NO reflux into the oesophagus and also NO concentrations 
comparable to those following ingestion of oral nitrate.
• Smaller amounts of nitrite are present in saliva in the fasting state. In 
our model of the subsequent formation of NO at the gastric cardia, 
there was no effect on the resting pressure of the LOS. There was 
also no effect on the length of the LOS.
• At high concentrations (>4mM), NO can come out of solution to form 
gaseous NO. In vitro experiments demonstrated that at the 
experimental concentrations used, and also at 37®C, no significant 
quantities of NO gas were formed, excluding the possibility of intra- 
gastric gaseous distension as a confounding factor in our studies.
• Post-prandial studies were performed in 15 healthy volunteers. 
Initially, the manometric effects of a meal on the LOS were observed. 
Subsequently, double-blinded solutions were perfused into the lumen 
at the gastro-oesophageai junction. Hydrochloric acid, NA and NO 
solutions, all at the upper physiological limit, were perfused and 
recordings made.
• The effect of a meal on the LOS, was to cause a reduction in the total 
sphincter length with a preferential loss of the abdominal portion. 
There also appeared to be a slight elevation of the diaphragm, but no 
shortening of the oesophagus.
• Nitric oxide caused an increase in TLOSRs and reflux at the distal 
oesophagus. Nitrous acid caused a reduction in intra-gastric pressure 
during the infusion. It caused no alteration to the acid reflux profile.
• No solutions caused any major alterations to oesophageal peristaltic 
parameters following ‘dry’ swallows.
• These findings support the need for further research into this area. 
The threshold for effects caused by nitrite chemistry must be 
addressed. Also, these studies were performed in healthy volunteers. 
It would be reasonable to examine the effects of this luminal chemistry 
on those with pre-existing upper gastrointestinal diseases such as
hiatus hernias, reflux oesophagitis and Barrett’s oesophagus. Repeat 
studies looking more simply at the effects of swallowed nitrite on 
oesophageal acid exposure would be enlightening.
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The potential effects of the acidification 
of salivary nitrite on the physiology 
of the upper gastrointestinal tract
Chapter 1
20
Thesis aims
This thesis brings together a set of experiments to examine the 
potential physiological effects of luminal nitric oxide, generated from salivary 
nitrite, on the oesophagus and lower oesophageal sphincter of humans. A 
review of the literature regarding gastro-oesophageai reflux disease and 
nitrite chemistry is undertaken. Subsequent chapters describe the design and 
testing of the experimental equipment both in vitro and in vivo, prior to 
undertaking the two studies. The first study analyses the effects of these 
chemicals, in healthy subjects, in the fasted state and then this is followed by 
a study examining the effects following a meal.
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1.1 Introduction:
The human oesophagus and stomach are common sites of symptoms 
and disease. In particular, the incidence of oesophageal adenocarcinoma 
has increased by about 600% since 1975 exceeding the relative increase 
over that time period of melanoma (1). In Iran, which has a high prevalence 
of H. pylori infection, the pattern of upper gastrointestinal malignancy has 
changed recently from one of predominantly antral adenocarcinoma in the 
1970's (2) to the gastric cardia in 2000 (3).
Gastro-oesophageal reflux disease (GORD) is extremely prevalent in 
the adult population of the Western world. Approximately 15% of adults will 
experience symptoms on a weekly basis, and 5% daily, although only a small 
proportion of these will consult their General Practitioner (4). A greater 
frequency of reflux symptoms is associated with an increase in the relative 
risk of developing oesophageal adenocarcinoma (5). Although, in 
contradiction, oesophageal inflammation and oesophagitis do not always 
correlate with heartburn and reflux symptoms (6).
1.2 Anatomy:
An understanding of the anatomy is important in appreciating the 
pathophysiology that occurs. Grossly these organs comprise two hollow 
tubes separated by a muscular valve or sphincter. This separation is 
important in keeping the two specialised environments apart. The primary 
function of the oesophagus is the propulsion of foodstuffs to the stomach, 
which is achieved by co-ordinated peristalsis of the musculature. The 
oesophagus passes through the thorax in the posterior mediastinum and has
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both an outer longitudinal and inner circular layer of muscle. In its upper 
quarter the fibres are those of striated muscle, with an increasing mixture of 
smooth muscle in the next quarter. The lower half is comprised entirely of 
smooth muscle.
Careful dissection of the muscle layers has shown that the fibres are 
organised in a helical fashion. Those in the circular layer form a tight helix 
and those in the longitudinal layer an elongated one (7). There are several 
important layers lining this muscular tube. The mucosa comes into direct 
contact with the luminal environment. The mucosa comprises an epithelium, 
lamina propria and muscularis mucosa. In the human oesophagus this is a 
partially keratinised stratified squamous epithelium measuring 
300micrometres thick. The lamina propria is deep to this and is primarily a 
connect tissue and vascular layer. The muscularis mucosae is a 200- 
400micrometres thick layer of smooth muscle, with its proximal insertion at 
the cricoid cartilage (7). The muscle bundles are orientated longitudinally in 
the oesophagus and become significantly thicker at the gastro-oesophageal 
junction (GOJ) (8). Here, the muscularis is thicker than that of the stomach, 
and can be mistaken for the muscularis propria on biopsy. The orientation 
changes on passage to the stomach showing both a circular and longitudinal 
arrangement. The elastic submucosa with glands completes the picture, lying 
between the two muscle layers (9);{10) -  see Figure 1.1.
A broader band of circular muscle exists at the lower end of the 
oesophagus and is often termed the lower oesophageal sphincter (LOS). 
Definitions of this area are very complicated as no definite anatomical 
sphincter exists. It's location can be described by measurements of the 
pressure it exerts, but in different states of disease, such as hiatus hernias,
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these figures are unreliable. This is true for mucosal definitions of the 
sphincter, which are also subject to variations in disease (11). Anatomical 
descriptions such as the peritoneal reflection from the stomach to the 
diaphragm are only of use in surgical resection specimens (12).
In a fasting state the oesophagus is a collapsed structure (13), devoid 
of air or fluid, with the mucosa thrown in to longitudinal folds. Endoscopic 
insufflation of air distorts this, giving a false impression of the resting state. 
Normally the inner oesophageal surface has a pink-white colour. The upper 
margin of the diaphragmatic indentation can be seen at endoscopy and is 
one landmark used as the GOJ. Another is the proximal folds of the gastric 
mucosa, which is said to approximate to the muscular junction (14). The 
mucosa of a healthy oesophagus differs to that of the stomach. In contrast to 
a healthy oesophagus, the stomach is lined by a columnar epithelium. The 
change from one epithelium to another is quite distinct and appears as a 
serrated border or ‘z-line’.
Small projections of gastric epithelium up to 5mm long can be seen 
rising up into the squamous epithelium, and are often asymmetrical. This 
mucosal definition of the GOJ differs to the muscular definition, as the 
squamo-columnar junction (SCJ) often lies within the high pressure zone of 
the LOS. That is to say, in the presence of a normal size cardia, almost the 
whole of the lower half of the mucosa within the LOS is of an acid secreting 
type (15). These descriptions show the differing opinions and conflicts that 
can exist between anatomists, physiologists, pathologists, surgeons and 
gastroenterologists, when describing an important area of disease; the 
location and features of which are paramount in disease classification and 
management.
24
1.3 Swallowing and reflux:
Incompetence of the LOS is one mechanism that allows the harmful 
gastric juices to cause symptoms and damage to the lower oesophageal 
mucosa. Although this is a well-understood concept, the actual causes of 
sphincter failure are poorly understood. Acid reflux occurs as a consequence 
of the retrograde movement of the luminal contents of the stomach back into 
the oesophagus and can lead to pain, inflammation, ulceration, stricture 
formation, bleeding and cancer. Physiological reflux as measured by high- 
frequency intraluminal ultrasound probes has been shown to be relatively 
small in volume. The cross-sectional area of refluxed liquid in healthy 
subjects averages 7.5mm diameter (16).
Ultrafast CT scanning has shown that on average 15mls of air 
accompanies a swallowed liquid bolus (13). Repetitive swallowing can 
therefore cause gas accumulation in the stomach. It has also been shown 
that the nature of the refluxate into the oesophagus is highly variable. 
Refluxate can be acidic, non-acidic, liquid or a mixture of liquid and gas. 
Acidity can be measured intraluminal pH catheters or endoscopically clipped 
Bravo capsules (17). Deciphering either liquid or gas status can be 
ascertained by impedance devices (18). The frequency of gastro- 
oesophageal reflux, which is a normal physiological event, has been shown 
to be similar between healthy controls and GORD patients. One third of reflux 
episodes are non-acidic in both groups, with liquid-gas episodes being the 
most common.
Pure liquid reflux is more acidic in GORD patients (19) and indicates 
why GORD patients have higher 'DeMeester scores' (20) on 24 hour pH
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recordings. This suggests variations in gastric acid secretion or distribution 
within the stomach. Oesophageal acid clearance is also important. This study 
did not compare hiatus hernia patients to hernia free subjects. When present 
together, liquid reflux precedes gas on approximately 40% of occasions, with 
gas initiating only 25% of episodes (21). Reflux in GORD patients is as likely 
to occur in the upright posture as in the supine (22), which differs from 
normal subjects.
Gastric acid secretion increases following a meal. Buffering of the 
meal contents causes the intragastric pH to rise. In the fasting state, the pH 
step-up from the fasting acidic stomach to the neutral oesophagus occurs at 
the SCJ (23). Post-prandially, one would assume that buffering causes the 
step-up to be lost. However, an unbuffered pocket of acidified gastric juice 
occurs at the cardia region, with a pH as low as 2 (23). This is likely to be the 
source of the acidic refluxate. Subtle features can occur at the GOJ in reflux 
patients, even before the evolution of oesophagitis. The presence of cardiac 
mucosa, carditis and intestinal metaplasia at this site are frequent. This 
indicates that the cardia region is not resistant to acid or the other noxious 
stimuli in the refluxate (24). The gastric contents become hypertonic after a 
meal. A Barrett's segment is insensitive to acid, but causes symptoms when 
exposed to hypertonic matter (25).
A Los Angeles group demonstrated that an elevated body mass index 
resulted in a greater acid exposure of the distal oesophagus in those with 
reflux symptoms (26). A further retrospective questionnaire of U.S. nurses 
correlated BMI to symptoms of GORD which varied with changes in BMI over 
time (27). This contradicts the Swedish data collected in an interview based 
study. It compared reflux symptoms to patient BMI, without subjective
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evidence of oesophageal acid exposure (28). Surgical procedures aimed at 
aiding obesity affect gastric emptying and as such influence patterns of 
gastro-oesophageal reflux. Roux-en-Y gastric bypass is efficacious for acid 
reflux by aiding gastric emptying. Whereas gastric banding is an aggravating 
factor, possibly by altering food distribution and acid buffering within the 
stomach (29).
There are several features associated with the integrity of the LOS. 
The pressure exerted in this high pressure zone is important. There are 
numerous components to this including the circular muscle of the 
oesophagus, gastric sling fibres and the diaphragmatic crura. The LOS is an 
asymmetrical structure with regards to both the pressure exerted and muscle 
thickness (30;31). Intraluminal ultrasound probes have shown that the 
circular muscle is the thicker of the 2 layers. The distribution of longitudinal 
muscle thickness parallels the circular muscle. The maximum pressure 
recorded at the high pressure zone correlates to the point of maximal muscle 
thickness (32). In the relaxed state, the LOS is a more symmetrical structure. 
Its' resting asymmetry probably relates to the mucosal folds and pressure 
from external structures. Sphincter pressure is a labile phenomenon, even 
reacting to emotional stress (33).
The length of the LOS, and more importantly, the proportion exposed 
to intra-abdominal pressure, also has a role. The crural diaphragm is a key 
component in the anti-reflux barrier (34). Although not directly comparable to 
disease in humans, the angle of insertion of the oesophagus into the 
stomach in dogs has been shown to be one of the major factors in preventing 
reflux oesophagitis (35). As well as the angle of insertion of the oesophagus 
into the proximal stomach (36), the mucosal folds at the cardia form the final
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tight seal of this protective barrier (37). Within these mucosal folds are, as 
described, a well-defined layer of muscularis mucosae and venous network. 
Studies have shown some parts of this make-up to be more important than 
others and some are overlooked entirely. Normally the veins lie deep to the 
muscularis mucosae. However, the tributaries responsible for variceal 
formation perforate the muscularis mucosae just above the SCJ (38).
Some investigators believe that the proximal gastric mucosa plays the 
part of a flap valve (39), which is pushed into position by the increased 
intragastric pressure during inspiration. A  series of in vivo experiments with 
dogs, under anaesthesia, showed that the pressure of water required to 
cause flow from the oesophagus to the stomach was 15cm. However, the 
pressure required to cause retrograde flow was 100cm. This gradient was 
reduced from 100cm to 30cm following severance of the left side of the 
diaphragmatic loop, which is key to the insertion angle at the cardia (40). A 
flap-like structure has been seen in humans whilst retroflex!ng during 
endoscopy (39). A diminished or absent mucosal flap has been associated 
with reflux symptoms and oesophagitis (41).
The LOS pressure, contributed to by the factors above, certainly 
appears to be lower in patients with increasing degrees of oesophagitis. LOS 
pressure also reduces with an increasing extent of Barrett’s oesophagus, 
partly due to the presence of a hiatus hernia and dissociation of the circular 
muscle from the diaphragmatic crura. Smokers have lower resting LOS 
pressures. They seem to suffer from more reflux events, where the LOS is 
overcome by coughing and also more prolonged LOS relaxations (42). 
However, there is a wide overlap that exists even amongst healthy 
volunteers. Some have low pressures and paradoxically, some with
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oesophagitis have normal pressure measurements (15). Extrinsic innervation 
of the human LOS alone does not regulate the resting tone, as demonstrated 
by surgical vagotomy (43). In vitro LOS muscle strips from controls and 
Barrett’s patients exhibit similar basal tone. There is only minimal contraction 
to substance P in either group with resistance to axonal sodium channel 
blockade in the Barrett’s patients. Neurokinin 2 (NK-2) receptors predominate 
over NK-1 and NK-3 subtypes (44).
A hiatus hernia always accompanies Barrett’s oesophagus. As well as 
the change in anatomy there comes a movement of the SCJ. In normal 
individuals the SCJ, identified by endoscopic clipping, is 0.5cm below the 
diaphragmatic hiatus. Manometry shows that the high pressure zone extends 
approximately 1.1cm distal to that. In hiatal hernia patients, the GOJ high 
pressure zone has two segments -  the intrinsic LOS and the crura. In non- 
Barrett’s hernia patients the SCJ appears at the lower end of the intrinsic 
LOS, in an area almost devoid of pressure and abutting onto gastric, acid- 
secreting mucosa (45). There is good data to show that larger hiatal hernias 
are associated with weaker, shorter LOS’s and impaired oesophageal acid 
clearance (46). Non-reducing hiatus hernias especially have impaired acid 
clearance and increased acid exposure. One study of this showed that fewer 
reflux events occurred. This was probably related to impaired acid clearance 
and serial reflux events being missed due to no perceivable drop in pH (47).
It is important to keep in mind that the majority of clinically invasive 
investigations tend to take place in the fasting state, when the GOJ is not 
being directly ‘stressed’ or ‘tested’. Body position and gastric distension play 
crucial roles, as both have important physiological implications.
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Pressure measurement techniques of the upper Gl tract have 
developed over the last 20 to 30 years. Accurate assessment of individual 
components of the LOS, intraoesophageal and intragastric pressure (IGP), 
and their changes with respiration are now possible (48). Analysis of the 
abdominal portion of the sphincter also shows variation with disease. During 
respiration there are large changes in intra-thoracic and intra-abdominal 
pressure. During inspiration a negative pressure exists in the thorax, which 
one would expect to tend to induce a reflux episode, if it were not for the 
physical barrier of the LOS. The abdominal length of the sphincter can be 
calculated with differing accuracy from manometry tracings. The respiratory 
inversion point (RIP) shows a change in pressure on the tracing, at end 
expiration, from a positive to a negative deflection (49). The distance from 
this point to the distal end of the sphincter is the abdominal sphincter length. 
This length is significantly longer in healthy volunteers than in any patients 
with lower oesophageal disease. In fact, restoration of the abdominal 
sphincter has become the feature of some corrective surgeries available for 
severe reflux disease.
The role of H.pylori in GORD patients remains controversial. Gastric 
colonisation causes chronic gastritis with loss of glands over time, in a 
majority of patients (50). The rate of progression is slow and dependent on 
the severity and distribution of the gastritis. Those with maintained acid 
secretion have gastritis mainly in the antrum and are unlikely to develop 
atrophy in the corpus. Eradication of H.pylori does not alter the dose of 
proton pump inhibitor required or the pattern of reflux symptoms in GORD 
patients (51).
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1.4 Oesophageal mucosal resistance:
pH recordings from the lower oesophagus will show that a healthy 
volunteer has a reduced acid exposure in comparison to a reflux patient. The 
three mechanisms for acid clearance from the oesophageal lumen are 
gravity, peristalsis and neutralisation of the acid by swallowed saliva and 
mucosally secreted bicarbonate. Inbuilt defence mechanisms exist to protect 
the oesophageal mucosa from the physiological phenomenon of gastric acid 
reflux. Within the oesophageal lumen, and before the epithelium is even 
reached, there is a mucus layer, along with water and secreted bicarbonate 
ions. This is more marked within the stomach and duodenum (52). If 
breached, the tight junctions between the partially keratinised squamous cells 
slow the passage of H  ^ ions into the interstitial space, where buffering takes 
over. Cell membrane transporter proteins also participate in the epithelial 
defence systems. If destroyed, new squamous cells can be regenerated, with 
a 7-day cycle observed in rats (53).
Oesophageal epithelium cell turnover has also been shown to 
increase in dogs in response to acid exposure and injury (54). A different 
mechanism, known as ‘epithelial restitution’ occurs in gastric and duodenal 
mucosae in response to breach ment. In the stomach and duodenum it takes 
30-60 minutes and involves the epithelial cells adjacent to the area of injury 
flattening and migrating over the bare basement membrane, to restore 
integrity. The most important post-epithelial defence mechanism is the 
presence of an adequate blood supply to the tissue. It maintains acid-base 
balance as well as supplying oxygen and nutrients. This is demonstrated as
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the blood supply to the oesophagus increases in response to stress caused 
by luminal acid exposure (55;56).
1.6 LOS function:
Several studies have looked at the effects of food-stuffs on static LOS 
parameters, in particular resting LOS pressure. Using 240cc intragastric 
meals, Babka et a! found no effect on LOS pressure from still water. Both 
orange and tomato juice individually showed reduction in LOS pressure for a 
15-minute period, post-ingestion. Whole milk caused a small reduction in 
LOS pressure, which was sustained. Non-fat milk showed a significant rise in 
LOS pressure, 40 minutes post-ingestion (57). Alkali alone had previously 
been shown to increase LOS pressure (58). The obvious difference here 
between the 2 milk products was the fat content, indicating that a slower 
mechanism, probably hormonal, being responsible rather than that of minimal 
gastric distension. Low-fat chocolate syrup causes an almost dose-response 
reduction in LOS pressure thought to be mediated by the phosphodiesterase 
inhibition properties of methylxanthines (57).
Looking at products with lower caffeine loads than chocolate syrup, a 
set volume of a carbonated cola product was infused into a supine human 
stomach and compared to a caffeine-free equivalent (59). A drop in pressure, 
but not significantly different, was seen in both groups. Carbonated water 
caused a significant drop in LOS pressure compared to a similar volume of 
still water (59). These studies indicated the importance of gastric distension 
by gas in reducing resting LOS pressure.
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1.6 Oesophageal function:
During peristalsis, external longitudinal muscle contraction precedes 
that of the circular muscle. Distal propagation speed is normally about 
2.5cm/second (60). Physiological changes induced by pregnancy cause a 
lower wave speed and lower wave amplitude of oesophageal peristalsis (61). 
Repeated acid exposure to the oesophagus increases its sensitivity and also 
its contractility (62). Oesophageal contraction in the absence of acid can 
sometimes mimic heartburn symptoms (63-65). Although acid reflux or 
oesophageal acid exposure can induce cardiac type pain it does not alter 
cardiovascular parameters, such as pulse, blood pressure or EGG 
recordings, in any way (66;66;67).
There is good evidence to show that with an increasing severity of 
oesophagitis there is an increasing frequency of dysmotility. The resting LOS 
pressure is lower in patients with oesophagitis and any length of Barrett’s 
compared to controls. The peristaltic wave amplitude of patients with long- 
segment Barrett’s oesophagus (>3cm) is significantly lower than that of 
controls and those with short-segment Barretts. It is, however, no different 
from reflux oesophagitis patients. The percentage of non-propagated wet 
swallows was significantly higher in all 3 groups compared to controls, as 
was the time of oesophageal pH exposure < 4.0, on 24 pH recordings (68).
Oesophageal contraction in response to intraluminal balloon dilatation 
occurs primarily distal to the point of stretch. This can be a sustained 
‘duration response', which causes shortening of the oesophagus. This is 
caused by contraction of both the longitudinal muscularis externa and 
muscularis mucosae (69). Electrical stimulation of isolated longitudinal strips
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showed this to be of equivalent force in both the muscularis mucosae and 
muscularis externa. Winship and Zboralske previously commented that they 
thought this phenomenon would contribute to the oesophageal propulsive 
force; a mechanism to expel luminal obstruction (70). Secondary peristalsis 
of the oesophagus aims to clear luminal residue, including refluxed material. 
It is vagally mediated and sensitive to both atropine and capsaicin. Acidic 
fluid triggers it at lower levels of distension, and is more resistant to atropine 
(71).
1.7 Oesophageal shortening:
Changes in the length of the oesophagus have been noted with a 
shortening in response to acid exposure. It was demonstrated to be a 
persistent feature in an opossum model, preceding the reduction in LOS 
pressure and impaired oesophageal motility seen in GORD subjects (72). 
Chronic oesophageal shortening has even been considered as an early 
component in the development of a fixed hiatus hernia (73). However, it has 
been shown that shortening of the oesophagus is less marked with 
increasing size of hiatus hernia, probably due to less effective contraction of 
the longitudinal muscles against the phrenoesophageal attachments (61).
Shortening of the oesophagus by up to 2cm occurs each time we 
swallow, but is a transient phenomenon. It is observed when assessing the 
movement of naso-oesophageal pH probes, clearly indicating the reason for 
positioning them 5cm above the LOS during standard recordings (74). If one 
swallow quickly follows another, the latter is able to abolish the distal 
oesophageal contraction and shortening caused by the first swallow. This is a
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phenomenon known as deglutitive inhibition (75). fn vitro studies suggest that 
pre-treatment with mast cell stabilisers can prevent acid-induced 
oesophageal shortening, but not that caused by electrical field stimulation 
(76), alluding to more complex mechanisms being involved via the lumen.
1.8 Gastric motility:
The migrating myoelectric complex (MMC) of the human stomach was 
described by Stanciu in 1975 (77). It is characterised by bursts of 
depolarisation that move from the stomach to the ileocaecai valve at regular 
frequency during the interdigestive period. Individual cycles of activity can 
last from 1 to 2 hours. One of the major roles of the MMC is to maintain 
upper gut sterility by sweeping bacteria in the upper bowel downstream and 
transporting gastric acid from the stomach into the proximal gut. On initiation 
of a swallow sequence, the gastric fundus undergoes vagally mediated 
receptive relaxation. Fundal tone is controlled by a balance of both excitatory 
(cholinergic) and inhibitory (nitrergic) inputs. As a meal enters the stomach, 
both tone and phasic contractions in the proximal stomach are inhibited. This 
is the process referred to as gastric accommodation. This allows the volume 
of the stomach to increase by 2-3 fold in order to retain the meal, before 
distributing to the antrum. In the presence of a meal, the antrum is able to 
separate solids from liquids by a combination of ‘sieving’ and gastric 
relaxation (78). Emptying from the stomach is then dependent on phasic 
pressure waves of the pylorus (79).
Relaxation of the fundus, often as a means of controlling the rate of 
gastric emptying, is controlled by various physiological events. Antral 
distension (gastrogastric reflex) is one such event. Acidification of the
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duodena! lumen, as well as the presence of lipid and protein (duodenogastric 
reflex) will also cause this, as will distension of the colon (cologastric reflex). 
Gastric emptying of liquids is exponential, for those with no nutrient content, 
and proportional to the intragastric volume. Nutrient containing liquids such 
as dextrose are emptied slower.
Impaired gastric accommodation in response to a meal has been 
demonstrated in functional dyspepsia [Tack, J et af\, showing an association 
with disease states. Abnormal gastric emptying is also thought to play a role 
in GORD. Impaired post-prandial gastric motility with an altered distribution of 
food, leading to variations in proximal gastric distension and acid-buffering 
which could impact on the disease. In patients with Barrett’s oesophagus, 
duodeno-gastro-oesophageal reflux with bile and pancreatic enzymes (ie: 
retrograde motility) is considered a key agonist (80). Gastric emptying has 
been shown to be impaired in 40% of GORD patients with a solid-liquid meal, 
resulting in larger post-prandial gastric volume (81). Other studies have 
shown gastric emptying to be normal or rapid in GORD patients (82;83). This 
could mean that either gastric emptying is irrelevant or that it is important in 
only a certain subgroup of GORD patients.
1.9 Muscularis mucosae:
Whether impaired motility due to oesophagitis or Barrett’s oesophagus 
is caused by an intrinsic smooth muscle defect or as a result of acid injury to 
the mucosa, is not known. If the answer lies with smooth muscle dysfunction, 
then a separate question must be asked. Is the smooth muscle defect within 
the main muscle bulk of the longitudinal and circular fibres, or is it related to
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the often overlooked, muscularis mucosae? Oesophageal clearance requires 
effective oesophageal peristalsis and delivery of salivary bicarbonate. It takes 
7ml of saliva to neutralise 1 ml of 0.1 M HCI (84). In healthy people, the rate of 
salivation is the key factor to duration of acid exposure. Impaired ability to 
empty fluid, as in hiatus hernia patients, can vastly prolong acid clearance 
(85).
From histological analysis we have seen a marked thickening of the 
muscularis mucosae at the lower end of the oesophagus (86). This 
observation has also been seen in felines and guinea pigs (87). In humans its 
function has not been properly investigated. Thickening of the muscularis 
mucosae has also been noted in other anatomical sites such as the gastric 
antrum (88) and rectosigmoid junction (89).
There are reports of double contrast barium studies of the oesophagus 
in humans revealing both transient and fixed transverse folds in its lower half 
(90). These have been seen in felines as well, but are a more fixed entity, 
and restricted to its lower third. In humans the folds are 1-2mm in thickness 
and cross the entire width of the oesophagus. They have only been seen on 
‘spot’ films and have never been witnessed at GOJ during such studies. 
These folds are reportedly seen in 1-2% of barium studies, but due to their 
transient nature, it is thought that the figure could be higher (91). It is 
certainly a relatively common feature at endoscopy, to induce a corrugated 
appearance to the oesophagus following air insufflation, perhaps due to 
reactivity from the muscularis mucosae. This radiological phenomenon has 
also been seen in barium studies of the gastric antrum (92).
As long ago as 1923, Forsell showed that the mucous membrane of 
the gastrointestinal tract was freely mobile over the muscularis externa (93).
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It’s movement being dictated by the muscularis mucosae. Seymour and 
Meredith also witnessed fine gastric antrum and oesophageal ‘rimpling’ on 
double contrast barium studies which were eradicated with increasing 
distension. The authors attributed these effects to contraction of the 
muscularis mucosae (94). They also concluded at the time that these folds 
were of no pathologic significance. During studies to examine the structure of 
oesophageal varices and the venous network (95) at the GOJ, it was 
demonstrated that the muscularis mucosae was much thicker at the lower 
end of the oesophagus. Where the distal mucosa is thrown into longitudinal 
folds they showed that the muscularis is up to five times thicker at the top of 
these folds (38). These were in cross-sectional views and the comparative 
areas were the inter-fold regions.
It is difficult to Imagine that this complex arrangement and muscle 
hypertrophy is not to serve a specific purpose. Using an animal model, 
isolated strips of muscularis mucosae from the opposum contract in response 
to electrical field stimulation, giving a sustained response which results in 
shortening of the oesophagus (69). Although not seen on the barium studies, 
transverse folds of the lower oesophageal mucosa have been seen in fixed 
human post-mortem specimens (30;96). These folds are prominent on top of 
the longitudinal folds already described, and are located at the region of what 
would relate to the high pressure zone of the LOS. It is possible that during a 
barium study, and with distension of this area, these folds may be lost until 
the area returns to it’s resting state. The question of embalming artefact 
should also be considered.
It is therefore highly plausible that the well-defined layer of muscularis 
mucosae at the top of these folds contracts to cause a ‘bunching’ of the
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overlying mucosa, creating these transverse folds. This would pull the 
mucosa into the sphincter to form the final part of the seal. Therefore, within 
the sphincter would be a combination of both longitudinal and transverse 
folds. The longitudinal folds are formed by heaping of the mucosa by external 
smooth muscle contraction and the transverse folds by the more superficial 
muscularis mucosae. There is also some evidence that this thickening of the 
muscularis may even extend to just below the SCJ (86).
In healthy volunteers a barium study following clipping of the SCJ, 
showed that in the fasting state, the clips were up to 3cm from the 
radiological lower border of the LOS. When the gastric fundus was distended 
the junction was brought to the brink of the stomach proper. This indicated 
that in a state of distension, the SCJ is likely to be at the interface between 
the stomach and the oesophagus (97). On occasions during this study, 
spontaneous migration of the clips, of upto 2cm, toward and away from the 
stomach would occur. These were not related to gastric emptying or 
respiratory effort. They were classed as movements of a mobile mucosa 
propelling itself over the deeper tissues.
With the longitudinal, axial contraction of the muscularis in mind, the 
issue arises as to whether the SCJ is in fact mobile. Are there any deep 
fixings of the junction to the underlying tissues? If there is not, and the 
junction is mobile, this would be very important in relation to diseases at this 
site. If the z-line were to migrate up the oesophagus, then acid-secreting 
mucosa below the cardia would have free exposure to the oesophageal 
mucosa. Vice-versa, if the lower oesophageal mucosa were pulled down into 
the acid secreting environment of the proximal stomach then acid exposure 
would also cause subsequent damage.
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If a mobile z-line exists, then to keep physiological harmony, it would 
be important to keep it within the lower oesophageal sphincter. Ideally the 
transverse corrugated pattern would be best confined to the squamous 
mucosa portion as otherwise it may promote acid ‘trapping’. We are aware 
that the z-line moves in different states of disease. If there is no change to 
the lining epithelium then it is important to work out what the cause of this is. 
Also, if this can be ascertained, then it may indicate whether the movement is 
the cause or effect of the disease. It may be that there are many temporary 
minor movements of the SCJ. It could occur in relation to meals and gastric 
distension, ingestion of active compounds in meals and beverages, or 
ingestion of pharmacological drugs for non-gastrointestinal ailments.
The opposum’s oesophageal structure and function closely relates to 
that of humans. Acetylcholine causes phasic contractions of it’s muscularis 
mucosae via Mi receptors and substance P a tonic contraction (98). 
Acetylcholine exists alone and sometimes in the same nerve endings as 
substance P, albeit in separate granules (99). This itself confirms the 
complex neurochemical control systems that exist to regulate the function of 
the muscularis mucosae. Opiate, adenosine, a2 adrenoceptors and 
prostaglandin receptors have all been looked for in this tissue but do not 
appear to be present (100).
The rabbit oesophagus has striated muscle along its length with a 
muscularis mucosal lining (101). Contracted strips of rabbit oesophageal 
muscularis mucosae relaxes completely when exposed to 10'^^molar sodium 
nitroprusside. Sodium nitroprusside acts as a NO donor, indicating that NO 
generating pathways are involved in the control of oesophageal smooth 
muscle relaxation (102).
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1.10 Intestine:
The canine small intestine mirrors closely that of humans, in particular 
with regards to lumen size and ratio of muscularis mucosae thickness to 
muscularis externa. This makes it a relatively good model for the effects of 
neurohumoral and pharmacologic agents in the human intestine. In vivo, 
strips of canine jejunal muscularis mucosae contract in response to 
intravenous acetylcholine and pentagastrin, as does the muscularis externa. 
Both layers relax in response to cervical vagi electrical stimulation. They 
differ in most other responses, with the muscularis mucosae giving relatively 
tonic responses to intravenous histamine and serotonin compared to the 
muscularis externa (103).
Increases in small bowel motility in response to CCK, secretin and 
somatostatin are confined to the muscularis mucosae (104). This work is key, 
as paradoxical motor effects of the 2 muscle layers had probably been 
previously misinterpreted or overlooked. Increase in segmenting muscularis 
mucosae activity associated with atonia of the muscularis propria is seen in 
the presence of diarrhoea (103), indicating that the muscularis mucosae can 
dictate disease states. These findings can be reproduced by reserpine, 
somatostatin and serotonin (103). The muscularis clearly has a vital role in 
the equilibrium of intestinal function.
These findings backed up earlier work, which showed p adrenergic 
stimulation lead to contraction of the proximal stomach and small intestine, 
with relaxation of the antrum. These responses were also attributed to the 
muscularis mucosae (105-107).
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1.11 Transient lower oesophageal sphincter relaxations:
Transient lower oesophageal sphincter relaxations (TLOSRs) were 
first described in 1980 by Dent et al. Initially referred to as ‘inappropriate’ 
relaxations of the LOS, TLOSRs are now recognised as the physiological 
mechanism permitting venting of gas from the stomach. They showed that 
nocturnal reflux occurred in response to LOS relaxation during arousal from 
sleep or when fully awake (108). TLOSRs also require selective inhibition of 
the crural diaphragm (109), which is also seen in vomiting (110) and 
oesophageal distension (111).
Properties of TLOSRs have been quantified, to classify them 
separately from swallow-induced LOS relaxation. Dry swallows precede LOS 
relaxation by a median of 1.4 seconds. The LOS relaxes at a rate of 
>1mmHg/sec, and the relaxation nadir always occurring within 7 seconds 
(112). Relaxation duration is always less than 9 seconds. TLOSRs are not 
associated with swallows either 4 seconds before or 2 seconds after their 
onset. Relaxation rate is also >1mmHg/sec, with time to complete relaxation 
of less than 10 seconds. Nadir LOS pressure is <2mmHg. Mean duration of 
LOS relaxation with swallowing is approximately 4.5 seconds compared to 18 
seconds for TLOSRs. TLOSRs also appear to be associated with a 
prominent LOS after-contraction (112).
A consequence of TLOSRs is often the reflux of gastric contents 
during ‘common cavity’ events. Common cavity events are not exclusively 
related to TLOSRs, with almost 40-60% occurring during loss of sphincter 
tone by other causes, but not necessarily associated with reflux (113). In 
healthy subjects TLOSRs and gas venting are suppressed in the supine
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position (114) and this has been confirmed to be the case in GORD patients 
as well (115). In the upright posture TLOSRs cause gas or liquid reflux in 
70% of cases in healthy volunteers, but the handling of the refluxate varies in 
GORD patients as described earlier.
A Nissen fundoplication increases the mechanical rigidity of the high 
pressure zone, the total high pressure zone length and the abdominal length 
of the LOS. It also helps to maintain the high pressure zone (HPZ) pressure 
and length in response to gastric distension and a rise in intragastric 
pressure (116; 117). It appears to be useful in patients with early disease and 
abnormal LOS features, and also in patients with early disease but 
mechanically normal sphincters. Due to the maintenance of the HPZ length, 
the fundoplication procedure reduces the amount of post-prandial TLOSRs 
(118; 119). The degree of gastric distension is clearly an important factor in 
sphincter function. The length of sphincter improves the mucosal seal by 
decreasing the importance of gastric wall tension. Less compelling evidence 
of TLOSR triggering suggests that stretch receptors of the cardia are more 
important than tension receptors (120).
It has been shown that TLOSRs are responsible for most reflux 
events. HPZ parameters have been measured before and after the 
fundoplication procedure. As stated, surgical procedures involving a ‘wrap’ 
around the proximal stomach and LOS region can improve the anti-reflux 
barrier of the LOS by improving the maintenance of HPZ length In response 
to gastric distension. In the early stages of disease, the lower portion of the 
sphincter is inclined to be lost at lower gastric distension pressures, but with 
maintenance of resting LOS pressure. At the more severe end of the disease 
spectrum, both sphincter length and resting LOS pressure are reduced
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permanently. Complete fundoplication impairs the ability to belch, also 
reducing the number of common cavity events. With this comes moderate 
discomfort and the potential limitations of the therapy (113). Although resting 
LOS pressure is not always effected by fundoplication, a significant increase 
in nadir pressure during swallow-induced relaxation occurs (121).
Gastric distension itself is a potent stimulus for triggering TLOSRs. 
Gastric accommodation allows for an increase in intragastric volume as 
previously described. There comes a point when the forces exerted on the 
proximal stomach are such that stimulation of receptors here are sufficient to 
trigger a TLOSR. In the presence of a hiatus hernia the anatomy suggests 
that these receptors may be under different stresses than when a meal is in 
the main body of the stomach. In another study, Dodds et al showed 
TLOSRs to be the main cause (94%) of physiological reflux in healthy 
volunteers, compared to reflux patients (65%) (122). In reflux patients, rises 
in intra-abdominal pressure and spontaneous free reflux due to sphincter 
incompetence constitute the other causes, with approximately equal 
frequencies.
Kahrilas et al showed that a 4mmHg rise in IGP was needed to trigger 
a TLOSR (123). A shortening of the distal end (abdominal portion) of the LOS 
was also seen. A static, non-anchored, multi-lumen manometry catheter was 
used to assess this. These findings are consistent with the IGP surpassing 
the pressure of the lower end of the LOS. Using an inflatable bag, Holloway 
et al had previously shown that the rise in fundal pressure required to trigger 
a TLOSR was in the region of 2-6mmHg (124). LOS topography has shown 
that the distal region of the LOS distended by a rise in IGP has an intrinsic 
tone of approximately 3mmHg (125). This is the ‘tail’ region of LOS pressure,
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which is seen on both slow-motorised and vector volume pull-throughs. 
Overcoming this closure pressure appears to be a key step in initiating the 
cascade for TLOSRs to occur. Compliance in the fasting state and also 
relaxation of the proximal stomach shortly after a meal are not altered in 
reflux disease (126). Gastric tone reduces in both healthy subjects and 
GORD patients following a meal. It takes almost 90 minutes for a healthy 
subjects’ gastric tone to return, whereas tone often remains significantly 
impaired in GORD patients (127). Penagini et al showed that GORD patients 
have a larger proximal gastric volume post-prandially. This reflects delayed 
recovery of proximal gastric tone, highlighting a potential caused for 
increased TLOSR frequency (126).
A ‘program generator’ area in the brainstem is thought to play a role in 
controlling TLOSRs. This area contains GABAergic neurones which act in an 
inhibitory fashion. Baclofen at a dose of 40mgs, which is a GABA agonist, 
causes a rise in resting LOS pressure and a reduction in both post-meal 
TLOSRs and reflux events, in healthy volunteers. However, degrees of 
oesophageal acid exposure and clearance conflict in different studies. (128- 
130). Similar effects in GORD patients, in bedside studies have been seen, 
with no clear indication for the role of GABA-B agonists in GORD (131).
Richter described TLOSRs as a vagally mediated reflex, in which 
gastric distension plays an obvious role (132). TLOSRs have been abolished 
in dogs following vagal blockade (133). Atropine reduces LOS tone and 
inhibits TLOSRs in healthy volunteers (134). In canines, atropine at high 
doses (381+0.13pg/kg) can abolish all components of the anti-reflux barrier 
and at lower doses can reliably produce gastro-oesophageal reflux (135).
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Various set-ups have been used to trigger TLOSRs. Kahrilas' group 
used a continuous air infusion just distal to the GOJ as their stimulus. In their 
hiatus hernia patients, this may have been above the diaphragm. Air-trapping 
within the hiatal sac was excluded as no pressure gradient was seen 
between this area and the gastric body. A greater frequency of TLOSRs was 
seen in hiatus hernia patients and particularly those with a shorter LOS (123). 
With the absence of the gastric sling fibres at the lower end of the LOS, it is 
almost in a state of partial distension, even in the fasting state. Thus, for each 
unit increase in IGP seen, there was a greater effect on the LOS. The 
increased frequency of TLOSRs was proportional to the hernia size, with no 
altered IGP threshold (136).
Due to their neurally mediated mechanism, and as previously 
described, TLOSRs can be interfered with by pharmacological means. A 
pharmacological reduction in TLOSRs, such as that caused by morphine, has 
been shown to cause a reduction in the frequency of gastro-oesophageal 
reflux events in both healthy volunteers and GORD patients (134; 137-139). 
The vagal triggering of TLOSRs is a reflex mediated via the brainstem. 
Cooling of the vagus nerve abolishes TLOSRs in canines as does vagal 
transection (136). The compound LNMA inhibits NO synthesis by blocking 
nitric oxide synthase and has been found to inhibit gastric distension and 
post-prandial increases in TLOSRs. This implies that neuronal NO controls 
gastric relaxation and is involved in TLOSRs. No obvious effect of this 
compound on resting LOS tone has been observed (140; 141).
Loxiglumide is a CCK-A receptor antagonist. CCK acts on CGK-A 
receptors in the proximal stomach to decrease TLOSRs induced by gastric 
distension. At a dose of 10mg/kg/hr, loxiglumide significantly reduces the
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number of TLOSRs and common cavity events in healthy volunteers, without 
interfering with swallow-induced LOS relaxation (137). This is true for both 
gastric distension with air and also following an ingested meal or duodenal 
meal infusion (142). CCK triggers TLOSRs via CCK-A receptors in canines, 
as does endogenous production of NO (143).
Intraduodenal fat appears to cause a reduction in LOS pressure in 
healthy subjects but not those with GORD. It suggests that the reduction is 
equivalent to the inherent tone already lost by GORD patients. It also causes 
more acidic reflux events during TLOSRs in GORD patients, with no change 
in TLOSR frequency (144). Although commonly associated with reflux 
disease, the majority of studies have shown that meals with a higher fat 
content do not increase oesophageal acid exposure in healthy volunteers or 
the already altered pattern in GORD subjects, compared to a balanced fat 
meal (24%) (146). One study showed an increased oesophageal acid 
exposure after a high fat meal, but only in the supine position (146). Once 
again, TLOSR frequency was not influenced by a high fat load (147).
Some endoscopic procedures for GORD have failed to deliver 
improvements over existing treatments. The ‘Stretta’ procedure improved 
GORD symptoms and quality of life scores, but did not decrease 
oesophageal acid exposure or medication use at 6 months. The Stretta 
procedure involves exposing the GOJ to radio-frequency energy in an 
attempt to either scar the GOJ tissues and/or cause damage to those nerves 
which trigger pathways involved in TLOSRs and reflux events (148; 149).
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1.12 Cardia compliance:
There is good evidence that dilatation of the cardia, whether it be by 
gastric distension or by pharmacological means, predisposes to disruption of 
integrity of the LOS and consequences of GORD (150). An endoscopic, 
laser-induced scar, through to the muscularis propria, placed 
circumferentially around the cardia has been shown to increase the yield 
pressure of the LOS in response to increased IGP (151), probably due to a 
‘stiffening' effect on the cardia region.
Reduction in compliance of the gastric cardia is part of the theory 
behind the success of endoscopic full-thickness plication. Acid reflux is 
reduced by decreasing the frequency of TLOSRs, but also by reforming the 
valve-like system at the GOJ (152). It is not surprising that the compliance of 
the LOS is different in healthy subjects compared to hiatus hernia patients. 
However, functional behaviour of the GOJ also differs in those GORD 
patients without a hiatus hernia. Distension of the LOS region and specifically 
the cardia is more likely to trigger TLOSRs at much lower pressure rises 
(153).
1.13 Physiology & pharmacology:
High doses of the calcium channel antagonist diltiazem, when given 
intravenously, do not affect the contractility of the healthy human oesophagus 
in vivo (154), although sublingual nifedipine does in spastic oesophageal 
conditions (155).
Cisapride was routinely used as an upper gastrointestinal pro-kinetic, 
until cardiac interaction caused its withdrawal from mainstream clinical
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practice. Its mechanism of action is not completely clear. It has 5HT4 receptor 
specificity which could potentially stimulate acetylcholine release from post­
ganglionic neurones in the myenteric plexus (156). At therapeutic doses in 
GORD patients, no obvious effects on peristaltic amplitude, duration of 
contraction, propagation speed or oesophageal acid clearance were seen. 
Resting LOS tone and post-prandial TLOSR frequency were unaltered in 
response to gaseous gastric distension. With the effect of gastric emptying 
on GORD being unclear, this study showed that cisapride's perceived 
benefits did not appear to alter any of the key components associated with 
the dysmotility of GORD (157).
Ambulatory oesophageal pH recordings in GORD patients, post­
baclofen 40mg po, showed it to cause a reduction in oesophageal acid 
exposure in the 4 hours after dosing only, and a reduction in belching, 
presumably linked to TLOSR suppression (139; 158).
1.14 Nitrate:
The physiological effects of dietary nitrate on the upper Gl tract are 
still not clear and demand further work (159). Nitrate ingestion has previously 
been implicated in carcinogenesis (160; 161). Nitrate consumed from the diet 
undergoes an entero-salivary circulation. Over 98% is absorbed in the 
stomach and proximal small bowel. It is then actively transported to the 
salivary glands to achieve higher concentrations (mean 252 pmol/l, range 32- 
600juimol/l) than that found in the blood stream (mean 95 p.mol/1, range 32- 
152 pmol/l) (162). Nitrate is secreted into the mouth where it is converted to 
nitrite by bacteria on the dorsum of the tongue and the buccal mucosa. This
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step is accomplished by the bacterial enzyme, nitrate reductase (163). 
Salivary nitrite is then swallowed, passing down the oesophagus by 
peristalsis, reaching the LOS and cardia region. The pH within the upper Gl 
tract varies with its location. The pH is often between 6.4-8.0 in the mouth 
depending on salivary flow-rate, ingested food and mouth sterility (164). 
Within the lumen of the oesophagus the pH is neutral (6 .5-7.0). However, in a 
healthy acid secreting stomach, the pH is approximately 1.0-1.5 in the fasted 
state. In the absence of luminal anti-oxidants the salivary nitrite will 
immediately be converted to nitrous acid, of which 1% will exist as dissolved 
NO (165). In the presence of luminal anti-oxidants such as ascorbic acid, 
which is secreted by the mucosa of a healthy stomach and also abundant in 
foodstuffs, the nitrite will be immediately converted to NO in a 1 to 1 molar 
ratio. Thiocyanate is secreted into saliva and is swallowed along with the 
nitrite. It then catalyses its conversion to NO within the stomach (166).
Ingestion of 2 millimoles of nitrate causes salivary nitrite levels to rise 
to millimolar concentrations and when this is swallowed it causes the level of 
gastric ascorbic acid to decrease, due to its oxidation (167). Work by 
Casselbrant's group in 2002 reconfirmed that luminal oesophageal NO 
required saliva rich in nitrite. This accounts for 95% of the production. The 
other 5% is formed by L-arginine metabolism in the epithelium of the 
oesophageal mucosa (168). The NO concentration has also been shown to 
increase in the oesophageal lumen during reflux events (166), but under 
normal conditions, its generation is maximal at the SCJ (162).
N-nltroso compounds are formed in the proximal stomach when the 
nitrous acid, in the absence of anti-oxidants, react with secondary amines 
present in food. These are potentially carcinogenic due to their ability to
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alkylate DNA. Thiol compounds present in food can also react with the 
nitrous acid to form nitrosothiols which behave as long-acting NO donors. 
Therefore, depending on the availability of ascorbic acid in gastric juice at the 
proximal stomach, various physiologically active compounds may exist. For 
some time now, colonisation of the achlorhydric stomach by denitrifying 
bacteria has been considered as a major precursor for gastric carcinogenesis 
(169). The bacteria can potentially produce nitroso-compounds from 
swallowed nitrite (170). The incidence of atrophic gastritis in the Western 
world is decreasing and with it gastric cancer.
The duration taken for ingested nitrate to appear as oral nitrite is 
approximately 25 to 30 minutes, with a peak at 1 to 2 hours. Some work was 
performed to look at the effects of several proprietary mouthwashes and anti­
plaque toothpastes on the reduction of oral nitrate. Using a chlorhexldine 
containing mouthwash (0.2%) reduced the mean percentage of salivary 
nitrite from 16.1 ±  6.2% to 0.9 ±  0.8%. There was no effect from 0.03% 
triclosan or amyloglucosidase mouthwashes. 0.3% triclosan/0.75% zinc 
citrate ‘anti-plaque’ toothpaste also failed to have any impact. The use of 
chewing gum caused a rise in the pH of the oral cavity from 6.8 to 7.3, 
associated with a significant rise in the conversion of nitrate from 12.2 ±  10.7 
mg/l to 31.7 + 21.3 mg/l. This is most probably due to the pH being closer to 
optimal pH of 8 for the nitrate reductase enzyme. Previously thought to play 
only an anti-bacteria! role (171), luminal NO has since been shown to 
modulate mucosal functions such as gastrin release (172). It is plausible that 
local luminal NO in the LOS may affect afferent receptors and by the reflex 
arcs described, in turn modulate LOS function.
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1.15 Nitric oxide:
Endogenous NO release was discovered to be the ‘endothelium 
derived relaxing factor’ responsible for vascular smooth muscle relaxation 
(173; 174). Binding of NO to soluble guanylate cyclase in the cytoplasm of the 
smooth muscle cell, increases its activity. Conversion of guanilyl tri­
phosphate (GTP) to cyclic-guanilyl mono-phosphate (cGMP) alters Ca^^- 
Calmodulin binding affinity, to reduce tone (175) -  see Figure 1.2.
Cyclic GMP is metabolised to the inactive form GMP by 
phosphodiesterase V. Sildenafil is a phosphodiesterase subtype V inhibitor 
thereby enhancing the end action of NO (176; 177). Sildenafil causes a 
significant reduction in human LOS tone in vivo, with the potential to abolish 
lower oesophageal peristaltic contractions. At a moderate level of action, 
sildenafil impairs oesophageal acid clearance in the supine position. Only if 
the effect is very severe does impaired oesophageal motility impact on 
oesophageal acid clearance in the upright position, with a healthy human 
oesophagus (178). Sildenafil is also effective in treating patients with 
hypertensive oesophageal or LOS conditions (179), but side effects are 
limiting.
Thirty minutes of acid exposure into the human oesophagus causes 
an increase in luminal NO production, which is more marked in GORD 
subjects (168). It does not appear attributable to increased iNOS activity 
(180). The raised levels of NO occur even without the presence of swallowed 
saliva (168; 180). Endogenous NO influences pyloric tone (181) and also 
increases gastric mucosal blood flow in response to gastric acid secretion 
(182). Non-adrenergic non-cholinergic nerves release NO in response to
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increases in gastric pressure, in the guinea pig, this is by 2 distinct neuronal 
pathways. One is a local reflex arc causing NO release, and the other is a 
ganglion nicotinic controlled mechanism (183). NO donors, such as glyceryl 
trinitrate (GTN) have been shown to reduce pyloric pressure waves, wave 
amplitude and frequency in humans (184). Sublingual GTN has also been 
shown to reduce gastric emptying of a liquid meal in healthy humans (185).
In the dog antrum CCK-B receptors initiate contraction, whereas they 
initiate NO release and relaxation in the intestine. This study reaffirmed that 
in targeting a particular receptor pharmacologically, it will not always have a 
simple physiological effect (186). In contradiction with standard effects, one 
group has shown a mild excitatory component of NO in the feline 
oesophageal body (187). This illustrates the need to appreciate that each 
animal model varies, even when considering well-known neurotransmitters 
with recognised mechanisms of action. The site of NO production varies, 
depending on the activity of the generating enzyme. In porcine small bowel 
iNOS is present in the epithelium, with the endothelial and neuronal subtypes 
located in deeper layers of the jejunal wall (188).
1.16 Other potential mechanisms of nitric oxide other than 
cyclic GMP & soluble guanylate cyclase:
The NO molecule is a free radical. In biology the principal reactants 
are transition metals, in particular iron (189). NO has been shown to bind to 
the iron binding site of haem in a reversible manner (190). NO controls 
intracellular oxygen consumption by inhibiting cytochrome c oxidase, which is 
an electron acceptor in the mitochondrial electron transport chain. At high
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concentrations NO binds to the ferrous ion at the binding site in a reversible 
fashion, and to oxidised iron at lower concentrations. The O2 binding site 
contains both iron and copper.
It is a dynamic system with NO playing an important role in cell 
respiration and perhaps mechanisms of cell survival and death (191). The Og 
tension in vivo in mitochondria is probably in the region of SO-SOpm and 
<10|^m in highly active tissue, or tissue with a poor blood supply (192). Of 
note, for luminal NO to reach these concentrations in cellular mitochondria, 
the diffusion gradient would need to be so high that smooth muscle effects, 
are likely to be inevitable.
Nitric oxide inhibition of cytochrome oxidase may also be involved in 
the cytotoxicity of NO and may cause increased oxygen radical production by 
the mitochondria. This may lead to the generation of peroxynitrite (NO and 
superoxide anion: ()g (O2 minus an electron)), which can damage
mitochondria, and is a potential contributor in a variety of pathologies (193). 
Nanomolar levels of NO inhibit cytochrome oxidase, raising the Km for 
cellular respiration (194). Peroxynitrite, as well as micromolar NO can 
irreversibly inhibit this enzyme, with potentially dramatic effects in tissues 
with low oxygen concentrations (195).
Nitric oxide can come out of solution to form gas. Its activity at this 
point is greatly reduced. Whilst in solution it can react with thiol groups to 
form N-nitrosothiols, which are relatively stable at 37°C. Their haemodynamic 
effects, when delivered intravenously, mimic those of nitroprusside and 
Glyceryl Trinitrate (196). Similar effects have been seen in rat gastric tissue 
(197). Thiols exist in vivo and are ingested in large quantities. Nitrosothiols,
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or thionitrites as they are also known, are synthesised when parent thiols 
react with nitrous add (198).
Two nitrosothiols of biological relevance have been isolated and 
characterised. S-nitroso-N-acetylpenicillamine (SNAP) and S- 
nitrosoglutathione (GSNO). The biological half-life of the latter is 10 hours at 
37°C. These compounds are able to bypass normal mechanisms of NOS 
activity and still deliver a source of NO to tissues (199-201). SNAP and NO 
cause an increase in cGMP activity and have been shown to depress GABAa 
receptor function in retinal cells in vitro (202).
Nitric oxide generated in the body will react with Og and preferentially 
form S-nitrosothiol adducts rather than nitrate (203). This is a process that is 
likely to occur in the region adjacent to the epithelium of the cardia. 
Glutathione concentration in cells is approximately lOmM and in plasma 5- 
25]uM (204). S-nitrosothiol circulates in plasma and its concentration is 
approximately 20nM (205). Plasma ascorbic acid concentrations are 
generally in the range of 40-80pM. Ascorbic acid, in the presence of copper, 
at concentrations >0.1 mM causes dissociation of NO from S-nitrosothiols 
(206).
1.17 Research aims:
The aim of this series of experiments is to assess the potential effects 
of luminal nitric oxide in the upper g astro-intestinal tract, by modelling the 
acidification process of luminal salivary nitrite, generated from ingested 
nitrate, in humans. A sensitive system needs to be developed, from the 
currently available equipment, in order to collect useful data that may
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enhance our ability to ascertain physiological effects that may occur in both 
healthy subjects and those with upper gastro-intestinal disease.
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Figure 1.1: Histological appearance of the mucosa at the human gastro- 
oesophageal junction.
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Figure 1.2: Neuronal nitric oxide generation is normally formed intracellularly 
(A), and can then diffuse across cell membranes and into neighbouring cells 
to activate soluble guanylate cyclase (B).
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Figure 1.3: Reaction occurring in the generation of nitrosothiols.
HNO2 + H NO^ + H20
RSH (Thiol) + NO' RSNO (S-nitrosothiol) +
[Hogg N Free radical Biology & Medicine 2000;28( 10); 1478-1486]
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A novel system for delivering nitric oxide to the 
lumen of the proximal stomach, adjacent to the 
cardiac mucosa, with concurrent pressure analysis.
Chapter 2
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Chapter aims:
This chapter describes the design process and testing of the 
manometry catheters and perfusion set-up that would be used for both our 
fasting and post-meal protocols. We would be using a unique NO generating 
solution perfused through the manometry catheter. The justification for this 
solution and laboratory assessment of the NO dose generated for each study 
is described. Evidence of a biological effect of the NO solution on human skin 
is shown.
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2.1 Abstract:
2.1.1 Background:
The incidence of cancers at the GOJ and lower oesophagus is 
increasing (207). Recent work has shown that NO is generated at high 
concentrations in the lumen of the upper gastro-intestinal tract, and that this 
is maximal at the interface of the GOJ (162). Nitric oxide from this source is 
derived from dietary nitrates and not the L-arginine route of neuronal 
generation (208). Neuronal NO is key in the relaxation process of the LOS 
(196). An important issue to explore Is whether NO generated within the 
lumen can affect LOS pressure and hence predispose to acid reflux, which is 
a major risk factor for cancers at this site (209).
2.1.2 Aim:
To design systems that can record manometry of the oesophageal 
body and LOS, whilst delivering test solutions to the lumen of the cardia 
region. This would need to be viable in both a fasting and post-prandial state.
2.1.3 Method:
A standard water perfused manometry system was adapted to record 
pressure and also deliver a test solution. These systems were validated 
against standard clinical apparatus. Selected manometry channels, normally 
perfused with water, were perfused with a NO generating solution from a 
syringe driver. Profiles of NO concentration were assessed using various in 
vivo and in vitro techniques.
61
2.1.4 Results:
We have designed separate systems that accurately deliver a known 
volume and concentration of NO solution to the luminal surface of the gastric 
cardia. It is still possible to record pressure accurately and detect LOS 
relaxation. This chapter describes system testing with validation of results.
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2.2 Introduction:
Oesophageal manometry has long been used as a tool for 
investigating patients with difficult reflux disease and oesophageal 
symptoms. Several studies have looked at individual dietary components to 
assess their effects on LOS parameters, such as maximal pressure and total 
sphincter length (57;59). Motility studies of the upper Gl tract are commonly 
undertaken in both the diagnostic and research settings. In order to 
investigate the oesophageal body and the ‘sphincters’ at both its proximal 
and distal ends, the two choices available to the clinician are to use either a 
solid-state catheter or a water-perfused manometry system for the recording 
and analysis of pressure.
Sterilisation procedures for both types of catheters are similar and the 
initial cost of a water perfusion hydraulic pump system may be offset by the 
high costs of a solid-state catheter. In clinical practice, protocols with 
standardly available catheters are used widely for both symptom 
investigation and pre-operative assessment. When used as a research tool, 
standard manometry catheters can be used, but individual designs can be 
accommodated by most manufacturers, in order to address a specific 
question.
Working in a Research Unit with a focus on the luminal generation of 
NO at the GOJ, we were keen to explore its effects on both motility and acid 
reflux. About 25% of nitrates ingested in the diet are absorbed from the small 
bowel and subsequently taken up and concentrated in the salivary glands 
(210). When secreted into the mouth, buccal bacteria converts approximately 
25% of the nitrate into nitrite (211) (Figure 2.1). This nitrite is swallowed and
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when it encounters gastric acid in the presence of ascorbic acid, which is 
actively secreted by the stomach, it could theoretically be entirely converted 
to NO in a 1:1 molar ratio (162;212) (Figure 2.2).
One particular study has looked at the effects of dietary nitrates on 
oesophageal motor function. Bove et al supplemented patients with oral 
nitrates (159), but found no significant effect on LOS function in healthy 
volunteers or GORD patients. In their study they measured salivary nitrate 
when fasted for manometric assessment. Their healthy volunteer’s values 
(mean 7.1pmol/l + SD 8.4pmol/l) are lower than we have recorded in the 
laboratory (mean 252 pmol/l, range 32-600 jumol/i). Certainly the issue of 
patient compliance in taking nitrate supplementation was raised. The entero- 
salivary circulation of ingested nitrates takes approximately 30 minutes and 
tails off thereafter. Therefore, it can be assumed that the levels measured at 
the time of the manometry study are not those maximally achieved.
They also found no difference in the LOS pressure, but the absolute 
pressure values did appear to be rather on the low side, especially for 
healthy volunteers and even for patients without a hiatus hernia or Barrett’s 
oesophagus (15). There was also no measure of the LOS pressure after 
distension and whether this varied between the healthy volunteers and the 
GORD subclasses. One observation made of the 24 hour intragastric pH 
recordings was that the total time that intra-gastric pH was below 3 was less 
in the GORD group than the healthy volunteers. Although not reaching 
statistical significance, compliance of abstinence from anti-secretory 
medication must also be brought into question. These reflections alone
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highlight the difficulties experienced in trying to detect what is expected to be 
a subtle physiological change.
We were keen to measure LOS parameters in the presence of high 
concentrations of NO. We have measured luminal NO in the upper Gl tract in 
the region of 60 micromoles per litre. We felt that these concentrations could 
actually be surpassed as these levels measured were at the upper limit of our 
customized probe’s sensitivity (162). We decided to see if much higher 
concentrations of NO would show a difference on sphincter function, primarily 
pressure, and initially in the fasting state. The challenge was to measure the 
pressure profile of the LOS whilst delivering controlled amounts of NO to the 
mucosa. In order to achieve this we decided to design a delivery system of 
known NO concentration rather than rely on unreliable and variable salivary 
values.
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2.3 Fasting study:
2.3.1 System design and method:
A standard 8-lumen water-perfused manometry catheter commonly 
used for fasting oesophageal analysis has 4 radial channels at the same 
level orientated at 90° to each other. The remaining 4 channels are placed at 
5cm increments proximaily, in a helical arrangement, up to 20cm proximal 
from the 4 ‘LOS’ channels. Each lumen is perfused individually, by a column 
of water, from a ‘common’ manometry chamber. The water in this chamber is 
under constant pressure from compressed air and the water is pumped 
through capillary tubing before passing through 8 pressure transducers. 
These then connect onto the 8 ports of the manometry catheter. Pressure 
registered to the transducers is relayed to a Personal Computer and 
processed by a software package; in our case. Polygram N e f^  (Medtronic, 
Denmark). This relay of information occurs by the back pressure of the 
column of water pressing on a sensing chip which sits in a hollow covered by 
a sealant gel. Back pressure implies that the hole is occluded and therefore 
in contact with the mucosa. At the GOJ, using these flowing columns of fluid 
as a vehicle, this would give a system for NO delivery that would have direct 
mucosal contact, similar to that under normal physiological conditions.
Our delivery solution would, therefore, have to mimic the physiological 
components present in the upper Gl tract. These include salivary nitrite in the 
form of Sodium Nitrite salt (Sigma, UK) at a concentration of 1.6mM. Basal 
salivary nitrite levels are variable (mean 36]Limoi/l: range 19-153p.mol/l), but 
after a standard 2 millimole nitrate meal they can rise substantially (mean 
252jLtmol/l: range 32-600pmol/l) (162). Taking into account the flow rate of
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saliva, and therefore the total amount of nitrite delivered, we are dealing with 
equivalent post-prandial levels in our protocol. Thiocyanate, a normal 
component of saliva, which aids catalysis of the reaction, also present as the 
sodium salt (Sigma, UK), 1mM, is within the normal physiological range. 
Ascorbic Acid (Sigma, UK) would be in solution at 5mM, which is higher than 
occurring naturally, but in total will equate to 250 pmoles. Within the enclosed 
syringe, it is present in excess, (SOpmoles in the syringe), compared to the 
nitrite and therefore will encourage the reaction as described. This will be 
described in more detail, for the fasting study, in 2.6.1.
Finally, as this is a pH dependent reaction, hydrochloric acid at a pH of 
1.8 was added, to mimic the environment of a healthy acid-secreting 
stomach. A summary of the solution contents can be seen in Table 2.1. The 
delivery of this solution raised two main issues. Firstly, where in the upper Gl 
tract we Intended to run this solution, and also, how many of the 8 standard 
manometry channels we wished it to pass through? If we had wanted to use 
our solution through all 8 of the available channels then simply placing our 
solution, as described above, into the manometry pressure chamber would 
have been an option. However, the hydraulic water chamber supplied with 
our Mui Scientific system (Model PIP-4-8, Mui Scientific, Canada) is 
equipped with brass fittings, which would corrode in the presence of 
hydrochloric acid at our intended pH. This would also deliver NO along the 
length of both the catheter and the oesophagus.
The chemistry of swallowed salivary nitrite is a pH-dependent reaction 
and its conversion to NO occurs as soon as it meets the acid environment of 
the stomach. To mimic the physiological state as close as possible, and aid
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catheter placement, it benefits us to know where this pH gradient occurs. 
Fletcher et al (23) placed radiolucent clips endoscopically at the SCJ and 
performed slow pH pull-throughs with antimony crystal pH catheters. This 
showed that, in the fasting state, the pH step-up point from the acidity of the 
gastric cavity to the neutrality of the oesophageal lumen occurs just distal to 
the SCJ. With the aid of manometry studies Csendes et a! also showed that 
in a healthy population the SCJ is positioned almost centrally within the high 
pressure zone of the LOS (15). This implies that the nitrite chemistry takes 
place adjacent to the mucosa in the lower portion of the LOS, an area 
referred to as the gastric cardia.
This is the area on which we concentrated. We decided to limit the 
delivery of NO to the four distal radial channels. These could be located in 
the gastric portion of the LOS (ie cardia), and left for a period of infusion - 
Figure 2.3. Positioning of the catheter was achieved by performing a pH pull- 
through and then relocating the manometry catheter to the pH step-up level. 
The problem then arises with how to supply the NO to these channels and 
still measure pressures from the transducers.
2.3.2 Alternative designs and flaws:
The initial setup to split the inflow from the syringe driver to the 4 
transducers gave variable and erratic pressure recordings. The syringe 
supply was divided into 4 using a ‘traffic light’ junction. Each of the 4 outflows 
came off in turn to feed their respective transducer. The reason for the 
variable flow became clear when blue food dye was added to the syringe’s 
solution. This revealed a preferential and greater flow-rate through the first 
outlet, with increasingly reduced flow through the subsequent 3 channels,
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manifested by a more dilute colour - Figure 2.4. Splitting a common inflow 
supply, in the form of the syringe, was perceived as the correct way forward, 
and a further variation of this theme was devised.
We decided that the ‘oesophageal’ channels would be supplied from 
the standard water chamber and the water flow to the other four channels 
switched off using the array of stopcocks on the compressor unit. An external 
syringe driver (Perfusor^, B.Braun Medical Ltd, UK) was used to deliver 
standard perfusing water and also a NO generating solution to the remaining 
4 channels. It’s occlusion alarm pressure was 300-600mmHg. This syringe 
driver used pump-specific 50ml syringes (Original-Perfusor-Spritze OPS 
50ml) with a leur lock connection, and a variable flow-rate of 0.1 -  99.9 
mIs/hr. A four-way dividing loom was designed to supply each of the 4 LOS 
transducers directly to their lower poles - Figure 2.5. A short section of tubing 
(Female-Female Luer, R809, Avon Medicals, UK) took the outflow from the 
syringe driver via a three-way stopcock (876.00, Vygon, UK). A Y-connector 
(884.04, Vygon, UK) divided this flow equally, each arm of which then joined 
a further R809 section.
Each of these two sides would supply two of the pressure transducers. 
A further Y-connector (884.04) on each side lead to a lectro-cath (1155.01, 
Vygon, UK), totalling four in all. Each lectro-cath, by means of a male luer 
connection, was then secured onto the inferior pole (inflow) of a pressure 
transducer. The individual components of this assembly were secured 
together using an epoxy resin based adhesive (Araldite Rapid*^, Bostik). The 
50ml syringe of the syringe driver was connected to the 3-way stopcock with 
a 100cm luer-lock Lectro-Cath (1155.10, Vygon, UK).
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2.3.3 Design performance:
It was important that we could rely upon this system to accurately 
record pressure changes at the LOS. Rigorous testing took place, initially to 
see how these 4 channels compared to standardly perfused channels, when 
they were being calibrated prior to a study. For water perfused manometry 
systems, a two-point calibration is usually performed. Low and High values, 0 
and +680mm apart vertically, are used which is equivalent to a pressure 
difference of 50mmHg. The 4 radial channels were tested on the bench top in 
2 ways. Firstly, pressure differences were measured with these channels 
sitting in a measuring cylinder and water added to increase the pressure in 
5mmHg increments, up to 25mmHg. Secondly, the catheter was placed in 
the same measuring cylinder and a similar column of water added in a rapid 
fashion, to look at the response time to pressure changes. Regular pressure 
transducers are perfused by water passing through capillary tubing. This is 
accepted as the gold-standard for pressure measurement with water 
perfused manometry. For both the 5mmHg-equivalent increments and the 
fast-fill procedure there was less than +2% difference between the two 
manometry methods. With this knowledge we progressed onto in vivo 
studies.
Our study would involve periods where the catheter was static and 
also periods when we were required to move it in a controlled fashion. 
Moving the catheter recording channels proximaily from the stomach to the 
oesophagus is important to collect data on the LOS characteristics. 
Specifically data related to the pressure, length, and especially these factors 
relative to the position within the sphincter. In most out-patient set-ups, the 
station pull-through technique is used to accomplish this. This involves the
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manometry recording channels starting in the stomach and being withdrawn 
proximaily a designated distance (0.5 to 1cm) from the patient's nostril every 
30 to 60 seconds. A marker is routinely added to the computer software and 
data can be interpreted for these set places. This technique serves well for 
clinical practice, but when assessing pressure changes on a trace, there is 
the possibility that a higher pressure may have occurred between the two 
data markers. Also, the proximal or distal end of the sphincter may not have 
been picked up accurately. If using 1cm data collections the sphincter border 
measurement could be inaccurate by up to 9mm. It is possible that this could 
occur at both ends of the LOS and the errors could then be compounded into 
the calculation of sphincter length.
This system may work in clinical practice, by picking up very short 
sphincters or those which are profoundly hypo- or hypertonic. However, in a 
study which may be addressing very small changes in the sphincter 
parameters, a more technical approach is required. This is where a 
motorised catheter puller is essential. These are computer controlled 
devices that withdraw the catheter from the nostril, at a pre-set velocity, 
between two points. Whilst the catheter moves, the software is able to 
constantly record the data and therefore build up a profile of data over the 
whole sphincter length. During this pull-through period the patient is 
requested to breath with a pattern of normal respiration, which causes 
oscillation of the pressure tracing. Analysis of the trace can pick-out either 
end of the sphincter, to the nearest millimetre, and also the location of the 
respiratory inversion point (RIP). The lower border of the sphincter is picked 
out as the breath in which the end expiratory pressure remains above that of 
gastric baseline pressure. The upper border of the sphincter is marked as
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that breath in which the pressure drops below oesophageal baseline 
pressure in end expiration.
The LOS normally passes through the diaphragmatic hiatus, which 
exerts several effects on the pressure tracing. Firstly, the addition of pressure 
to the HPZ by a pinchcock effect. Secondly, it acts as a barrier between the 
two zones of intra-abdominal and intra-thoracic pressure. The RIP can be 
detected on the tracing, which correlates, with good accuracy, to the hiatus. 
This manifests itself on the pressure recording as the first breath cycle in 
which the pressure deflection decreases in expiration. This RIP mark is used 
to be able to analyse abdominal sphincter length. This calculation is not 
possible in the rapid motorised pull-throughs (>1 cm/sec), which are often 
performed with breath holding, and no reliable production of an RIP.
Manometry pull-throughs, in our studies, were performed using a 
motorised puller (Medtronic, Denmark) at a puller rate of 1 mm/sec over a 
10cm pull distance. There is a slightly slower response to pressure changes 
with the syringe driver set-up, which in itself produces a smoother trace. This 
slower response time makes this system unsuitable for acquiring data looking 
at both large and rapid changes in pressure such as those seen at the upper 
oesophageal sphincter during a swallow. However, at the LOS where the 
pressures are lower, in combination with a slow pull-through speed, which 
also allows for accommodation to changes in pressure, this system produces 
accurate recordings (Figure 2.6). There may be a very small underestimate 
of pressure at the LOS with this system, but it is accepted that this small error 
will be incurred for all analyses over the range of volunteers and patients 
studied. Despite this minor reservation, the values recorded for the maximum
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end expiratory pressure of the LOS’s of our range of healthy volunteers 
match those ranges established in clinical practice.
The nature of capillary tubing makes it very difficult for water to flow 
through it unless under high pressure, such as those created by a hydraulic 
water chamber (approximately 100kPa/15psi). These pressures are not 
attainable by the Braun syringe driver used in our design, restricting us to the 
narrow, one millimetre internal diameter Lectro-caths. Retrograde water flow 
through a pressure transducer fed by capillary tubing would only occur at 
pressure way above those found in the upper Gl tract, because as well as 
countering the perfusion pressure of the pump, the resistance to flow of the 
water in the tubing, due to surface tension, also has to be overcome.
Idiosyncrasies of our design only make it suitable for use in this type of 
study, where the arrangement of the distal four recording channels on the 
manometry catheter are in the stated fashion. As the internal diameter of the 
supply tubing proximal to the pressure transducers in our design was one 
millimetre, there was a possibility that in some situations either retrograde 
flow, or more likely a failure to transmit pressure to the sensor, could take 
place. This was discovered in bench top testing. Despite the similarity in 
High-Low calibration and water column exposure, a ‘single-channel occlusion 
test’ gave differing results between the two systems. The Perfusor syringe 
driver was set at 99.9 mIs/hr, which is equivalent to the sum flow rate of four 
channels when the hydraulic water chamber is at its standard pressure 
setting of 15psi. When the individual water flow from one of the four radial 
channels is completely occluded there is a response relayed to the PC, but 
not as much as would be expected from a standardly perfused transducer. 
For the reasons discussed before, when a single channel is occluded, with
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our design, and there is no obstruction to flow at the other three channels, 
the flow around the loom is preferentially through these three and not against 
the resistance of the occluded site (Figure 2.7). This could lead to an 
inaccurate pressure recording.
The anatomy of the LOS is such that it is often subject to a degree of 
asymmetry with regards to external circular muscle bulk (30). Along with this 
can go a slight asymmetry of the pressure profile along the length of the 
HPZ, in differing directions. However, the location of the highest recordable 
pressure, (which with a slow motorised pull-through (SMPT) is the location of 
the maximum end expiratory pressure (MEEP), is relatively constant for each 
person’s LOS. So, with all four of our data collection channels at the same 
depth during a manometry pull-through there is no risk of the type of pressure 
tracing loss, as initially feared. The only knock-on effect was that there may 
have been a partial equalization of pressure throughout the four channels 
during acquisition. This equilibrium may make the data tracings from each 
quadrant look rather similar compared to a standard set-up. However, we 
calculated our LOS pressure as an average of the four separate MEEPs 
recorded, and with no pressure losses from the HPZ during a pull-through, no 
noticeable effect would be seen on the result.
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2.4.1 Positive control studies:
In order to properly test the recording capabilities of the manometry 
system, it was necessary to undertake a ‘positive’ control study. This meant 
that we needed to perform an in vivo study that would bring about a known 
measurable effect on the features of the LOS. Following a meal, gastric 
distension causes changes to the proximal stomach. Stretch placed on the 
muscular wall by the intragastric meal, as well as the effects of hormone 
release, cause the LOS to shorten. This is similar to the neck of a balloon as 
it is inflated. As well as shortening, there is also a reduction in the pressure of 
the LOS. The combination of these two events renders the subject more 
susceptible to reflux events. With regards to LOS shortening, in healthy 
volunteers, where the LOS spans the diaphragm, the shortening favours the 
LOS on the abdominal side.
2.4.2 Method:
We undertook baseline recordings of the LOS in 3 volunteers under 
fasting conditions. This was performed with the syringe pump perfusing 4 
radial channels, which acquired the data, as previously described. A fasting, 
SMPT was undertaken in a reclined position, during shallow respiration, and 
with a pull speed of 1 mm/sec. Distilled water was flowing through the 
manometry channels at a rate of 0.42 mIs/minute. From this pull-through, 
data regarding the LOS could be assessed, including the total sphincter 
length, location of the RIP, length of the abdominal portion of the LOS and 
also the MEEP relative to the fasting IGP.
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The catheter was then reinserted into the stomach, taped to the nose, 
and the perfusion stopped. The volunteers were sat upright and ate a meal of 
battered fish and chips, with a glass of still water. Five minutes after meal 
consumption the patients were reclined and perfusion of the catheter 
recommenced. The catheter was then withdrawn, using the SMPT technique 
as described before.
2.4.3 Results:
In all 3 volunteers there was a reduction in total sphincter length from 
a mean of 5.0cm (SD 0.13cm) to a mean of 3.9cm (SD 0.26cm) (p<0.006). 
Abdominal sphincter length reduced from a mean of 2.73cm (SD 0.49cm) to 
a mean of 1.74cm (SD 0.66cm) (p<0.085), and the MEEP reduced from a 
mean of 23.2mmHg (SD 6.27mmHg) to a mean of 11.2mmHg (SD 
6.35mmHg) (p<0.056) following the meal.
2.4.4 Conclusions:
The system design is capable of and sensitive enough to detect the 
physiological changes of the LOS which predispose to reflux. It is therefore 
suitable for our fasting study. The issue of NO delivery is discussed later in 
this chapter (2.6.1).
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2.5 Meal study manometry design:
2.5.1 Measurement of transient lower oesophageal sphincter 
relaxations (TLOSRs):
2.5.1a Background:
The reflux of gastric contents into the distal oesophagus is a normal 
physiological phenomenon. Damage and compromise to the squamous 
epithelium is prevented by effective clearance of the refluxate due to 
peristalsis. The acidic pH is also neutralized following the delivery of 
swallowed saliva, and to a lesser degree by bicarbonate secreted from the 
oesophageal epithelium. There are three main methods by which reflux is 
said to occur. Firstly by sphincter failure or incompetence. This often occurs 
in sphincters with lower resting pressures, those of shorter overall sphincter 
length, or those with shorter ‘abdominal’ components to the sphincter (116). 
Failure of the sphincter leads to ‘common cavity’ events between the 
oesophageal and gastric compartments. This mechanism is more commonly 
associated with the reflux events in patients with symptomatic oesophagitis, 
hiatus hernias and Barrett’s oesophagus. However, TLOSRs are the most 
frequent generators of reflux events in both GORD patients and the healthy 
population (122).
When swallowed, synchronized oesophageal peristalsis propels the 
bolus of solid matter, liquid or gas, towards the stomach. Sensory loops allow 
the LOS to anticipate the arrival of the bolus and relax to aid its passage. 
TLOSRs are relaxation events of the LOS not preceded by oesophageal 
peristalsis. They are more common in the post-prandial state and also with 
an erect posture. TLOSRs are likely to serve as a means of venting gas from
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the stomach, which can be associated with acid reflux. If they give rise to a 
reflux event this can subsequently trigger peristalsis to aid acid clearance. A 
pharyngeal sensor to assess the co-ordination of swallowing allows an 
observer to identify these scenarios. The mechanism by which TLOSRs 
occur is not well understood. It is thought that the vagus nerve plays a major 
role in coordinating them (133). It would appear that afferent receptors react 
to mechanical forces in the proximal stomach to initiate TLOSR events (120). 
Some feel that shortening, and loss of the abdominal portion of the sphincter, 
whether by gastric distension or hormonal means, is key (116; 124). There is 
also evidence that TLOSRs last for longer than normal LOS relaxation events 
(213).
The manometry recording channels with our first system, designed to 
examine the LOS in the fasting state, were all located at the same level. For 
the measurement of TLOSRs a different catheter configuration is required. 
We were keen to deliver NO to the same area of mucosa as before, and 
record data concurrently, but with a slightly different setup. A Dent Sleeve 
catheter is often used to measure pressure across the LOS, recording the 
highest pressure along the sphincter at any one time. The pressure recording 
‘zone’ for the LOS is comprised of a covered lumen and the water supplying 
this runs off into the proximal stomach, and has no direct contact with the 
LOS mucosa (Figure 2.8). There are often uncovered oesophageal ports on 
the catheter as well and also a gastric channel which can measure pressure 
in the standard way. With a covered unit sitting within the LOS, there is no 
opportunity for NO delivery as before. A catheter with serially spaced ports 
along its length can be used as an alternative.
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We are intending to record TLOSRs after a meal. We have shown that 
following a meal, the HPZ shortens in length. This would mean that there 
may not be as many recording channels sitting in the LOS as in the fasting 
state. Using a catheter with the 4 distal channels spaced sequentially 1cm 
apart allows for slight axial movement of the catheter, with continual 
measurement of both intragastric and LOS pressures. Test solutions would 
be delivered through the lower 4 channels of the catheter (Figure 2.9), which 
is a different distribution to the previous protocol. Surprisingly, this does fit 
with the physiology of the post-prandial state. It would now be expected that 
our NO delivering ports would be both above and below the SCJ.
We previously mentioned that the NO chemistry is a pH-dependent 
reaction and that what is now suggested for the channel distribution goes 
against this. A study by Fletcher et el revealed that a ‘pocket’ of highly acidic 
unbuffered gastric juice existed in the proximal stomach following a battered 
fish meal. The limits of this showed that the proximal pH step-up point 
occurred on average 1.8cm proximal to the SCJ (23). This is clearly 
important with respect to both the exposure of the squamous mucosa to 
highly acidic and potentially damaging gastric juice, and also to the extent as 
to which parts of the gastro-oesophageal mucosae are exposed to the high 
levels of NO.
2.5.2 Method:
We selected a catheter made of the same polymer as the 2281-R 
model for its NO delivery properties. This was a 2282 model, single use, 
eight channel manometry catheter (Mediplus, UK). It has its most distal port 
at 5cm from the tip. Subsequent port spacings are 1cm, 1cm, 1cm, 2cm,
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5cm, 5cm & 5cm proximal to this. At the lower end, this gives 5 ports within 
5cm. We aimed to position the catheter with the most distal channel in the 
proximal stomach, and this would record gastric baseline pressure. The next 
4 channels should sit within the LOS and record pressure locally. The 
remaining proximal channels would record oesophageal contractions and 
with a pharyngeal swallow sensor in place, both primary and secondary 
oesophageal peristalsis, as well as TLOSRs would be identifiable.
As discussed, there can be problems encountered with the 4-way 
splitting tubing arrangement in Figure 2.5. When any of these four channels 
are not under constant pressure there is a failure of the pressure built up in 
the 4 columns of water to be transferred back to the pressure transducers 
(Figure 2.7). As, in the second protocol, the catheter recording points would 
be spanning from gastric pressure, across the LOS and maybe into the distal 
oesophagus (all at differing pressures), this system had to be changed to 
record TLOSRs. So, each of the 4 channels was supplied individually by a 
separate syringe driver (Figure 2.10). The flow-rate through each channel 
was set to 99.9 mIs/hr for each channel to increase the delivery of NO to the 
LOS and proximal stomach. This is an attempt to mimic increased salivary 
flow and nitrite delivery that occurs at the time of a meal. With each syringe 
containing only 50mls of solution, a change-over period would be needed half 
way through the 1 hour observation period, where each syringe is renewed, 
and a minor drop in NO delivery concentration might occur.
Concentration profiles of NO from the 2282 catheter tip can be seen in 
Figure 2.11. NO concentration from the catheter tip was assessed using the 
Greiss reaction (214). Samples were collected into phosphate buffer solution 
pH 7.4, with the catheter at 37°C in a water bath. A profile of NO delivery and
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total exposure of NO can be calculated. These methods are described further 
in 2.6.1.
2.5.3 Results:
• The calculated concentration of NO at the tip of the 2282 catheter, for 
the meal study, is 1.1 millimoles/litre and reaches this level after 
several minutes of infusion
• The total exposure of NO for the 1 hour period is calculated as being 
400 jumoles, (Average concentration of Nitrite / NO is 1 millimole/litre 
with 400mls of solution delivered). This is comparable to the 125 
pmoles of NO predicted after a KNO3 meal, which could be as high as 
500 nmoles, due to the variability of nitrate reduction caused by the 
buccal bacteria.
2.5.4 Discussion:
This system has been validated as a manometry set-up and also as a 
suitable delivery system for a physiological NO solution. We have observed 
the slightly slower pick-up of pressure with the syringe driver system, and 
these limitations have been discussed. However, this system is very good at 
detecting the drop of pressure being recorded as in a TLOSR, or any other 
sphincter relaxing episode (Figure 2.12). With pH probes attached to the 
manometry catheter, episodes of acid reflux could also be analysed in 
relation to the swallowing, peristalsis and sphincter relaxation events. Our 
delivery of NO is as a smooth curve, whereas in reality it is more likely to be 
bursts of NO exposure, as the boluses of nitrite rich saliva enter the acid
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environment of the stomach. This is merely hypothesis, and whether one way 
is more likely to have an effect than the other, is open for debate.
2.6.1 Nitric oxide delivery -  solution to be used for fasting study:
Proof of biological effect -
In our laboratory, we have forumlated a unique solution that will 
generate soluble nitric oxide in vitro. The constituents of this are described 
below. This solution mimics the luminal chemistry occurring within the lumen 
of the upper GI tract. There is no evidence within the literature that a solution 
of this type has been used in such experiments before. We have previously 
squirted this NO solution on to gastric rugae during routine endoscopy to see 
if there were any obvious relaxation effects. This proved difficult to quantify 
due to the constant slow remodelling of the stomach’s inner surface. We, 
therefore, took this solution and placed it on the skin of the forearm of a 
volunteer, with three other controlled blebs. One of hydrochloric acid, one of 
the NO generating solution minus the nitrite and one of acidified nitrite plus 
thiocyanate, but without ascorbic acid. After less than 30 seconds a change 
could be seen and after two minutes the difference was striking. A well- 
defined red area, limited to the area of NO exposure, can be seen which 
presumably is due to the dilatation of pre-capillary arterioles (Figure 2.13). 
This is thought to be due to the smooth muscle relaxation properties of NO 
and serves as proof of a biological effect. This fuelled our theories that NO 
generated within the lumen of the upper Gl tract may be able to cross the 
epithelium and have some effect on the underlying tissues.
Nitric oxide is a small lipid soluble molecule able to traverse lipid 
membranes in vivo. Although not able to permeate glass it can pass through
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certain plastic and rubber tubings to varying degrees. In our experiments, we 
needed to be sure that the system that had been designed and tested to 
measure pressure, would also be able to deliver NO to the end of the 
manometry catheter in concentrations suitable for our study. As described, 
our delivery system contained several components made from various 
plastics. The total distance from syringe driver to catheter tip measured 
approximately 2 metres. With a low flow-rate the time delay for the solution 
travelling from syringe to catheter tip would also allow any escape of NO to 
be amplified.
NO levels were initially measured using a pre-calibrated bench-top 
probe (ISO-NOP, World Precision Instruments, USA) (215). Samples were 
collected from time zero, and every 5 minutes upto 25 minutes, and then a 
final sample taken at 28 minutes. For comparison, samples were analysed 
from the syringe at zero and 30 minutes to compare and assess and deficit 
over the length of the tubing. As described earlier, the contents of the syringe 
were sodium nitrite 1.6mM, thiocyanate ImM, ascorbic acid 5mM, 
hydrochloric acid pH of 1.6 and EDTA ImM. This solution should generate 
1.6mM NO.
Certainly, when trying to attain higher concentrations of NO by 
increasing the nitrite concentration (e.g. 4mM), and with more ascorbic acid 
present to ensure the reaction is driven, the inside of the plastic syringe was 
completely covered with small bubbles, which over the time of the 30 minute 
infusion had coalesced to form large bubbles throughout the whole loom, 
including the pressure transducers. This made the system unworkable, and it 
was assumed that what was being witnessed was bubbles of NO coming out
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of solution. So, at room temperature and atmospheric pressure, the 
saturation point for NO in distilled water was accepted as 1.6mM.
2.6.2 Method:
A standard manometry catheter from clinical practice was used to 
deliver the NO solution (2281-R, Mediplus, UK). These catheters are made 
from medical grade PVC. In order to mimic physiological conditions, the NO 
probe was calibrated at 37°C and the distal 45cm of the catheter, which 
would be in the patient, were also placed in a water bath at 37°C. This was 
also done with the catheter at room-temperature just to make sure that an 
increase in temperature did not cause a significant loss of NO from the 
system.
Cations in solution can theoretically interfere with NO generation and 
so EDTA was included as a chelator to assess its benefits on NO generation. 
In order to try and reduce all types of NO losses from the system we 
removed the dissolved oxygen from distilled water. This is because the 
oxygen in solution reacts with the NO to form nitrogen dioxide and this is then 
recycled back to nitrite. In this final stage there is a 50% loss of nitrite to form 
nitrate, which is then lost from the ongoing recycling process, and this 
reduces the total nitrite available to produce NO (208). In preparing the 
syringe contents, one litre of distilled water was gassed with zero grade 
Argon (BOG Gases, UK) through a gassing ‘stone’ for 10 minutes to 
accomplish this. This was initially verified by a calibrated oxygen probe (ISO2, 
World Precision Instruments, USA) in the laboratory and used thereafter as 
the standard gassing time. This degassed’ water was used to make up the
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syringe solutions, prime the tubing loom and also to fill the manometry 
reservoir. The hydrochloric acid was gassed individually.
In another assessment, distilled water was pumped through the 4 
proximal ‘oesophageal’ ports on the manometry catheter. This was done to 
investigate two questions. Firstly, did the concentration of NO drop when 
there was water in these other 4 channels and secondly, if so, was there any 
significant quantities of NO in the out-flow from these other channels? We 
know that NO can pass through certain plastics and we considered that this 
may happen within the catheter length as each of the eight individual lumens 
sit in close proximity to each other (Figure 2.14).
Losses of NO gas to the atmosphere were postulated as a cause for 
the lower levels of NO. Therefore, a different sampling method was 
employed. The concentrations of NO at the catheter tip were reassessed 
using the Greiss reaction (214). Sample collection without pipetting reduces 
losses of NO to the atmosphere. Therefore, samples from the catheter tip 
were collected into glass scintillation vials containing known volumes of 
phosphate buffer solution at pH 7.4. The submerged catheter tip was agitated 
to mix the solutions and the amount of NO generating solution added over a 
30 second period. To allow for inaccuracies of the syringe driver flow rate, 
the volume of NO solution added was calculated by a 3 decimal place 
weighing balance. Calculating the change in mass, and knowing the density 
of the NO generating solution, the volume deposited could be calculated. By 
raising the pH of the samples, all NO is captured and stabilized by 
conversion to nitrite. Spot nitrite analysis on each sample was then carried 
out by the Greiss reaction using spectrophotometry (214).
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2.6.3 Results:
• Loss of NO due to dissolved oxygen was apparent even at low 
concentrations of NO formation -  approximately 50%, 6 v 
12|Limoles/litre (Figure 2.15a).
• The addition of EDTA, which removes any small metal cation 
impurities from our salts does increase the NO levels (from 12 to 
16jLimoles/litre) and this is independent of temperature -  increase by 
upto 33% (Figure 2.15b).
• With the bench-top NO probe it can be seen that it takes 
approximately 6-8 minutes for there to be recordable levels of NO at 
the catheter tip, which gradually rises and plateaus at 20-25 minutes, 
with a NO concentration of 350 jumoles/litre, before slowly decreasing 
(Figure 2.15c).
• There is no alteration to the NO concentration associated with a 
change of temperature (Figure 2.15c).
• Analysing the effect of water within the ‘oesophageal’ perfusion 
channels showed that there was no drop-off in the NO levels and that 
there was no recordable NO in the out-flow from the other channels 
(Figure 2.15c).
• Analysis of nitrite concentrations by the Greiss reaction showed that 
the NO concentration at the catheter tip plateaued after 15 minutes of 
the infusion, at a concentration of SOOpmoles/litre (Figure 2.16a). Also, 
the concentration of NO in the syringe at the start of the infusion was
1.4 millimoles/litre and 1.2 millimoles/litre after the 30 minute infusion 
(Figure 2.16b).
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2.6.4 Discussion;
The absence of NO detection within the ‘oesophageal’ ports solution 
was very useful to know, as we did not wish there to be any inadvertent NO 
exposure to the oesophagus. However, if it were to be present there by the 
reflux of the infusion during the experiment then that would need to be taken 
into account when interpreting the data.
It was accepted that there were errors involved in the sampling 
procedure using the bench-top NO probe. Immeasurable, but consistent 
losses of NO to the atmosphere during pipetting occurred. Even when a 
sample was taken from a well-mixed, freshly made syringe, there was a large 
discrepancy compared to the expected concentration of NO. Certainly, a lot 
less than the expected 1.6mM of NO with 100% conversion of nitrite, was 
found. These lower than predicted values of NO were also found in the 
solution pumped through to the catheter tip, and were in fact lower again than 
those found in the syringe. There was a degree of dilution of NO as it passed 
through the loom and mixed with the deoxygenated distilled water in the loom 
and pressure transducers, which measures several millilitres. This would 
account for only a small degree in the drop of the NO level from the syringe 
to that maximally attained at the catheter tip. It was thought that this further 
drop in measured NO was due to losses through the plastic tubing by 
diffusion.
At low, micromolar concentrations of nitrite, the conversion to NO, 
under the correct conditions described, is virtually 100%. The assessment of 
NO generation at the higher levels (millimolar) that we are dealing with has 
not been looked at. We can theoretically extrapolate the reaction to assume 
100% conversion at concentrations above 1 millimole per litre. We mentioned
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that we would expect there to be an underestimate of the NO concentration 
by our first sampling method. We also expect to see higher concentrations of 
NO, in the form of nitrite, in our samples assessed by the Greiss reaction. 
Due to a lack of complete certainty with these second results, it is probably 
safe to assume that the actual NO concentration is somewhere in between 
the two.
Seeing the levels of NO being generated we had to decide if these 
were appropriate for our protocol. The majority of the NO was present 
between 8 and 28 minutes of the infusion. With an average concentration of 
700 j.imol/litre in 33.3 mis of solution delivered, this would give a NO load of 
23 pmoles. You can see how this compares to a predicted 24 hour exposure 
of NO derived from salivary nitrate with both a basal nitrite secretion and after 
a 2 millimole nitrate meal (Figure 2.17).
Of a 2 millimole potassium nitrate meal we would expect, on average, 
approximately 1/16^ *^  to end up as luminal NO ie: 125 micromoles. This 
appears In the lumen about 30 minutes after ingestion and dissipates over 3 
to 4 hours. A 4 hour period contains 12 x 20 minute segments, which would 
average at 10 micromoles per segment, comparable to our exposure. Useful 
to note is that in the fasting state less ascorbic acid is secreted from the 
stomach and so less NO would be produced (216). Our initial look at the LOS 
is in the fasting state and so we are likely to be equating, or slightly 
exceeding, normal NO exposure. The effects of NO on LOS pressure are 
difficult to assess in the post-prandial state due to TLOSRs. Manometry pull- 
throughs can be performed lying down, but this is less physiological, as 
people often have an erect posture immediately after a meal. There certainly
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is a place for investigating aggravating factors of supine reflux, but we were 
not focusing on this with our protocols.
It would be expected that the effect of NO is dependent on total dose 
delivered, flow rate and concentration of the delivered solution. In the fasted 
state, as in the first study set up, the flow rate is relatively slow and 
comparable to a standard water-perfused manometry system. Also, the NO 
delivering solution is In direct contact with the mucosa and its overlying 
mucous layer. Therefore, it should be able to have its maximum effect, 
having the opportunity to diffuse across the epithelial tissues, although we do 
not know the optimum NO concentration / diffusion gradient to cross the 
epithelium, and this would be difficult to measure. As the active solution 
would be delivered as the perfustae through the manomerty channels, it 
would be given as a constant infusion. This varies to normal physiology, 
where swallowed nitrite in saliva would be delivered to the stomach in more 
discrete boluses. This was an accepted limitation of the methodology.
At higher flow rates, the solution would simply run off into the empty 
stomach. There is a question as to what may happen when there is a meal 
present within the stomach. With the knowledge of the ‘acid pocket’ and 
knowing that there is a small potential ‘space’ in the proximal stomach, it is 
postulated that the NO that flows in, either by syringe or generated by 
salivary nitrite after a meal, may collect in this region over time and be able to 
exert its effects accordingly.
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2.7 Summary:
The pathophysiology of GORD is not fully understood, but it is known 
that both anatomical and dietary factors play a role to varying degrees. In the 
presence of a healthy acid secreting stomach, dietary nitrates generate NO in 
the lumen of the upper Gl tract and the concentration is maximal at the 
gastric cardia. The effect of this NO on LOS function is not clear and so we 
have designed systems to analyse this further. Oral supplementation with 
nitrates has been used before to address this question, but salivary nitrite 
levels are often unpredictable.
We believe that it is first necessary to assess the NO effect on a 
fasting LOS before embarking on the more challenging situation following a 
meal. The tubing looms described here give reproducible and reliable 
delivery of a NO generating solution. The pressure recording capabilities of 
the system vary only slightly to those of the low compliance capillary tubing 
arrangement in standard clinical use. It is a system that calibrates equally as 
well and gives good quality tracings suitable for clinical interpretation. These 
features combined, allow for the investigation of our test solutions’ effects.
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Table 2.1: Constituents of the NO generating solution in their final 
concentration.
Constituent Final concentration
Ascorbic acid 5mM
EDTA 1mM
Nitrite 1.6mM
Hydrochloric acid pH 1.8
Thiocyanate ImM
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Figure 2.1: Diagram to show the entero-salivary re-circulation of dietary 
nitrate (NO3 ), its conversion to salivary nitrite (NO2 ) and delivery to the 
stomach. Approximately 25% of dietary nitrate is concentrated into the 
salivary glands and a further 25% is then converted to nitrite. This conversion 
is variable, but on average, 1/16^ of ingested nitrate will end up as oral 
nitrite.
Bacteria /  Salivary Glands
Dietary ^nitrate
\
Ascorbic 
A c id i\^
Nitrate
X
^  Nitrate
25%
XEndogenous NO
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Figure 2.2: Demonstration of the nitrite chemistry that occurs in the acid 
environment of the stomach -  Acid catalysed nitrosation.
Saliva Nitritei
HNOo + no"
Acidic Gastric 
Juice SCN Ascorbic
R « NOSCN I
. DHAA
N-Nitrosocompounds Nitric Oxide
In acidic gastric juice nitrosation maximal:
- at pH2.5
- in presence of nitrite
-in presence ofThiocyante (SCN) in saliva
- in absence of Ascorbic Acid
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Figure 2.3: Location of the four radial manometry channels in the LOS.
Mediplus Catheter. 2281R
Oesophagus
Oesophageal port 
-10cm
High
Pressure
Zone
Gastric
Fundus
Oesophageal port 
-5cm
Four Radial Channels in 
LOS positioned at SCJ 
Placement at 0cm
Figure 2.4: Diagram to show how the Traffic lights’ system causes 
preferential flow through some fluid channels, with subsequent inaccurate 
pressure recording. Fluid flows in at port 1, with the majority of this solution 
exiting via channel 2. Decreasing amounts exit via channels 3 to 5.
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Figure 2.5: Arrangement of the tubing delivery system to the 4 LOS 
transducers with the Mediplus 2281R manometry catheter.
To the 4 manometry transducers
Male ports distallyLectro-Caths, 
1155.01 
(Vygon, UK)
'Y' connectors, 
884.04, (Vygon, UK)
Fernale/Fernale 
Luer, R809, (Avon 
Medicals, Ul<)
3-way stopcock, 
876.00, (Vygon, UK)
Inflow from Perfusor 
syringe driver
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Figure 2.6: Tracings with manometry pump and syringe driver for 
comparison.
Single channel trace taken from the same patient on different days. Scale in 
mmHg. One centimetre pull-through markers on trace. LLB = Lower 
oesophageal sphincter Lower Border. RIP = Respiratory Inversion Point. LUB 
= Lower oesophageal sphincter Upper Border. Horizontal hatched line 
represents gastric baseline pressure.
Slow motorised pull-through of LOS with standard manometry chamber.
mm LLB ( R IF (1)I 44 LUBi4748 46 43 42
Slow motorised pull-through of LOS with syringe driver supplying radial 
channels.
20
0.0 :
48 LLBC1) R IP (1 )\ 4 '
L U B (1 ) 42
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Figure 2.7: Diagram to show how the 4-way split loom can cause preferential 
flow up one side of the loom (A) and poor pressure recording on the other 
side (B), as well as poor NO delivery to this site.
Free flow of the 
majority of the 
syringe contents 
through this side
Two channels 
only occluded
f
inflow from Perfusor 
syringe driver
B
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Figure 2.8; The use of a Dent sleeve catheter could measure LOS pressure 
and TLOSRs. However, NO in the solution delivered via the sleeves port 
would not contact the cardiac mucosa.
High
Pressure
Zone
Dentsleeve perfused by 
single proximal port Gastric Pressure 
Recording ChannelFlow of NO generating 
solution into proximal stomach
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Figure 2.9: Location of the Manometry Channels for delivering NO and 
recording TLOSRs.
Oesophageal port 
-15cm
Oesophageal port 
-5cm
Four Channels straddling
LOS. Lower channel
recording gastric ----------►
pressure.
Mediplus Catheter. 2282
Oesophageal port 
-10cm
High 
Pressure - 
Zone
Three channels 
located in this.
Gastric Pressure 
Recording Channel
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Figure 2.10: Arrangement of the NO delivery system to the 4 pressure 
transducers with the Mediplus 2282 manometry catheter.
To the 4 manometry transducers individually
and subsequently onto the catheter lumens
Lectro-
Caths,
1155.10
(Vygon)
3-way
stopcock,
876.00,
(Vygon)
Inflow from 
Peifusoi 
syringe driver
inflow from 
Peifusoi 
syringe driver
Inflow from 
Peifusoi 
syringe driver
Inflow from 
Peifusoi 
syringe driver
100
Figure 2.11: Graph to show concentrations of nitrite (assuming correlation 
with NO concentration) measured by capturing the catheter’s solution (2282, 
Mediplus, UK) under phosphate buffer solution (pH 7.4) and then analysed 
by the Greiss reaction.
1200
^  800
10 20 30 40
Time / minutes
50 60
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Figure 2.12: Example of TLOSRs recorded on Polygram Net using the 4 
syringe arrangement. Taken from a tracing following a battered fish meal. 
Note varying scale for pressure for different channels. Channel positions are 
in centimetres from the nostril. Channel at 42cm positioned at the proximal 
border of the LOS giving an unreliable trace. Note LOS shortened from 
4.1cm pre-meal to 2.1cm post-meal. Reflux episode apparent after TLOSR.
bw  allow
Swallow triggered
P r o -11X1.711 O e  25mmUg
Mid i._'es 30 Wave of peristalsis to clear refluxed acid
mmHg ;
M id I Jes  35mmHg
mmHg ]
m m Hg
TLOSR in 3 channelsmmHg
mmHg 1
mmHg "
pH 6.0
4.0 Acid Reflux event
2.0
Scale: 1 minute
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Figure 2.13: Example of the effect of NO 
generating solution on the skin of the forearm. 
Separate controls used for comparison.
Key: NO2" - Nitrite, SON -  Thiocyanate, HCI -  
Hydrochloric Acid, AA -  Ascorbic Acid.
Solution constituents:
1; N02'(1.6mM)
2; SCN (1mM), HCI (pH 1.6), 
AA (5mM)
3: SON (ImM), HCI (pH 1.6), 
N02(1.6m M)
4 : SCN (ImM), HCI (pH 1.6), 
N02'(1.6mM), AA(5mM)
Skin pre-application
1 2  3 4
Solution application. 
Time = zero
Solution application. 
Time = 5 minutes
\
Solution removed. 
Time =10 minutes
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Figure 2.14: Cross-section view of an 8 lumen manometry catheter. Water 
filled channels (W) run in close proximity to the test solution filled channels 
(S), and NO could potentially travel from one to the other depending on the 
properties of the lumen wall. The open-ended, empty central catheter lumen 
is also depicted (0).
wManometry ^  
Catheter Wall
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Figure 2.15: NO concentrations achieved at manometry catheter tip against 
time, under various intra-syringe conditions. See legend prior to each chart 
for details.
A: Common solution components for both series are Hydrochloric acid pH 1.6, Thiocyanate 
ImM, Ascorbic Acid 5mM and Nitrite 80|o.M.
Effect o f distilled w ate r deK>xvaenation 
on NO generation capacity.
4 
2 
0 * -
X  D stilled V A te r
o Ce-oxygenated 
Dstilled Vtàter
10 20 
Time / Minutes
B: Common solution components for both series are Hydrochloric acid pH 1.6, Thiocyanate 
ImM, Ascorbic Acid 5mM and Nitrite 80pM all made in de-oxygenated distilled water.
Effect o f EDTA Im M  on NO generation from 
80 m icfom oies/litre Nitrite
60 micromoles 
/litre Nitrite
80 rricromoles 
/litre Nitrite + 1 mM 
H3TA
10 15 20 25
Time / Minutes
26
C: Common solution components for all series are Hydrochloric Acid pH 1.6, Thiocyanate 
ImM, Ascorbic Acid 5mM, EDTA ImM and Nitrite I.GmM all made in de-oxygenated distilled 
water.
Effect of de-oxygenated distilled water pasdnq 
through oesophageal channels anti also 
Increased temperature on JN01 at catheter tip
& 400
350 -
300
Er 250200150100
I
0 5 10 15 20 25 28
Time /Minutes
-  NO through 4  radial 
channola alone
■ o -  - W ater through 4 
oesophageal 
channote
■ W ater through 4 
oesophageal 
channels - distal 
catheter at 37 
Degrees
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Figure 2.16:
A: Graph to show concentrations of NO converted to nitrite measured by 
capturing the catheter's solution (2281-R, Mediplus) under phosphate buffer 
solution (pH 7.4) and then analysed by the Greiss reaction.
g 800 -
«T 200 -
10 20 
Time f  m inutes
B: Chart to show syringe driver concentration of NO at the start and end of 
the experiment, measured by Greiss reaction.
1800 1
1400 -
t 1200 -a
c 1000 -
800 -p
E 600 ■
T 400 -
1 200 -z
0 \
Time = • 30 minutes
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Figure 2.17: NO calculation for saliva etc and 24 hours.
NO concentrations in the Upper Gi Tract
Salivary flow rate of 1-2 litres/day 
= Average 1.5 litres/24 hours = ISOOmls/1440 mins
Saliva Nitrite levels:
Basal = 50-500 jiimoles/litre
After 2 millimoles KNO3 meal ~ 200 nmoles/litre-2 miliimoles/litre
Potential NO levels:
Basal “ 0.05-0.5 pmoles of NO/min
Post KNO3 meal = 0.2-2 jumoles of NO/min 
Potential NO generation:
Daily low level 0.05 ^moles of NO/min x 1440 mins/day 
= 72 pmotes/day
4-way syringe driver runs at 100 mIs/hour = 1.667 mis/min 
Exposure at end of catheter for 20 minutes = 33.33 mis
Concentration of solution at the tip of the catheter is 300-700 micromoles / 
litre
= 300-700 jumoles / 1000 mis 
= 0.3-0.7 iLimoles / ml
Total exposure to NO during the experiment 
=0.3-0.7 (imoles / m i x  33.33 mis
= 10-23 ILimoles NO delivered during the fasting study protocol.
Standard Nitrate meal of 2 millimoles KNCk
Expected to recycle 25% to salivary glands 
Average conversion of 25% to nitrite in oral cavity 
1/16^  ^of meal ends up as nitrite over 3-4 hours 
Potential conversion to NO (Amount of Nitrite)
= 125 jumoles
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Indirect assessment of NO exposure to the 
oesophageal lumen by nitrite anaiysis 
in a segmented siiastic tube.
Chapter 3
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Chapter aims:
Within this chapter, is a series of experiments using segmented 
siiastic tubes in the upper gastrointestinal tract. Our research group has 
previously used these tubes as an epithelial mode! which responds to the NO 
and nitrite chemistry in a physiological fashion. These would be in passed at 
the same time as our manometry catheters and experimental solutions run as 
per our planned protocols. Each of these silastic tubes contains phosphate 
buffer solution, which traps NO passing into each segement by converting it 
to nitrite. On removal of the tubes, each segment can be analysed for nitrite, 
which will act as a surrogate marker of NO. The distribution of NO in the tube 
will allow us to interpret with more confidence where our solutions are being 
delivered in both fasting and fed stomachs. This will allow us to interpret our 
physiological findings with more confidence.
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3.1 Abstract
3.1.1 Background:
Ijima et a/demonstrated that 20-30 minutes following a nitrate meal, in 
a healthy volunteer, luminal NO is detectable in the upper GI tract using a NO 
probe (162). This is most prominent at the gastric cardia, correlating with the 
gastro-oesophageal pH step-up point. Suzuki et al then took this one step 
further. They showed, that in a refluxing patient with Barrett’s oesophagus, 
NO production can be detected with the same intraluminal NO probes, up 
into the oesophageal lumen (166). The Barretts’ studies were performed with 
the patient fasted and in a recumbent right lateral position.
3.1.2 Aim
This series of experiments was designed to analyse the NO 
distribution profile, in the upper GI tract, produced by our experimental 
catheters, without intraluminal NO probes.
3.1.3 Methods
Our studies here involved only healthy subjects. Entry criteria required 
our subjects to be free of symptomatic acid reflux. Although the total HPZ 
length varied between subjects, none were found to have a hiatus hernia on 
manometry. Although the calculated doses of NO delivered were within 
physiological realms, the manner in which it occurred was not. Nitrite is 
converted to NO in the presence of acid and ascorbic acid. Nitrite is 
swallowed in saliva and therefore delivered down the oesophagus in boluses. 
Our experimental NO would be delivered as a constant infusion to the pH 
step-up point, in the fasted state, and in the predicted region of the ‘acid
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pocket’ post-prandially. Also, saliva has a variable and different viscosity to
that of our distilled water solution.
We were unsure if this would mean that the solution would simply run 
off down the lesser curve of the stomach and have no local effect 
whatsoever. Therefore, if there was no apparent effect from the test solution, 
we could not be sure whether it was because it was not being given a fair 
chance to exert any local effect. We designed some experiments to try and 
describe the distribution of the NO delivery and at least rule out a false 
negative result. This would involve a segmented silastic tube, being attached 
to the manometry catheters and our test solutions infused. Analysis of the 
tube segments was performed on withdrawal.
3.1.4 Results
In the fasting study, virtually no NO was detected within the 
oesophagus and the majority at the distal LOS. In the post-meal experiments 
it was shown that NO was found in the area of the expected acid-pocket. It 
was also present in the body of the stomach, but there was also evidence of 
NO reflux into the oesophagus. Concentrations were similar to those 
expected by oral ingestion of nitrate.
3.1.5 Conclusions
Our series of experiments have shown that the NO distributions and 
concentrations produced by our experimental systems are similar to those 
expected under normal physiological conditions. This reinforces the use of 
our experimental system to collect this data.
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3.2: Assessment of NO delivery profile to  the gastro-oesophageal
junction, from a 2281-R manometry catheter, in the fasting state.
3.2.1 Aim;
To assess the distribution of luminal NO exposure around the GOJ 
following delivery of a NO rich solution, by a 2281-R manometry catheter as 
described in section 2.6.2.
3.2.2 Method:
Two healthy subjects attended fasted, having followed a low nitrate 
diet for 48 hours and gargled with 15mls of 0.12% chlorhexidine mouthwash 
bd for 48 hours prior to their visit. Initially a 2-channel (7cm apart) paediatric 
pH probe (26270, Mediplus) was passed nasogastrically. This was withdrawn 
at 1cm increments every 1 minute to locate the pH step-up point. 
Confirmation of the step-up point was made following withdrawal of the distal 
pH probe. The pH probe was then removed. A manometry catheter (2281-R, 
Mediplus, UK) was passed nasogastrically and after several minutes a SMPT 
was performed. Distilled water was used as the perfusate, and the water was 
delivered by a syringe driver via the loom, as described in section 2.3.2 and 
Figure 2.5. This allowed a pressure profile of the LOS to be recorded and 
would confirm the location of the pH step-up to be within the LOS. The 
manometry catheter was then removed.
A segmented silastic tube of internal diameter 2.5mm and wall 
thickness 0.5mm (Altec, UK) was divided into sections measuring 16mm in 
length. A 180° degree clockwise twist was placed on the tube between the
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segments. This twist was secured with a surgical silk tie -  see Figure 3.1. 
The lumen of the segmented tube contained phosphate buffer solution at pH 
7.4. A silastic tube was used as it allows NO to diffuse through it readily, akin 
to an epithelium. After passing through the silastic membrane the rise in pH 
causes the NO to react with the dissolved oxygen in the phosphate buffer, 
forming nitrite. This is then trapped within the segment. The ratio of nitrite 
formed from NO is 1:1.
Ten segments in total were created. This was attached to the 
manometry catheter with thin strips of Mefix tape (SCA Molnlycke Ltd, 
Sweden). There is 5cm of dead-space distal to the 4 radial NO delivery 
channels on the manometry catheter. Segment number 3 of the tubing was 
placed with the NO delivery holes at its mid-point. Two sections were placed 
proximal to this. This meant that almost 10cm of segments would be below 
the level of the catheter. This is a relatively floppy structure, and for ease of 
intubation, a short section of a naso-gastric tube was taped to it, prior to 
insertion -  see Figure 3.2.
Segmentation of the tube allows us to interpret the nitrite and NO 
profile exposed to the local environment for each individual 16mm segment. 
The fluid from each segment was extracted using a glass syringe. Each 
segment in turn was analysed by adding Greiss reagent and performing light 
absorption analysis (214). The nitrite concentrations would represent the 
profile of NO along the tube’s length.
The manometry catheter with attached silastic and nasogastric tubes 
was then passed back into the subject via a nostril. The catheter was taped 
to the nose when the 4 NO delivery holes were at the level of the pH step-up 
point. The subject was then sat upright and the syringe driver, containing a
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NO generating solution (see section 2.3.1 and Table 3.1), was commenced 
at the standard experimental flow-rate (99.9mls/hr) for 23 minutes. Taking 
into account the distilled water perfused through the dead-space, this is 
equivalent to 15 minutes of NO solution from the catheter ports. De- 
oxygenated distilled water was perfused through 2 proximal oesophageal 
ports (flow rate of 0.42mls/channel/minute) to match the conditions of the 
actual study.
3.2.3 Results:
The levels of nitrite detected varied slightly for each subject. Both 
subjects had little if any nitrite detected in the proximal two segments, 
followed by a rapid rise distal to this. Subject A had a maximum nitrite 
concentration of 294|iimol/! in segment 4 compared to 76|amol/i in segment 4 
for Subject B. Subject A ’s nitrite levels reduced rapidly over several distal 
segments, whereas the nitrite concentration of Subject B tailed off more 
gradually over the length of the silastic tube. A summary of the segmental 
nitrite concentrations can be seen in Table 3.2. A schematic histogram 
depicting the variation of nitrite concentration for Subject A, correlating to the 
LOS pressure profile, the NO delivery site and the pH step-up point, can be 
seen in Figure 3.3.
3.2.4 Discussion:
When NO was delivered via the 2281-R manometry catheter to the pH 
step-up point of a healthy subject, virtually no NO was detected above the
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HPZ in the lower oesophagus. For Subject A the majority of the NO Is found 
in segments 3 and 4, with a little in segment 5 as well. For this particular 
Subject this was almost exclusively in or at the lower border of the LOS. 
Subject B had a less intense exposure at the lower border of the sphincter 
and also had more nitrite detected further away from the sphincter. However, 
it has to be appreciated that each Subject’s anatomy may be slightly different 
and it is not known if the tube is lying down a gastric fold where it is more 
likely to come into contact with a pool of the NO solution. Factors such as this 
will dictate the profile within the tube. Regardless of this, the segmented tube 
is useful for detecting NO present within the stomach. We have shown 
reasonable levels present after 20 minutes and not all in the distal stomach.
3.2.5 Conclusion:
With a slow infusion rate of NO solution there is no great amount of 
run-off into the distal stomach. This reassures us that any absence of an 
affect seen on the LOS, for the doses of NO used in the fasted study, cannot 
be attributed to the disappearance of NO into the distal stomach following its 
infusion. The single syringe driver and loom is an effective way to deliver a 
NO solution locally to the environment of the upper GI tract. Its delivery flow- 
rate allows a good local exposure when attempting to perfuse an NO rich 
solution to the gastric cardia environment of the LOS.
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3.3: Assessment o f lum inal NO delivery profile in the stomach, from a
2282 manometry catheter fo llow ing a meal.
3.3.1 Aim:
To assess the distribution of NO at the GOJ after a meal using a 
segmented silastic tube and a 2282 manometry catheter as a NO delivery 
system.
3.3.2 Method:
The same question was asked of the meal study as of the fasted 
study. Not only was the total delivery of NO greater over the test but also the 
catheter delivering it was different as well. Also, the flow rate of each test 
solution was greater per channel, and the concern was that there might be a 
greater opportunity for the solution to run off, away from the proximal 
stomach. The manometry catheter used for the meal experiment was a 
Mediplus 2282 model, which has perfusion ports at a different location to the 
2281-R. The distal 4 channels, used for recording during the experiment, but 
also delivering a NO solution, are placed 1cm apart (ie: spanning 3cm). 
These channels were located with the most distal channel in the proximal 
stomach and the other 3 traversing the LOS.
The fasting experiment had 4 perfusion ports all at the same level, and 
within the LOS. This delivered a highly acidic solution. With shortening of the 
LOS occurring after a meal, the spacing of the ports on the 2282 catheter 
meant that the upper of the 4 distal ports may only be just within the LOS or
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even in the lower oesophagus. Acid from this port would cause reflux 
contamination of the oesophagus. Therefore, hydrochloric acid was only 
included in the distal 2 ports (gastric channels). The proximal channels were 
referred to as the ‘oesophageal channels’. Contents of the test solutions in 
the 4 channels can be seen in Table 3.3. As it is expected that an acid pocket 
would more than likely be formed after a meal, extending up into the distal 
LOS, locating a pre-prandial pH step-up point was not incorporated into the 
protocol.
Two healthy subjects attended fasted for this study. They had been on 
a low nitrate diet for the preceding 48 hours, and used chlorhexidine 
mouthwash for 48 hours, as previously described. A 2282 manometry 
catheter was passed nasogastrically and a SMPT of the fasting LOS 
performed. They were then asked to eat a battered fish and chip meal with a 
glass of still water. A post-prandial SMPT of the LOS was repeated. This 
allowed identification of the lower border of the LOS, just as would be done in 
the full study. A similar segmented silastic tube was attached to the side of 
the 2282 catheter using mefix tape. The most proximal tubing segment 
correlated to the most proximal of the 4 solution delivery channels. The distal 
of the 4 solution delivery channels correlated with the third tubing segment. 
This left 11.2cm of tubing extending past the distal delivery channel. Again, a 
short section of a naso-gastric tube was taped along side this to stiffen it and 
ease intubation -  see Figure 3.4.
The tube was passed naso-gastrically and placed so that the distal 
delivery port was located just distal to the lower border of the post-prandial 
LOS, and within the proximal stomach. The tube was taped in position to the 
nose. With the subject in the upright position, the test solutions were run at
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99.9mls/hr through the 4 syringe drivers for 20 minutes. Taking into account 
the dead-space of distilled water from the infusion, this is equivalent to 17 
minutes of NO solution from the catheter ports. The 4 remaining proximal 
channels on the manometry catheter were perfused with de-oxygenated 
distilled water (flow rate 0.45mls/channel/minute), to match the conditions of 
the study. The tube was removed and the phosphate buffer solution removed 
from each segment in turn. Each was analysed individually for nitrite content.
3.3.3 Results:
As would be expected, with a slightly longer NO infusion time and also 
a greater volume of solution, the cumulative amount of nitrite seen in the tube 
segments is greater in this meal study than the fasting equivalent. The 
majority of the NO appears to be in the proximal stomach. However, there is 
also NO seen in the most proximal segment of both patients. This is at a level 
proximal to the NO delivery site. For Subject C the level of nitrite is slightly 
higher in the proximal segment (177pmoles/litre) than in segment 2 
(158|j.moles/litre). For Subject D the level is very much higher in segment 1 
(306pmoles/litre) than in segment 2 (147^moles/litre). A breakdown of the 
segmental nitrite results can be seen in Table 4. A schematic histogram of 
the nitrite profile in the tube for Subject C, with correlation of the post-prandial 
LOS pressure profile and the location of the manometry infusion ports can be 
seen in Figure 3.5.
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3.3.4 D iscussion:
There is clearly a reasonable amount of NO retained in the proximal 
part of the stomach. It is not running off directly to the distal stomach. More 
strikingly than this is the appearance of nitrite in the segments of the tube 
which are above those delivering the NO solution. Each segment is twisted 
and bound, to prevent leakage between segments, and reduce inter-segment 
contamination. Therefore, nitrite found in the silastic tube above the lower 2 
ports is in fact NO that has reached there by means of reflux. The subjects 
had an erect posture for this protocol demonstrating reflux against gravity.
Comparing this to the previous work discussed would suggest two 
methods for the luminal appearance of NO seen in Barrett’s patients 
following a nitrate meal (166). The NO could itself be refluxed from the 
proximal stomach, or hiatus hernia as described here. Alternatively, the 
salivary nitrite and thiocyanate travelling down the oesophagus could meet 
refluxed gastric acid and ascorbic acid and generate the NO within the lumen 
of the oesophagus, in a more proximal position than what happens with the 
normal chemistry.
3.3.5 Conclusion:
After 17 minutes, the NO, and subsequently the nitrite captured in the 
silastic tube, delivered by the 2282 manometry catheter following the meal 
appears to be retained in the proximal few centimetres of the stomach. This 
is almost in keeping with normal upper gastro-intestina! physiology. There is 
also evidence of probable NO reflux occurring into the oesophagus. This led 
us to examine this closer in the next experiment.
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3.4 : Assessment o f lum inal NO delivery profile in the oesophagus, from
a 2282 manometry catheter fo llow ing a meal.
3.4.1 Aim:
To assess the distribution of NO in the oesophagus after a meal, using 
a segmented silastic tube and a 2282 manometry catheter as a NO delivery 
system.
3.4.2 Method:
The same protocol for the previous meal experiment was performed. 
Two healthy subjects were fasted and had followed a low-nitrate diet. They 
also used 0.12% chlorhexidine mouthwash bd, as described before. They 
were given a battered fish and chip meal with a glass of water to eat. A slow 
motorised post-prandial LOS pull-through was performed. This allowed the 
manometry catheter to be placed, as before, with the distal delivery channel 
in the proximal stomach. A segmented silastic tube was again attached to the 
manometry catheter, but this time with the segments extending up into the 
oesophagus. The middle of the distal segment of the silastic tube 
corresponded to the distal NO delivery lumen. Unlike experiments 3.2 & 3.3 
of this series, no extension was added onto the end of the manometry 
catheter as the full length of the silastic tube ran within the limits of the 
catheter -  see Figure 3.6.
Following the meal the catheter was placed naso-gastrically, in the 
location described previously. The NO solutions (see Table 3.3) were infused
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for 20 minutes (flow rate 1.67mls/minute/channel), equivalent to a 17 minute 
NO exposure, with de-oxygenated distilled water perfusing the oesophageal 
ports (flow rate 0.45mls/channel/minute). After this, the assembly was 
removed. Extractions of the phosphate buffer were made with the glass 
syringe from each tubing segment. The nitrite levels in each segment were 
assessed using the Greiss reaction and compared to those of the previous 
experiments.
3.4.3 Results:
A different nitrite distribution was observed between the 2 subjects. 
Subject E has nitrite present as proximal as segment 3. Here it is present in 
low concentration (Gjuimoles/litre). However, there are more significant 
concentrations present distall y to this in segments 4 and 5 (90 and 
SOjumoles/litre respectively). The pattern of NO exposure in Subject E shows 
greater levels on moving closer to the LOS. Subject F, however, has little 
evidence of NO exposure to the oesophagus with only 18pmoles/litre 
measured in segment 8, just above the LOS, but a similar pattern of NO 
exposure within the LOS compared to Subject E. A schematic diagram of the 
nitrite levels for Subject E can be seen in Figure 3.7 and a comparison of the 
absolute nitrite levels for both Subjects E and F in Table 3.5.
3.4.4 Discussion:
These two studies show the potential variation in distribution of nitrite 
through the silastic tube. This equates directly to different NO exposures to
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the tube, cardia and the oesophagus. Although the NO solution was only run 
for 17 minutes, both the amount of NO and the proximal extent of it's 
distribution is quite striking in Subject E. The level of proximal NO detection, 
in tube segment 3, is equivalent to 8cm above the upper border of the post­
prandial LOS.
No pH probes were attached to the manometry catheter. It is likely that 
the NO profile reflects that of the reflux episodes and their degree of proximal 
extension. Taking this into account, these experiments also show how some 
people are more prone to reflux episodes after a meal. Despite a significant 
degree of reflux in the first experiment, Subject E was entirely asymptomatic. 
When the manometry catheter is attached to the silastic tube, the assembly 
can measure almost 7mm in diameter. Due to the helical arrangement of the 
manometry outlets on the catheter it is also difficult to avoid the silastic tube 
sitting in close proximity to several of them. This makes mucosal contact and 
channel outlet obstruction unreliable. For this reason manometry recordings 
were not made during this brief infusion. The distilled water running through 
the oesophageal ports was continued to mimic our standard experimental 
conditions. Once again, the actual concentration of the nitrite measured in 
the silastic tube was itself not terribly important, but the evidence of its 
distribution was.
Winter et al performed similar silastic tube experiments in 15 healthy 
subjects. A 21-segment tube was passed nasogastrically and placed across 
the GOJ. Comparisons were made of the nitrite concentrations in the 
segments after both a control (water) drink and a 2 millimole potassium 
nitrate drink. The tube was left in situ for approximately 2 hours following 
ingestion of nitrate. These experiments were performed in the fasting state.
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Peak concentrations of nitrite (93.3"264jLiM), occurred following the nitrate 
meat, and appeared at the distal end of the LOS -  Figure 3.8 (217). These 
are comparable to the 2 maximum levels seen in our manometry catheter 
fasting experiments of 294]liM and 76pM (Section 3.2).
3.4.5 Conclusion:
From these experiments we can confirm that we have a delivery 
system for luminal NO, similar to that of upper gastro-intestinal physiology 
(217). Although, in our experiments, there were no pH probes present, we 
have seen evidence of the reflux of the luminally delivered NO, by its 
presence as nitrite in the silastic tubing segments. Also, there were no formal 
control runs for our experiments. It should not detract from the compelling 
nature of the nitrite results. We have also shown the variability seen between 
healthy subjects. Despite their ‘healthy’ status they show differences in their 
profile of NO exposure in the oesophagus. The reasons behind this are 
complex. These are the issues which possibly decide who goes on to 
develop GORD and its consequences, and who doesn’t. Furthermore, there 
are issues of variability in mucosal protection, separating those patients with 
GORD and those with non-erosive reflux disease (NERD). These 
mechanisms are not fully understood.
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Table 3.1: Syringe contents for the fasting NO-generating study day.
Syringe concentrations
Thiocyanate ~ 1 mM 
Hydrochloric acid -  pH 1.8 
E D T A -Im M  
Nitrite -  1.6mM 
Ascorbic Acid -  5mM
Table 3.2: Concentration of nitrite in segments of the silastic tube after a NO 
infusion from a 2281-R manometry catheter, in the fasted state. Section 1 is 
in the distal oesophagus, section 3 is at the level of the NO infusion and 
section 10 is in the mid-stomach.
Tube segment Subject A 
[Nitrite]/micromoles/litre
Subject B 
[Nitritej/micromoles/litre
1 6 0
2 15 2
3 (LOS) 163 62
4 294 76
5 56 66
6 4 69
7 7 55
8 3 29
9 11 39
10 (Stomach) 8 26
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Table 3.3: Syringe contents for the post-meal NO-generating study day.
Gastric channels/ 
Syringe concentrations
Oesophageal channels/ 
Syringe concentrations
Thiocyanate - 1  mM 
Hydrochloric acid -  pH 1.0 
E D T A -Im M  
Nitrite -  1.6mM 
Ascorbic Acid -  6mM
Thiocyanate -  ImM 
Nitrite -  1.6mM
Table 3.4: Concentration of nitrite in segments of silastic tube following NO 
infusion after a meal and with a 2282 manometry catheter. Section 1 is in the 
distal oesophagus, section 3 Is at the level of the NO infusion and section 10 
is in the mid-stomach.
Tube segment Subject C 
[Nitritej/micromoles/litre
Subject D 
[Nitritej/micromoles/litre
1 177 306
2 158 147
3 (LOS) 236 149
4 157 164
5 121 129
6 183 108
7 100 98
8 75 49
9 49 41
10 (Stomach) 39 31
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Table 3.5: Concentration of nitrite in segments of silastic tube following NO 
infusion after a meal and with a 2282 manometry catheter. Section 1 is in the 
proximal oesophagus and section 10 is at the level of the distal NO infusion 
port.
Tube segment Subject E 
[Nitritej/m icromoles/l itre
Subject F 
[Nitritej/micromoles/litre
1 (Oesophagus) 0 0
2 0 0
3 6 0
4 90 0
5 80 0
6 116 0
7 180 0
8 144 13
9 (LOS) 100 156
10 104 122
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Figure 3.1: A silastic tube segmented with surgical silk ties. Each segment 
contains phosphate buffer solution pH 7.4.
16mm silastic tube
phosphatesurgical silk ties buffer solution
pH 7.4
Figure 3.2: A segmented silastic tube attached to the 2281-R manometry 
catheter. Catheter used in the fasting study. Note the section of a nasogastric 
tube acting as a splint. Silastic tube will assess the NO profile of the fasted 
protocol at the GOJ and proximal stomach.
4 distaMediplus 2281R manometrycatheter channels
asogastric tube
extension
segmented
silastic tube
dhesive tape
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Figure 3.3: An example of Subject A s nitrite levels collected in the silastic 
tube after a 20 minute infusion of a NO generating solution (Table 3.1), with a 
fasted stomach. The 4 perfusion channels of the manometry catheter 
(Mediplus 2281-R) are represented by the ovals. Each segment measures 
16mm in length. The segments’ location relative to the LOS pressure profile, 
with an indication of the pH step-up point is shown. The histogram signifies 
the relative concentrations of nitrite compared to adjacent segments.
FASTED
pH step-up
I
Stomach
LLBO LUBO)
Oes.
I
Key: Oes -  oesophagus, LLB = Lower oesophageal sphincter lower border by manometry, 
LUB = Lower oesophageal sphincter upper border by manometry
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Figure 3.4: A segmented silastic tube, attached to the 2282 manometry 
catheter, with a section of a nasogastric tube acting as a splint. This is used 
to assess the NO profile of the meal protocol NO infusion at the GOJ and 
proximal stomach.
segmented 
silastic tube
adhesive tape
4 distal 
manometry 
channels
Mediplus 2282 
catheter
nasogastric tube 
extension
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Figure 3.5: An example of Subject C’s nitrite levels collected in the silastic 
tube after a 17 minute NO infusion. The 4 perfusion channels of the 
manometry catheter (Mediplus 2282) are represented by the ovals. Each is 
separated by 1cm. Only the 2 lower ports are generating NO, with the other 2 
proximal channels containing nitrite (NO2 ) and thiocyanate (SON) -  as per 
Table 3.3. There is an increase in the amount of NO delivered; 8-fold, 
compared to the fasting study. The location of the segments relative to the 
post-prandial LOS pressure profile is shown. The pH step-up point is not 
displayed as this changes location following a fish supper due to the proximal 
migration of the acid pocket. The histogram signifies the relative 
concentrations of nitrite compared to adjacent segments.
Fish supper in stomach 
8 X NO dose delivered
Stomach
NO INO,
Key: LLB = Lower oesophageal sphincter lower border by manometry, LUB = Lower 
oesophageal sphincter upper border by manometry
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Figure 3.6: A segmented silastic tube attached to the 2282 manometry 
catheter to detect NO oesophageal reflux following a meal. This is used to 
assess the NO profile of the meal protocol NO infusion at the GOJ and 
proximal oesophagus.
adhesive tape
segmented
silastic tube
4 distal
manometry
channels
Mediplus 2282
catheter
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Figure 3.7: An example of Subject E s nitrite levels collected in the silastic 
tube after a 17 minute NO infusion. The 4 perfusion channels of the 
manometry catheter (Mediplus 2282) are represented by the ovals. Each 
channel is separated by 1cm. Solution infusions were identical to those of 
Figure 3.5 and Table 3.3. Each segment of silastic tube measures 16mm in 
length, and their location, in comparison to the post-prandial LOS pressure 
profile is shown. The standard position of the 2 oesophageal pH probes is 
illustrated with the red ovals. The histogram signifies the relative 
concentrations of nitrite compared to adjacent segments.
LUB(1)46 44
Fish supper in stomach 
NO infusion as described
OESOPHAGUS
/
NO SCN/NO2 Distal pH 
probe
Proximal pH 
probe
Key: LLB = Lower oesophageal sphincter lower border by manometry, LUB = Lower 
oesophageal sphincter upper border by manometry
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Figure 3.8: Median silicone tube nitrite concentration by location for 15 
healthy subjects. Sections 1-13 lie above the pH step up point and 14-21 
below the pH step up point. Results following administration of the control 
drink are represented by (□) and following administration of 2 mmoles nitrate 
by (■ ). Nitrate meal peak level greater than Control (p<0.001). Whiskers 
represent interquartile ranges.
Silicone tube nitrite concentration by section
_______________________________ G-O junction___________300
250-
200 -
150-
50-
Reproduced with permission of Winter et al.
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Effects of luminal nitric oxide on the human 
lower oesophageal sphincter, in the fasting state
Chapter 4
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Chapter aims:
This set of experiments tests the hypothesis of luminal NO on the 
fasting LOS. Pull-through manometry of the LOS is performed before and 
after NO and control solutions have been infused into the cardia. MEEPs are 
compared as a measure of LOS pressure and statistical analysis performed 
on the results.
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4.1 Introduction:
It is acknowledged that NO is present at high concentrations within the 
lumen of the upper gastrointestinal tract (218). In the presence of a healthy 
acid-secreting stomach the highest concentration is located at the gastric 
cardia (162). This correlates to the pH step-up point from the gastric 
columnar mucosa to the stratified squamous mucosa of the oesophagus. 
This location has been confirmed by x-ray studies with clips placed on the z- 
line (23). Manometry investigations have also shown that in healthy patients 
the z-line is positioned almost centrally within the high pressure zone of the 
LOS (15). The GOJ and lower oesophagus is becoming an area of increasing 
symptoms, disease and pathology throughout the Western world. The reflux 
of gastric contents is known to play a role in the inflammatory changes of 
oesophagitis and mucosal ulceration, the mucosal changes of Barrett’s 
epithelium and even in the development of adenocarcinomas in this region 
(219:220).
The generation of NO is by a recycling process as previously 
described. 25% of nitrate absorbed from the diet or produced endogenously 
is taken up by the salivary glands and secreted into the mouth (221). Buccal 
bacteria convert a substantial proportion of the nitrate to nitrite. This results in 
a high concentration of nitrite in the mouth and throughout the length of the 
oesophagus for several hours after ingesting nitrate-containing foods (166). 
When the nitrite encounters acidic gastric juice, which contains vitamin C it is 
rapidly converted to NO.
Nitric oxide is well known as a messenger in cell signalling and 
smooth muscle relaxation. We know that NO is at its most concentrated at 
the cardia and that this is situated within the muscular high pressure zone of
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the LOS. This led us to hypothesise that it may, in fact, have some effects on 
the motor control and performance of the LOS. Factors that predict the 
likelihood and severity of acid-reflux disease and reflux oesophagitis have 
been described (132). These include the resting LOS pressure, the total 
sphincter length and the intra-abdominal sphincter length. However, the 
actual mechanisms that lead to acid reflux are not well understood.
The luminal NO is normally generated in a region where columnar 
epithelium exists on top of an arrangement of longitudinal folds (37). Deep to 
this epithelium lies the muscularis mucosae whose muscle bundles are 
arranged longitudinally in the oesophagus (7). The thickness of the 
muscularis mucosae is greatly increased on top of the folds in the squamous- 
lined portion of the high pressure zone and this partly crosses into the 
columnar-lined sphincter (38). Distal to the sphincter the muscle bundles are 
arranged in a criss-cross fashion (222). Outwith the muscularis is the circular 
muscle layer, which is more substantial in the sphincter area than in the 
oesophagus, and then the longitudinal layer outside this completes the 
picture.
It is conceivable that the NO generated in the sphincter could cross 
the epithelium, as shown in our skin experiments (Figure 2.13). Even if it 
were not to reach the circular muscle, it may interact with and alter the 
physiology of the muscularis mucosae. It is assumed that the circular smooth 
muscle is the main component of the sphincter pressure and that the 
longitudinal smooth muscle fibres externally are there to control swallowing 
and peristalsis, but this is not proven.
This leaves a big question as to the function of the muscularis 
mucosae. Its anatomical location, distribution and orientation are such that it
137
is likely to have a specific role. Whether this is the case, and what role it may 
play, is speculative. The squamous epithelium overlying the thickened areas 
of muscularis mucosae related to the sphincter mucosal folds occasionally 
has a rimpled effect giving the appearance of transverse folds (86). From a 
histological view it would seem that contraction of the longitudinal muscularis 
mucosae would be the cause of this. The benefits of such an action would be 
to bunch the mucosa up and plug a potential space where acid reflux may 
occur. Although, other schools of thought suggest that acid-reflux itself is the 
local stimulus to produce such an effect (91). Is it a secondary protective 
mechanism to prevent further acid exposure? The answer is unclear.
Therefore, does the muscularis mucosae also play a role in the 
prevention of acid reflux? Does it contribute to the resting tone of the lower 
oesophageal sphincter? If the answer to either of these is 'yes', then would 
luminal nitric oxide, which is likely to gain access to the muscularis mucosae, 
alter its role? If a resting tone exists in the muscularis mucosae, and this can 
be altered, this may then change the position of the overlying SCJ. Disease 
states of the oesophagus, including various degrees of oesophagitis and 
barrett’s oesophagus, show differing locations of the SCJ, which are often 
fixed (15).
There is also a possibility that even transient longitudinal movements 
of the z-line, in either a cephalic or caudal direction, may play a major part in 
the increasing frequency of disease seen at this site. These episodes could 
be related to luminal NO exposure after a meal, and may become fixed over 
time. The same is true in the case of oesophageal shortening. This is a brief, 
natural phenomenon which occurs with swallowing (60). More prolonged 
episodes of shortening can be induced by exposure of the oesophageal
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mucosa to acid conditions (73). Fluoroscopic techniques have shown this to 
be related to the muscularis propria (60), but no data is available as to the 
effect on the muscularis mucosae. If the oesophagus was to shorten, but a 
‘mobile’ muscularis mucosae did not, then the z-line would descend into the 
acid environment of the stomach.
Clearance of acid from the oesophagus is impaired in patients with 
oesophagitis (223). This, in itself is enough to drive the perpetuating cycle of 
mucosal damage and increased cancer risk. Sildenafil (Viagra, Pfizer) is a 
phosphodiesterase subtype V inhibitor known to increase cGMP 
concentrations, the end result of NG’s action, within the body, which is 
primarily used in male patients with erectile dysfunction. There is evidence in 
healthy volunteers, that increased levels of cGMP associated with sildenafil, 
play a role in impaired acid clearance (178). Although the NO origin of the 
cGMP rise in this instance is not intraluminal, it makes it all the more 
important to try and detect what effect luminal NO may have on the 
properties of the LOS and also oesophageal acid clearance.
The LOS is an incredibly complex and active structure. This could 
make it very easy to miss an effect from luminal NO, or even make it difficult 
to interpret a result. The best way to counter this is to break down the 
individual components of the sphincter and use both new and previously 
available techniques to address these in turn. We have developed a 
technique, which allows pressure measurements at the LOS, whilst delivering 
a controlled amount of externally generated NO to the lumen of the upper Gl 
tract (see chapter 2.3).
Therefore, the main priority of this study would be to examine whether 
the presence of NO at the GOJ altered the resting pressure or tone of the
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LOS. Although measuring changes in LOS pressure was the primary end­
point, other parameters would also be addressed.
4.2 Study participants:
This study was carried out in healthy subjectss, who had no past 
history of upper gastrointestinal symptoms or surgery. It was confirmed that 
they were not taking acid suppression therapy or any other medication that 
could affect the motility or tone of the upper gastrointestinal tract. 12 subjects 
were investigated (6 male and 6 female) with an age range of 22 to 50 years 
and mean age of 32 years (Male mean age 28.5, range 22 to 42; Female 
mean age 35.3, range 23 to 50). The mean Body Mass Index (BMI) of the 
subjects was 25.3 with a range of 19.3 to 31.2 (Mean male BMI 24.3, range
19.3 to 31.2: Mean female BMI 26.3, range 21 to 30.4).
The H.pylori status of all participants was assessed by a urea breath 
test (C '^ )^. Those found to be H. pylori positive were declined further 
involvement in the study. Pregnant or lactating females were also excluded. 
The participation of smokers was allowed, and their smoking status was 
documented. They were instructed not to smoke before attending on the 
morning of the study.
In the 24-48 hours prior to the investigation, the subjects were asked 
to follow dietary advice. This contained a list of ‘dietary exclusions' in order to 
keep the diet low in ingested nitrates (224). To further reduce the possibility 
of salivary nitrate conversion to nitrite, the subjects were asked to use anti­
bacterial mouthwash, containing Chlorhexidine Gluconate 0.12% (Chlorohex, 
Colgate Palmolive, UK). 15mls of the mouthwash was used to gargle and 
rinse the mouth for 1 minute on each of 3 occasions. This was done on the
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morning and in the evening of the preceding day, and also on the morning of 
the investigation. The subjects attended after an overnight fast on the 
morning of their investigation.
4.3 Ethics:
This study was approved by the North Glasgow University NHS Trust 
Ethics Committee and all subjects gave written informed consent.
4.4 Materials & methods:
4.4.1 Manometry:
Water perfused oesophageal manometry was chosen to perform the 
pressure measurements during this study and also to act as a delivery 
system for our compounds to the mucosa in the LOS -  as discussed in 
chapter 2.
4.4.2 Catheter:
An eight channel re-usable adult manometry catheter was used 
(2281R, Mediplus, UK). It was a standard 3.9mm diameter catheter with 5cm 
of dead-space distally. 4 channels were located at this point and arranged 
radially at 90° to each other. The other 4 channels were spaced at 5cm 
increments and in a helical fashion around the catheter, the most proximal 
being 20cm above the 4 radial channels. For the purpose of this study the 2 
most-proximal channels of the manometry catheter were not used and were 
capped-off externally. There were several reasons for doing this. Firstly, we 
were mainly concerned with measuring the pressure of the LOS and so 
excessive information about oesophageal motility was not required.
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Secondly, the 2 lower oesophageal recording channels were to be used as 
an indication of oesophageal peristalsis so that any form of LOS relaxation 
associated with these events could be discounted.
It was accepted that a submental proximal swallow sensor was not in 
place. This may make it difficult to differentiate between primary oesophageal 
peristalsis and the occurrences of secondary peristalsis following reflux 
episodes due to TLOSRs. It is known, however, that TLOSRs are very rare 
and infrequent in the fasting state (133). Finally, having only 2 channels 
proximal to the 4 radial channels, the volume of water running distally from 
here is reduced. This limits the theoretical dilution of drug at the LOS, giving 
a reduction in concentration but not total dose delivered. It also reduces the 
potential dilution of refluxed gastric juices, which may otherwise give an 
artificially high pH for the refluxate.
4.4.3 Pump devices:
Delivery of water through the manometry system was done in a novel 
manner. The 2 ‘oesophageal’ ports were supplied by an electrically powered 
manometric pump with hydraulic water chamber (Mui Scientific, Model PIP-4- 
8); set to a chamber pressure of lO.Spsi (70.2kPa). This pressure setting 
gave a flow rate of 18mls of water per channel per hour, which was found to 
be suitable at detecting oesophageal motility. The 4 radial channels were 
supplied by a 50ml syringe driver (Perfusor, B. Braun Medical Ltd, UK), at a 
flow rate of 25mls per channel per hour. The tubing arrangement and 
reproducibility testing data has been described in chapter 2.
4.4.4 Transducers:
Pressure changes were sensed by electrical pressure transducers 
(Synectics Medical Ltd, UK) located in series between the water infusion
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devices and the manometry catheter, sampling at a frequency of 16Hz. 
During the study the transducers were situated at a level equivalent to the 
subject’s stomach. The electrical signals from each channel were transmitted 
via a PVB transducer cable to a 12 channel Polygraph unit (Polygraf™ ID 12 
Channel, Medtronic Functional Diagnostics A/S, Skovlunde, Denmark). The 
Polygraph was connected to a personal computer and the data collected and 
analysed using Polygram Net^^ -  Oesophageal Manometry software 
(Medtronic Functional Diagnostics A/S, Skovlunde, Denmark).
4.4.5 Manometry calibration;
A 2-point calibration was carried out for the 6 pressure channels. With 
water flowing through the channels at the stated rates. A zero reference point 
(equivalent to the stomach height during the examination) and a point 68cm 
above this were used. This height difference was used as 68cm, which is 
equivalent to SOmmHg. The default measurement scale for pressure on the 
Polygram Net™ software is mmHg.
4.4.6 pH probes:
For the purpose of this study a multi-use antimony crystal pH catheter 
was used. For the subject’s comfort, ease of intubation and lack of distending 
properties to the oesophagus, a paediatric probe, 1.5mm in diameter, was 
selected. This was a dual channel model with the channels 7cm apart. The 
probe was equipped with an Ag/AgCI external reference electrode. The pH 
probe was attached to the manometry catheter with thin strips of adhesive 
tape. The lower recording channel was located 2cm above the 4 radial 
channels and the upper recording channel 9cm above the radial channels.
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4.4.7 pH calibration:
Both the pH sensors and the external reference electrode underwent a 
2-point calibration at room temperature, sampling at a frequency of 16Hz. 
Buffer solutions at pH 1.07 and pH 7.01 were used (Medtronic Functional 
Diagnostics A/S, Skovlunde, Denmark).
4.4.8 Solutions:
All solutions in this study were made with distilled water. One litre of 
distilled water was gassed with zero grade Argon (BOC Gases, UK) through 
a gassing ‘stone’ for 10 minutes to accomplish deoxygenation as described 
earlier (225). This was verified by a calibrated oxygen probe in the laboratory. 
This ‘degassed’ water was used to prime the tubing loom and also to fill the 
manometry reservoir. The manometry reservoir is pressurised by 
compressed air. Two factors would limit the amount of gaseous oxygen re­
entering solution. Firstly the chamber was filled close to the top to reduce the 
amount of compressed air required to achieve the pressure. Secondly, the 
chamber is, even under normal conditions, equipped with a plastic float to 
reduce air bubbles in the water and form a seal on top of it, and this too 
reduces the amount of compressed air in contact with the degassed water.
As we had de-oxygenated the distilled water in the manometry loom, 
we approached the contents of the syringe in the same manner. The nitrite 
arm of the study is where the NO would be present in its greatest 
concentration and also where its’ loss would be greatest. The rationale 
behind de-oxygenating the distilled water in the loom was that dissolved 
oxygen would mix with the NO solution on its way to the tip of the manometry 
catheter, and also potentially reduce its concentration by recycling.
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The 2 test solutions to run, differed only by the inclusion of either 
nitrate or nitrite at a syringe concentration of 1.6millimoles per litre. All other 
components were identical, including their final syringe concentration. They 
were Hydrochloric acid at a final pH of 1.8, Ascorbic Acid (Sigma, UK) 
Smillimoles per litre. Sodium Thiocyanate (Sigma, UK) 1 millimole per litre and 
Ethylenediaminetetraacetic acid (Sigma, UK) 1 millimole per litre. Each of 
these was added at slightly different volumes to achieve the final 50ml 
syringe capacity, as outlined in Table 4.1.
Sodium nitrate or sodium nitrite from the stock solutions were the final 
syringe additions at 40% of the total volume. The reason for such a large 
volume compared to the thiocyanate and ascorbic acid was because we had 
previously noticed the formation of a brown gas on top of the solution when 
concentrated nitrite was added to acid. This was the formation of nitrogen 
dioxide (NO2). This problem was rectified by altering both the concentration 
and volume of nitrite being added. Although this problem would not be 
encountered with sodium nitrate, we followed the same procedure, 
nonetheless, as the selection of nitrate or nitrite would be a blinded process. 
The hydrochloric acid was gassed with zero grade argon until deoxygenated, 
as was the sodium thiocyanate stock solution. The ascorbic acid was 
weighed out on a balance and also dissolved in deoxygenated distilled water.
It was not possible to gas the nitrite solution with Argon as it would 
reduce its total concentration. At pH 1.5 approximately 1% of nitrite exists as 
NO in equilibrium. At pH 7 (distilled water) less than 0.001% of nitrite exists 
as NO. This difference is due to a change in the equilibrium related to the 
pKa of nitrite. However, gassing a solution with Argon which contains NO, 
even in small quantities, would cause the NO to be lost to the atmosphere.
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Once this has occurred the equilibrium is maintained by producing more NO 
from nitrite, and so over the period of gassing time a small, but significant 
amount of nitrite would be lost.
We used concentrated stock solutions of both nitrate and nitrite 
(lOOmM sodium nitrite dissolved in standard distilled water -  not 
deoxygenated) and diluted this, 1 in 25 with deoxygenated distilled water. 
20mls of this mix was used for the final syringe. Therefore, the 1ml of stock 
sodium nitrite solution was the only solution in the whole system with any 
remaining oxygen in it, and this was considered acceptable for the purposes 
of the study.
4.5 Protocol:
The subject was positioned on the examination table with legs 
outstretched in front with their upper body elevated at an angle of 45 
degrees. In earlier pilot studies with the subject supine, when an acid 
containing solution was infused into the LOS, there was significant acid 
exposure to the oesophagus. This was presumably due to there being no 
control over which way the solution could flow because of its position in the 
sphincter. So, by sitting the subject up to 45 degrees, gravity could be used 
to preferentially direct the flow of the infusion. With the knowledge that 
TLOSRs are very rare in the fasting state we were satisfied that pressure 
recordings of the LOS could be made reliably during the resting phase and 
not during TLOSRs.
The external reference electrode was attached to the skin using 
electrode gel (Marquette Hellinge GmbH, Freiburg, Germany) to ensure good
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contact, and a nostril was anaesthetised with lidocaine spray (Xylocaine 
Spray^, Astra Zeneca AB, Sodertalje, Sweden). The tip of the manometry 
catheter and the pH probe was lubricated with a water-based lubricating jelly 
(K-Y Jelly, Johnson & Johnson, Sezanne, France) and passed through the 
nostril into the pharynx area. As much lubricant as possible was removed 
from the antimony crystals of the pH probe to ensure good recording. At this 
point the subject was asked to sip some water with a straw. In co-ordination 
with the swallows, the tube was passed into the oesophagus and through into 
the stomach.
Location of the assembly could be assessed by the distance markers 
along the side of the manometry catheter. Also, passage of the catheter from 
the neutral pH of the oesophagus to the acid of the stomach could be seen 
sequentially on each of the pH recording channels. At no point during the 
catheter insertion were any fluids being pumped through the manometry 
channels. The apparatus was left for several minutes to allow the patient to 
get used to the sensation of the catheter and also to allow more of the 
lubricant to be removed by the gastric mucosa and juices.
4.6 pH pull-through:
The assembly was withdrawn in 1cm increments each minute. A 
measurement was taken from the nostril at the point where the pH increased 
from acid (pH<2) to neutral (pH>6) (Figure 4.1). This location is consistent 
with the pH step-up point from acid to neutral which, in the fasted state, 
equates to the position of the SCJ. Once this position had been confirmed, 
the assembly was reinserted into the stomach, and all six channels of the
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manometry system were perfused with de-oxygenated distilled water, by the 
pumping arrangement, as described earlier.
4.7 Sphincter pressure analysis:
Measurements of sphincter length, pressure and RIP were achieved 
using a SMPT of the manometry catheter. A motorised catheter puller was 
used (Medtronic Functional Diagnostics A/S, Skovlunde, Denmark), the 
activation of which could be controlled by the Polygram Net software. The 
fasting pressure pull-through was used to show the location of the pH step-up 
point in relation to the LOS, and by locating the RIP, it could also show its 
relationship to the hiatus (226). The catheter pull was started with all 4 radial 
channels just below the LOS and measuring gastric baseline pressure. 
Pulling for 10cm at a speed of 1 mm/second gave a total pulling time of 1 
minute 40 seconds. The subject was allowed to breath with normal shallow 
respiration. A pull-through was not started at least until a full minute after a 
swallow. These could be detected by visual observation of the subject or 
direct indication by the subject and confirmed by readings from the 2 
oesophageal manometry channels, indicating oesophageal peristalsis.
The SMPT technique was used in preference to both a standard 
station pull-through and a rapid motorised pull-through. A standard station 
pull-through was not used as catheter withdrawals of 1cm or even 0.5cm 
increments were thought to be too inaccurate for measuring potentially small 
changes in LOS parameters. Even with the smaller catheter increment of 
0.5cm, when calculating total sphincter length by the difference between its 
upper and lower borders, there is the potential for almost 1cm inaccuracy.
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With a slow pull-through tracing on the Polygram Net software, 
markers are placed manually at the lower and upper borders of the LOS, and 
a time difference, in seconds, is displayed. With a constant pull speed of 
1 mm/sec, the LOS length can be calculated to the nearest millimetre. The 
reasons for not selecting a rapid catheter pull-through technique were that 
the RIP could not be identified and also there is known to be poor reliability 
with subjects’ breath holding, which is a necessity for this type of pull- 
through. Also, if not able to identify the position of the RIP, it would mean that 
the calculation of ‘abdominal’ sphincter length would not be possible. 
Furthermore, a recent study has also shown that inter-observer and intra­
observer variation is reduced significantly when analysing slow compared to 
rapid pull-through traces (49).
Of the six manometry channels, only the four radial channels were 
being used for the pull-through. So, the values given for HPZ length, RIP 
position, Abdominal Sphincter Length and MEEP are all taken as the average 
of four individual results.
4.8 Test solution infusion:
The manometry catheter was then re-inserted back into the stomach 
and withdrawn slowly to the pH step-up point (Figure 4.2). The assembly was 
taped to the nose and the infusion to the 4 radial channels was changed. The 
first syringe was pumped through the system for 28 minutes. During this time 
LOS pressure and oesophageal pH were recorded. The distal pH sensor was 
positioned just above the high pressure zone and the proximal channel 7cm 
above this, so that both short and medium segment reflux could be observed.
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Bench top laboratory studies had shown that when the nitrite was 
present in the syringe to produce NO, it took approximately 8 minutes for the 
NO to be detectable at the catheter tip. The NO level then rises to a plateau 
at 10 minutes and then starts to decrease at 25 minutes (Figure 2.15C). 
Figure 4.3 also gives an example of this, and compares this to an exposure 
of a standard nitrate meal.
With the knowledge of the NO concentrations and delivery profile, it 
could be correlated to the trace when the NO exposure would be expected. 
Once the syringe contents had been delivered the catheter was immediately 
pushed back into the stomach. A SMPT, with the subject reclined at 45°, was 
repeated. Post-drug LOS parameters could then be collected.
4.9 Reproducibility;
Initial pilot studies to assess the effects of the nitrate or nitrite solutions 
on sphincter pressure had raised issues about reproducibility of results and 
interpretation of the traces. When assessing MEEPs, using a nitrate 
containing solution as a control, there was often a difference when comparing 
it to a NO generating solution. However, when each post-drug pressure was 
compared to the fasting gastric baseline pressure of the first SMPT with de­
oxygenated distilled water from that particular study day, there was perhaps 
not as great a difference between these two. There also appeared to be a 
difference in the resting basal pressure of the sphincter on different study 
days. This would be addressed in the data analysis.
Therefore, in order to try and counter any problems with interpretation 
it was decided that the best way to approach the analysis was to undertake
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two study days. The change was made to give both nitrate and nitrite 
containing syringes sequentially on each study day, but in a different order at 
each visit. This would allow direct comparison to the basal, distilled water 
pull-through and also to the other solution pull-through on that day. It would 
also allow for a cross-over analysis, to see if reversing the order of the two 
solutions had any effect as well. The nitrate and nitrite containers were 
randomised by a technician and labelled ‘A ’ and ‘B’, to be unblinded at the 
end of the study.
At the end of the first syringes infusion, and at the time of the second 
pull-through, the second syringe was running through the four radial 
channels. Knowing that the solution took approximately 8 minutes to reach 
the tip, this gave a comfortable time period to perform the pull-through, which 
only took several minutes. There would be no possibility of contamination at 
the LOS by the second solution. After the second pull-through the catheter 
was re-introduced into the stomach and again withdrawn and secured, by 
taping to the nose, at the pH step-up point.
We have made the assumption that the pH step-up point (ie: SCJ) is 
at a constant location throughout the experiment, which is always in a fasting 
state. Any day to day variation in the location of the step-up point can be 
assessed by the initial pH pull-through profiles (Figure 4.4). A further SMPT 
was performed after the second syringe had been delivered. At the time of 
this third pull-through, de-oxygenated distilled water was flowing through the 
loom, but again this would not have reached the distal channels by the end of 
the procedure.
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When mixing the syringes, timing was quite critical. Solution ‘A ’ or B' 
was always the last to be added to the syringe as NO generation was an 
immediate phenomenon. Also, we had observed that the NO level dropped in 
the syringe over time, so it was important that this was done at the last 
possible minute prior to infusion to achieve the highest concentrations in the 
catheter. Following the third pull-through, both pumps were switched off, the 
catheter assembly removed and the pH external reference electrode 
detached.
4.10 Trace analysis:
Data from the traces was analysed after each study. The fasting 
gastric baseline pressure was taken as the zero reference. Each of the traces 
was marked for the respiration cycle in which the pressure in that channel 
was persistently raised above the gastric baseline pressure, and this was 
marked as the lower border of the LOS. Another marker was placed for the 
respiration cycle where the pressure was equivalent to resting oesophageal 
pressure, and this was taken as the upper border of the LOS. The software 
then calculated the time, in seconds, between these 2 markers and this was 
then the equivalent sphincter length in millimetres. On the trace before the 
end expiratory pressure changed from a positive to a negative deflection, a 
separate marker was placed at the peak point of inspiration. This was 
classed as the RIP (Figure 4.5). The measurement of sphincter pressure was 
taken as the MEEP. This was recorded using a mobile vertical measurement 
tool. Mean values for each of the parameters were calculated from the 4 
distal channels for that particular pull-through.
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4.11 Comparison o f results / statistics:
The issue of pull-through reproducibility had meant that the study 
design would allow various methods of results comparison. As far as we are 
aware, no one else has tried to deliver drugs or substances to the LOS by 
this type of set up, and neither have they tried to record parameters in this 
way. Creating a suitable control for this study meant that the only difference 
between ‘A ’ and ‘B’ would be nitrate compared to nitrite. However, other 
studies have always compared tests to pull-throughs perfusing water. We are 
assuming that any changes seen in the LOS parameters are due to the 
infusion period of the drug and not due to any exposure during the pull- 
through process. We expect that it would be extremely unlikely to have such 
a rapid effect during a pull-through on the LOS. However, due to a short 
period lapsing between the end of the test infusion (1-2 minutes) and start of 
the pull-through recording the next series of data, a loss of effect from the 
solution could be a possibility. This is to be considered with NO having such 
a short half-life. However, the skin changes seen with our test solutions 
(Figure 2.13) were apparent for up to 5 minutes after wiping them off from the 
skin.
Analysing individual study days, the effects of both A' and B' can be 
compared to the initial water pull-through using a paired sample t-test. Then 
they can be compared to each other. Addressing the two study days 
together, A ' data from one visit can be compared to B' data from another 
visit, which is what would have happened if the drugs were not run 
sequentially anyway. With both solutions being run on both days, this will 
give two sets of data. Variation caused by the order of the solutions on a
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particular study day will also be assessed. As part of the investigation into 
reproducibility, a fasted resting sphincter MEEP analysis was performed. This 
compared the two initial water pull-throughs by calculating a correlation co­
efficient. Then, finally, both A  s were compared to each other, and likewise 
both B’s. The method of cross-over analysis is outlined in Figure 4.6. Not 
only can the LOS MEEPs be analysed in this way, but also the total sphincter 
length, the abdominal sphincter length and the position of the sphincter lower 
border.
4.12 Oesophageal acid exposure:
Further information on the exposure of the oesophagus to acid, for 
each experimental scenario, was analysed. Bed-side pH analysis required 
each tracing to be assessed by eye and each reflux episode documented for 
both channels. A pH less than 4 was classed as significant, as this has been 
widely used and accepted in all major publications to date, as the critical 
value for enzymic damage to the squamous mucosa. When added together, 
the sum of two infusions came to 56 minutes. However, due to the ‘dead- 
space’ run in of the tubing the first 7 minutes of recording had to be excluded. 
So, the pooled reflux events were for a total of 49 minutes. The 3 criteria 
assessed were a) the number of reflux events over the time period, b) the 
total time that the pH was below 4, and c) the mean duration of each reflux 
event. As described the lower pH recording channel was placed 2 cm above 
the radial infusion ports. This would position it either right at the upper end of 
the LOS or in the very lower part of the oesophagus. The second channel 
was 7cm proximal to this.
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4.13 Results:
4.13.1 Lower oesophageal sphincter:
The study was completed by all of the 12 patients that enrolled. 24 full 
sets of interpretable data were obtained. Traces were analysed and the 
specific measurements taken as described and the solutions unblinded. 
Results for measured sphincter parameters were then grouped into either 
‘baseline’ (Water), ‘nitrate’ or ‘nitrite’. Each volunteer would, therefore, have 
results for 2 baseline, 2 nitrate and 2 nitrite pull-throughs. Due to the 
crossover design of the study the results for nitrite were pooled and likewise 
nitrate. Overall this gave 24 sets of data which were then compared using a 
2-sided paired T-test. The MEEP, the highest pressure within the sphincter 
length, is used as a marker of the LOS pressure, and changes to this classed 
as the primary endpoint for the study.
Pooled results can be seen in Table 4.2 and are displayed in Figure 
4,7. Furthermore, Tables 4.3 and 4.4 show the data split up to examine the 
effect of solution order. Similarly, results for sphincter length, abdominal 
sphincter length and sphincter lower border position were tabulated as sets 
of 24 pooled results, and then individually, in groups of 12, to examine any 
‘order’ effects. These can be seen in Tables 4.5 and 4.6 and statistical 
analysis of these values in Table 4.7. The pooled results can be seen as 
paired line graphs in Figure 4.8.
4.13.2 LOS MEEP:
Comparing the nitrate (control) group (Mean MEEP 23.7mmHg, SD 
12.3), to that of the nitrite group (Mean MEEP 23.9mmHg, SD 9.5), there is 
no significant difference between data sets. This applies to the data both
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when it is pooled (n=24) to remove the effect of solution order (p<0.96), 
(Table 4.2, Figure 4.7) and also when it is subdivided into the groups (n=12) 
to particularly look for effects due to the order of which the solutions were 
delivered (Tables 4.3 & 4.4).
Although the baseline water pull-through values did not technically act 
as a control, statistical analysis was performed to see if we were dramatically 
changing the LOS physiology by undertaking the experiment. The results 
showed that the LOS pressure was not significantly different after our 
solutions than what would be expected after a normal pull-through where the 
catheter has water perfusing it. Pooled data gave p values <0.15 & <0.08 
comparing baseline water pull-throughs to post-nitrate and post-nitrite 
respectively.
Addressing the issue of LOS pressure reproducibility, the day 1 
baseline measurements were compared to those of day 2. Table 4.4 has 
already approached this in the form of a T-test, but by plotting one day 
against the other for the 12 volunteers a correlation co-efficient can be 
calculated - Figure 4.9. Perfect reproducibility from one day to another would 
be demonstrated by a correlation co-efficient of 1.0. A Y=X line is plotted on 
the graph as a visual guide. The correlation co-efficient is calculated as 0.12, 
indicating relatively weak reproducibility. Looking at Figure 4.9 it can be seen 
that some of the pairs of subjects LOS pressures lie close to the Y=X line, 
but some do show greater variability from day to day, leading to the low 
correlation co-efficient value.
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4.13.3 Secondary LOS parameters:
We accepted that results of the other sphincter parameters would be 
classed as secondary observations. By this, we knew that if any analyses did 
reach statistical significance, then it could be related to chance. However, 
these would not be discredited, and may in fact give rise to further discussion 
points. The other parameters, total sphincter length (SL), abdominal 
sphincter length (ASL) and sphincter lower border position (SLBP) were also 
compared as pooled data (n=24) and as separate groups (n=12). As pooled 
data (n=24) there was no statistical difference between the nitrate or nitrite 
groups for these three variables (SL ; p<0.68, ASL ; p<0.35, SLBP : p<0.11). 
The same applied when the pooled nitrate and nitrite data was compared to 
the pooled water pull-through data, for the three variables. No group was 
statistically different from another (Table 4.5).
The same sub-group analysis (n=12) was performed for these three 
parameters. Analysis of the effects of the order of solution delivery as well as 
comparison to the water baseline results was performed (Tables 4.6 & 4.7). 
Virtually all of these results show no statistically significant difference. 
However, following the results seen for LOS MEEP, it was rather surprising 
to see that 2 of the ‘p’ values for Nitrite 2"^ vs Nitrite 1®^ (p<0.01) and Nitrate 
l^t Yg Nitrite 1®^ (p<0.01) reached statistical significance for the LOS lower 
border position. Mean values with 95% confidence interval for the pooled 
data can be seen in Table 4.8 and these are displayed as line graphs in 
Figure 4.10.
For the lower pH channel there was no statistical difference between 
nitrate and nitrite for any of the 3 criteria. However, there was a trend towards 
an increased number of reflux events (26.1 v 28.8, p<0.49), an increased
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mean acid exposure time (1205 secs v 1351 secs, p<0.26) and an Increase 
in the mean duration of each event (96.5 secs v 186 secs, p<0.30) for the 
nitrite (NO generating) group. For the upper pH channel the nitrite group had 
a statistically significant increase in the number of reflux events (4.41 v 6.2, 
p<0.02) although, due to the low number of events, this is thought to have 
occurred by chance. There was a trend towards a longer acid exposure for 
the nitrite group, but this did not reach significance (566 secs v 630 secs, 
p<0.29). The mean duration of each reflux event was slightly longer in the 
nitrate group, at the 9cm level, but this was not significant (62.3 secs v 60.8 
secs, p<0.91). Summary in Table 4.9.
4.14 Discussion and Conclusions:
As described, there was no effect seen on the LOS MEEP by the 
delivery of NO. There are several reasons why changes may not have 
occurred. It is likely that luminal NO simply does not have a marked effect at 
the GOJ with respect to resting pressure, in the fasting state. Although it may 
have been that an effect was too small for us to be able to detect it. NO can 
penetrate tissue as shown in our skin experiments. It is doubtful that NO is 
able to cross the tissues into the LOS circular muscle, not only due to its half- 
life, but also due to its affinity for haemoglobin in the rich blood supply of the 
submucosa. In the presence of oxygen and a more neutral pH environment, 
NO is converted first to nitrite and then to nitrate, rendering it irreversibly 
inactive. The speed of NO’s reactivity in vivo and the fact that this occurs in 
immediately adjacent cells makes significant diffusion unlikely.
We considered a change in LOS pressure of SmmHg as significant. 
Clearly this did not happen. In fact, in some patients, the pressure went up
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after NO delivery. Dent et al described cyclical contractions of the human 
LOS in the interdigestive period (227). These occur during phase 3 gastric 
migratory motor complex activity. We were not able to ascertain if this was 
the case during this study as we were not concurrently measuring gastric 
pressure during the infusions or any of the pull-throughs. Therefore, we do 
not know where in this 'cycle’ any of our pull-throughs have taken place. This 
also may well account for the day-to-day variation in baseline LOS pressure 
observed. The higher compliance of a syringe driver system with wide-bore 
tubing may also allow for both damping of the pressure signal as well as 
resonance in the fluid-line, which would be difficult to quantify. Experimental 
methodology could therefore be responsible for a ‘missing’ an effect.
It is also possible that after manoeuvring the catheter the effect of the 
solution may have worn off prior to the SMPT as described in section 4.11. 
We are also not entirely sure of the NO and nitrite chemistry at these high 
concentrations, and we are assuming equivalent chemistry above the levels 
where the reaction is certain. Despite these minor reservations, we expect 
the levels of NO to be somewhere between the two ‘bench-top’ curves and 
probably towards the higher concentrations.
The LOS is a very dynamic structure, which has fluctuating changes in 
it’s resting pressure from day to day, and hour to hour, as described above. 
This was demonstrated by the correlation co-efficient in Figure 4.9 of 0.12. 
This shows that there is weak reproducibility from day to day for a modest 
sized study group. Figure 4.9 shows that some of the patients fit quite close 
to the Y=X line but 3 or 4 out of the 12 lie quite far from the line. Pre-study 
interviews confirmed that none of our patients were taking any medications
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that would affect LOS pressure, and none of the smokers had smoked on the 
morning of the study (>10 hours since last smoked).
The lumen at the GOJ boasts the highest recorded levels of 
physiological NO in the human body. At a cellular level this lipid soluble 
molecule is known to cross cell membranes, and cell layers in the 
vasculature. We have shown that NO is able to cross the human epidermis 
and relax the smooth muscle of pre-capillary arterioles (Figure 2.13). In this 
experiment there are also 3 other solutions applied to the forearm in parallel. 
Nitrite alone and also acidified thiocyanate with ascorbic acid are used as 
controls (Blebs 1 & 2 on the forearm accordingly). Bleb 3 comprised acidified 
nitrite without ascorbic acid. We know that this will not generate large 
amounts of NO. However, it is thought that in the Gl tract after a meal, in the 
presence of thiol donors in food, or after interaction with Vitamin E on the 
epithelium’s cell membranes, NO generating compounds may develop and 
cause smooth muscle relaxation or other intracellular effects by this route. 
Bleb 4 is the NO generating cocktail of all the aforementioned ingredients, 
and produces a significant erythema on the underside of the bleb. This was 
visible after 2 minutes, whilst the other blebs produced no significant results 
after 10 minutes. This erythema persists for up to 5 or 6 minutes after the 
solution is wiped from the skin.
We have also been able to detect NO on the serosal side of an in vitro 
rats stomach when the mucosal surface is exposed to an NO generating 
solution of similar concentration to that used in this study (unpublished work). 
There appears to be a degree of NO saturation in the tissue prior to reaching 
high levels on the serosal side. Traversing of NO across the tissues is 
thought to be more effective in vitro due to the absence of a mucous layer
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and also an active intramural blood supply which could potentially decrease 
the amount of NO penetrating through to deeper structures.
Assessing the LOS in the fasting state is a very different situation to 
that accompanied by experimental gastric distension or the post-prandial 
state. After a fatty meal the LOS total length is reduced, with a preferential 
loss of the abdominal portion. After a fatty meal it has been shown that the 
pH step-up point migrates proximally, to a position above the SCJ (23). There 
Is also a prising open of the mucosal rosette in the proximal stomach, which 
is thought to be one of the protective barriers against reflux. Mechanisms 
behind this are considered to be both mechanical, comparable to the neck of 
a balloon shortening as it inflates, and also due to circulating hormonal 
factors such as cholecystokinin, released by both gastric distension and 
constituents of the meal.
In the fasting state, the LOS is therefore a tightly plugged hole and it is 
only under a more stressed situation, such as after a meal, that reflux events 
are more likely. We know that mucosal folds exist through the length of the 
LOS lumen. In this ‘bunched-up’ arrangement, the distance for NO to travel 
to reach the underlying structures theoretically increases. After a meal, or 
following distension, one would expect the bulky mucosal folds to lessen, 
thereby thinning out and presenting less of a barrier to NO diffusion.
It is useful to consider what actually generates the pressure that we 
measure at the GOJ. Two major factors, namely the external circular muscle 
of the GOJ and the diaphragmatic crura are known to exert radial pressure, 
which protects the integrity of the LOS. Little has been said of the role played 
by the mucosal folds in the ability to exert pressure. Also, what controls the 
way in which these folds are arranged? They appear to be consistent in their
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location as proved by the distribution of early tongues of oesophagitis sitting 
on the top of folds.
Do the folds represent regions of relaxed surface tissue that are 
passively concertinaed following contraction of the external structures, or do 
they have inherent tone which represents a third component to the LOS 
pressure? If the latter is correct, then the muscularis mucosae must be 
responsible for this. Again, the tone may be low and outwith the sensitivities 
of our equipment, but if the folds were put into a relaxed state, this may allow 
for subtle, but important changes to the reflux barrier. NO generated in this 
region would be more likely to have an effect on the sphincter function, but 
would not manifest itself as a gross reduction in LOS pressure.
It would be interesting to know what would happen if the mucosa in 
the LOS was stripped away. Would there still be a visible lumen previously 
occupied by the mucosa or would the circular muscle and crura obliterate 
this? Of course, this is very difficult to achieve in practice, and even in an 
animal model, trauma to the oesophagus and the physiological sequelae 
would make results almost un interpretable in the in vivo setting.
The reflux profiles measured at the distal pH probe showed no 
difference between the nitrite and nitrate groups. GORD is multifactorial. 
Namely, the presence of a hiatus hernia, reduced LOS tone, the frequency of 
TLOSRs and impaired oesophageal acid clearance. Neuronal generation of 
NO is key in the last three factors. NO in this setting is derived from L- 
arginine and stimulates intracellular soluble guanylate cyclase to form cyclic 
GMP from GTP. Cyclic GMP causes intracellular phosphorylation, inhibiting 
smooth muscle contraction.
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We have demonstrated the presence of NO in the lumen of the 
oesophagus following a reflux episode. It is not known how this luminal NO 
may alter acid clearance. The hypothesis would be that if it were to have any 
effect, then it should be inhibitory. Following this study, there is evidence for 
the lack of an effect, on the circular smooth muscle of the LOS, in the 
presence of modest doses of luminal NO. If NO were to penetrate at this site, 
it would very likely play a part. However, in the oesophagus, the longitudinally 
arranged muscularis mucosae, would be the first met and reachable target. 
What is the role of the oesophageal muscularis mucosae in acid clearance? 
The answer is simply that we do not know. Raising the intracellular cyclic 
GMP levels by oral sildenafil causes abolition of lower oesophageal 
peristalsis (178). Whether this could occur with luminal NO has not been 
addressed by any groups as yet. This is true for both healthy subjects and 
also Barrett’s patients with a columnar-lined oesophagus, and a potentially 
different diffusion pattern of NO.
There has been recent interest into ‘short segment’ reflux of the 
oesophagus. Standard ambulatory pH monitoring places a single pH probe at 
5cm above the LOS. However, although there may be a normal acid 
exposure at the 5cm level, there is often a potentially pathological exposure 
at the 2cm level (228). In healthy volunteers this pH drop is often 
imperceptible. This region is a common site of intestinal metaplasia in 
asymptomatic subjects (229), and the probable precursor for cancers here. 
Cancer of the gastric cardia is well established as not having any relationship 
with reflux symptoms (230). Clearly, if NO, which seems the most likely
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agent, were to be responsible for short segment reflux, rather than standard 
reflux, then this is a major factor that could be addressed in cancer formation.
It is well accepted that both nitrite and nitrate can form carcinogenic 
compounds (231). However, it is not known what role, if any, NO plays in the 
formation of the post-prandial acid pocket. Although not directly addressing 
this, our subsequent studies detailed here will deal with the effect of luminal 
nitrite on gastro-oesophageal motility after a meal. There will also be a focus 
on both short segment reflux and reflux of a more standard nature.
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Table 4.1: Stock solutions relative to the constituents of the 50ml syringes for 
both the Control and NO generating solutions.
[Stock solution]
Control solution / Nitrate
Volume [Final
Nitric Oxide generating solution / Nitrite
Volume [Final
[Stock solution]
added syringe] added syringe]
HCI/EDTA pH1.5/2.5mM 20mls pH1.8/1mM HCI/EDTA pH1.5/2,5mM 20mls pH1.8/1mM
Ascorbic Acid 50mM 6mls 5mM Ascorbic Acid SOmM Smls SmM
Thiocyanate 10mM Smls ImM Thiocyanate lOmM Smls ImM
Nitrate 4mM 20mls 1.6mM Nitrite 4mM 20mis I.SmM
Table 4.2: Comparison of lower oesophageal sphincter (LOS), maximum end 
expiratory pressures (MEEP), after nitrate (control) and nitrite (NO 
generating). Pooled data for 12 patients from both study days (n=24). 
Analysis by 2-sided paired sample t-test. Comparison by t-test to the pooled 
baseline water pull-throughs.
LOS MEEP I mmHg Post-Nitrate Post-Nitrite p value <
Mean
Range
Standard Deviation
p value vs 
Pooled Water Data
23.7
9.0-58.0
12.3
0.15
23.9
10.3-48.3
9.5
0.08
0.96
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Table 4.3: Table of LOS Maximum End Expiratory Pressures (MEEP) after 
each of the six protocol pull-throughs (n=12).
LOS MEEP 
/ mmHg Water 1 Water 2 Nitrate 1 Nitrate 2 Nitrite 1 Nitrite 2
Mean 18.3 21.4 23.6 23.7 23.5 24.1
Range 8.7-35.5 9.9-38.9 9.0-58.0 11.4-47.6 12.8-39.8 11.0-48,3
Standard
Deviation 8.28 9.28 14.93 9.69 7.54 11.55
Key;
1: First study day pull-through data 2: Second study day pull-through data
Table 4.4: Analysis of the effect of solution order (1®^  or 2"^) on the LOS 
MEEP, comparing both nitrate controls, both nitrite results and both baselines 
(Water pull-throughs), p value calculated using a 2-sided paired sample t- 
test.
Categories compared 
(n” 12 each group) p value <
Water 1 v Water 2 0.39
Water 1 v Nitrate 1®^ 0.18
Water 1 v Nitrite 2°^ 0.15
Water 2 v Nitrate 2"^ 0.54
Water 2 v Nitrite 1®^ 0.37
Nitrate 1®* v Nitrite 2"^ 0.98
Nitrate 1®^ v Nitrate 2"^ 0.99
Nitrite 1®^ v Nitrite 2"*^ 0.87
Nitrate 2"^ v Nitrite 1®* 0.90
Nitrate 1®* v Nitrite 1®^ 0.90
Nitrate 2"^ v Nitrite 2"^ 0.95
Key:
1: First study day pull-through data 2: Second study day pull-through data
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Table 4.5: Pooled data of other measured LOS parameters.
LOS length ! cm LOS abdominal length / cm LOS lower border / cm from nostril
n = 24 Mean Range S.D. Mean Range S.D. Mean Range S.D,
Water 3.93 2.6-5.9 0.78 2.73 0.6-4.8 0.95 46.89 39.1-50.0 2.83
Nitrate 4,22 2.5'5.9 0.94 2.87 1.2-4.7 0.94 47.19 40.8-51.6 2.63
Nitrite 4.15 3.1-5.2 0.67 2.65 1.6-4.3 0.76 46.68 39.1-49.8 2.88
Nitrate v Nitrite, 
p value < 0.68 0.35 0.11
Water v Nitrate, 
p value < 0.12 0.56 0.18
Water v Nitrite, 
p value < 0.24 0.73 0.49
Table 4.6: Analysis of sphincter parameters related to their order and day of 
delivery. Day 1 nitrate solution was given before nitrite and vice versa on day 
2 .
LOS length 1 cm LOS abdominal length 1 cm LOS lower border / cm from nostril
n = 12 Mean Range S.D. Mean Range S.D. Mean Range S.D.
Water 1 3.80 3.2-4.7 0.56 2.66 1.4-3.8 0.81 46.9 39.1-50.0 3.08
Water 2 4.07 2.6-S.9 0.96 2.80 0.6-4.8 1.10 46.9 39.7-49.4 2.69
Nitrate 1 4.22 2.5-S.9 1.10 2.85 1.4-4.6 0.90 47.4 40.8-51.6 2.94
Nitrate 2 4.21 3.3-5.S 0.79 2.86 1.2-4.7 1.02 47.0 41.6-50.1 2.38
Nitrite 1 4.25 3.2-5.2 0.72 2,79 1.8-3.9 0.78 47.3 40.6-49.8 2.54
Nitrite 2 4.04 3.1-5.2 0.82 2.50 1.6-4.3 0.74 46.0 39.1-49.7 3.15
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Table 4.7: Statistical comparison of the LOS parameters using a 2-sided 
paired sample t-test.
n = 12 each group LOS length / cm 
p value <
LOS abdominal 
length / cm
p value <
LOS lower border 
/
cm from nostril 
p value <
Water 1 v Water 2 0.46 0.77 0.89
Water 1 v Nitrate 0.20 0.56 0.21
Water 1 v Nitrite 2"^ 0.08 0.73 0.13
Water 2 v Nitrate 2"^ 0.40 0.84 0.61
Water 2 v Nitrite 1®* 0.95 0.35 0.11
Nitrate f  v Nitrite 2"‘^ 0.92 0.83 0.87
Nitrate 1®* v Nitrate 2"^ 0.98 0.98 0.29
Nitrite 2"  ^v Nitrite 1®* 0.46 0.18 0.01
Nitrate 2"  ^v Nitrite 0.51 0.32 0.09
Nitrate 1®* v Nitrite 1®* 0.58 0.29 0.01
Nitrate 2"'* v Nitrite 2"^ 0.90 0.87 0.33
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Table 4.8: Table of mean values with 95% confidence intervals (Cl) for the 
data sets.
LOS Pressure 
/ mmHg
Sphincter 
Length / cm
Abdominal Sphincter Sphincter Lower Border / 
Length / cm cm from nostril
Mean Cl Mean Cl Mean Cl Mean Cl
Pooled Water 19.9 2.38-37.3 3.9 2.4-S.5 2.7 0.8-4.6 46.9 41.2-52.6
Water Day 1 18.3 1.8-34.9 3.8 2.7-4.S 2.7 1.0-4.3 46.9 40.8-53.1
Water Day 2 21.4 2,8-39.9 4.0 2.1-6.0 2.8 0.6-5.0 46.9 41.5-52.2
Pooled Nitrate 23.7 -0.9-48.3 4.2 2.3-6.1 2,9 1.0-4.7 47.2 41.9-52.4
Nitrate 1=' 23.6 -6.2-53.5 4.2 2.0-6.4 2.9 1.1-4.6 47.4 41.5-53.3
Nitrate 2"" 23.7 4.3-43.1 4.2 2.6-S.8 2.9 0.8-4.9 47.0 42.2-51.8
Pooled Nitrite 23.8 4.8-42.9 4,1 2.8-5,5 2.6 1.1-4.2 46.7 40.9-52.4
Nitrite 1=' 24.2 1.1-47.3 4,0 2.8-S.3 2.5 1.0-4.0 46.0 39.7-52.3
Nitrite 2'*'* 23.5 8.4-38.6 4.3 2.8-57 2.8 1.2-4.4 47.3 42.2-52.4
Table 4.9: Reflux episodes at the 2 pH detector sites -  2cm and 9cm above 
the solution delivery site. Number of events was analysed using paired, 2- 
sided t-tests. Total time and mean duration were analysed using unpaired, 2- 
sided t-tests.
2cm 2cm 9cm 9cm
Nitrate Nitrite Nitrate Nitrite
Mean (SD) Mean (SD) p value < Mean (SD) Mean (SD) p value <
Number of 
events 26.1 (17.3) 28.8 (25.6) 0.49 4.41 (6.3) 6.2 (6.1) 0.02
Total time pH<4 / 
secs 1205 (938) 1351 (996) 0.26 566 (863) 630 (827) 0.29
Mean duration of
event/ secs 96.5 (188) 186 (472) 0.30 62.3 (84.3) 60.8 (63.0) 0.91
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Figure 4.1: Example of pH step-up at squamo-columnar junction.
C'istal p HpH 7 5 -
6 0
4 5
3 0
Key: numbers along top represent cm markers from the nares. pH on y axis. Time on x-axis 
in minutes.
Figure 4.2: Location of the Four Radial Manometry Channels (2281-R 
catheter, Mediplus) in the LOS and position of the 2 pH recording probes.
Mediplus Catheter. 2281R
Oesophagus
Oesophageal port 
-10cm
pH probe -9cm
Gastric
FundusHighPressure
ZoneOesophageal port -5cm
pH probe -  2cm
Four Radial Channels in 
LOS positioned at SCJ 
Placement at 0cm
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Figure 4.3: Graph to show concentrations of NO converted to nitrite 
measured by capturing the catheter’s solution (Mediplus 2281-R) under 
phosphate buffer solution (pH 7.4) and then analysed by the Greiss reaction. 
Also, for comparison, the [NO] recorded directly by a bench-top NO probe 
(ISO-NO Mark II, World Precision Instruments) from the catheter tip.
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Tim e / m inutes
Standard Nitrate meal of 2 millimoles KNO^
Expected to recycle 25% to salivary glands
Average conversion of 25% to nitrite in oral cavity by buccal bacteria 
Therefore, 1/16^ *^  of meal ends up as nitrite over 3-4 hours
Potential conversion to NO (Amount of Nitrite) = 125 umoles
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Figure 4.4: Day to day comparison of pH step-up points for the 12 
volunteers.
I l  43II:g
CL 49
Dayl Day 2
Minor differences can be seen between visits, but are within the expected 
errors of the procedure protocol.
Figure 4.5: Manometry tracing depicting how the sphincter Lower Border, 
Respiratory Inversion Point and the Upper Border can be cited.
Slow motorised pull-through of LOS with syringe driver supplying radial 
channels.
20
0.0 d
L L B d ,
/ \ ^45
R IP (1 ) 4' L U B (1 ) 42
Scale in mmHg. One centimetre pull-through markers on trace. LLB = Lower oesophageal 
sphincter Lower Border. RIP = Respiratory Inversion Point. LUB = Lower oesophageal 
sphincter Upper Border. Horizontal hatched line represents gastric baseline pressure.
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Figure 4.6: Diagram to show how the cross-over analysis will work. Data 
from each of the 3 pull-throughs (water - baseline, A -  post-nitrate & B -  
post-nitrite) from both study days (6 pull-throughs in total) can be compared 
to those on that day and also from their other visit.
DAY 1
DAY 2
Water A
VBWater
Figure 4.7: Comparison of the pooled data for the 12 volunteers. LOS 
MEEP/Pressure post nitrate and nitrite. n=24 for each group, p value < 0.96.
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Figure 4.8: Paired data for the pooled results of the other LOS parameters.
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Figure 4.9: Reproducibility graph of LOS MEEP (n=12). Correlation co­
efficient = 0 .12.
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Figure 4.10: Charts to show 95% confidence intervals (Mean +/- 2SD) for the 
4 measured sphincter parameters. These are subdivided into pooled data 
and subsets assessing the order of solution delivery.
(Statistics for pooled data - Table 4.2, un-pooied data -  Table 4.6)
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In vitro assessment of nitric oxide gas production.
Chapter 5
177
Chapter alms:
During creation and testing of the NO solution, with increasing 
concentrations of nitrite, a saturation point was reached. At this point NO 
came out of solution and manifested itself as gas bubbles lining the syringe. 
Although this appeared to be under control in the experimental equipment in 
vitro, we wanted to see if there was a possibility that this may still happen 
when the solution encountered acid and had left the tubing system.
A set of bench-top experiments was designed using a contained glass 
system, and modelling the experimental conditions of the meal study, when 
the amount of NO to be delivered would be greatest. NO gas volume 
produced was calculated by the differences in intra-container pressure 
caused on a vertical fluid column. The environment within the container was 
also modified to reduce oxygen levels, and increase inert volume, to assess 
the impact on NO production.
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6.1 in vitro  assessment of nitric oxide gas production
5.1.1 Aim:
To assess and quantify the possible contribution of NO gas formation 
following infusion of the test solutions into the stomach.
5.1.2 Background:
It is well characterised that TLOSRs occur as a result of gastric stretch 
and distension, primarily to the proximal stomach, and very likely the cardia 
itself. There is a theoretical risk that NO may come out of solution when it 
leaves the catheter and enters the stomach, forming a potentially significant 
volume of gas. 400p,moles of NO gas infused over 1 hour could occupy 
9.48m^ at 37°C and atmospheric pressure. With a patient sitting upright this 
gas would collect in the proximal stomach causing distension and potentially 
triggering TLOSRs.
5.1.3 Method:
In order to accurately measure gas volumes we needed to design a 
container to act as an ‘artificial stomach’. The chamber would need to be of a 
set volume, so that gas production could be accurately assessed. A sealed 
glass chamber was used for this purpose. It was filled over three-quarters full 
with pH 0.56 MCI. We lowered one of our study manometry catheters into it. 
The opening through which this entered the chamber was sealed with an 
epoxy resin. Other joints were held with safety clips and sealed with a film of 
high vacuum grease (Dow Corning, USA).
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Rising from the base and passing through the top of the sealed glass 
chamber was a hollow glass tube, approximately 8mm In internal diameter. It 
extended almost 80cm vertically from the chamber’s base, and its upper end 
was open to the atmosphere. This would act as a manometer, from which we 
could calculate the pressure of the potential air/gas mixture in the sealed 
chamber. Prior to any experimentation this would mean that the manometer 
pressure was equilibrating with the air pressure In the head of the chamber. 
The complete apparatus was submerged into a water bath, sitting on a 
heater plate. This was warmed to 37°C to mimic physiological conditions. 
The sealed chamber had glass feet to elevate it from direct contact with the 
heater plate. The water bath contained a magnetic stirrer to maintain a 
uniform temperature -  see Figures 5.1, 5.2 & 5.3.
Lowering the apparatus into the water bath caused a rise in 
temperature of both the gas and the acid in the sealed chamber. Although 
having a minor effect on the liquid, the gas expands, thus causing the level of 
the manometer to rise. Following a period of temperature equilibration, the 
manometer level was reduced, by withdrawing fluid back through one of the 
catheter lumens, until it was level with the main body of acid again.
The central lumen of the manometry catheter was sealed off with 
epoxy resin, as were the 4 proximal manometry channels. The same study 
infusions (Table 3.3) were then run through each of the 4 distal manometry 
channels at the standard study rates (99.9mls/hr/channel). The Nitrous Acid 
(NA) solution was identical to the NO generating solution apart from an 
absence of ascorbic acid from the ‘gastric channels’. The Control solution 
contained ascorbic acid, but not nitrite. This set of solutions would be used in 
our main study (Chapter 6) and the solutions detailed in Table 6.1. Solutions
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passed through identical lectro-caths and pressure transducers to mimic the 
study conditions.
5.1.4 Calculations:
The endpoint of the experiment would be when the manometer level 
had risen by a set vertical distance above its starting position. The volume of 
fluid needed to fill this part of the manometer column was measured. 
Recording the time needed for the infusion to produce this rise was 
documented for each solution. Prior to any experiments, the total volume of 
the sealed chamber was measured, as were the initial volume of hydrochloric 
acid and air (constant for all experiments). Simply by subtracting the amount 
of fluid infused from that in the manometer column would show how much 
had stayed in the chamber. If the NA (NO solution minus Ascorbic Acid) or 
NO solutions needed to infuse less volume than the control, then the 
difference would be the volume occupied by NO gas formation.
This volume of gas would be at atmospheric pressure plus the 
pressure from the manometer column. The volume at 37°C could then be 
recalculated at atmospheric pressure alone. There is always a little ‘dead- 
space’ within the lectro-caths and length of the manometry catheter. For this 
reason, the cumulative dead-space was measured for alt 4 channels. This 
could be subtracted from the total volume infused to give the actual volume 
of active test solution reaching the sealed chamber. Depending on the 
duration of the infusion, the gas volume could be extrapolated to suggest a 
potential volume of generation over the total hour infusion. This calculation 
would assume a linear production of gas over the hour infusion.
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5.1.6 Solutions:
The apparatus was first tested with distilled water followed by the 
study Control solution (Table 5.1). These baseline recordings would hopefully 
confirm that the Control solution itself did not produce any gas. Following 
this, the experiment was repeated with NA and then NO generating solutions 
in the syringes (Table 5.2). All test solutions including the distilled water in 
the manometry dead-space were deoxygenated by pre-gassing them with 
Argon.
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5.1.6 Results:
Total volume of artificial stomach = 640mls
Initial ratio of 476mls acid & 64mls of air
Volume of column of fluid caused by infusion = 23.5mls
Endpoint - duration of infusion to achieve manometer height of 0.7m
Distilled water / Control = 5 minutes (33.3mls infused)
NA = 4 minutes 45 seconds (31.7mls infused)
NO = 4 minutes 30 seconds (30mls infused)
Pressure calculations
Pre-infusion pressure in stomach chamber = atmospheric (100Pa) 
Post-infusion pressure = atmospheric + pressure from fluid column 
= 100 + (p X g X h)
=100 + (solution density x acceleration due to gravity x column height) 
[density of solution is 1.00 to 3 significant figures, g=9.81ms‘ ]^
= 100+ (1 X9.81 xO.7)
= 106.86Pa 
Gas volume
Volume of gas produced at 106.86Pa 
= difference between infusion volumes compared to control 
Volume of NO gas from NO generating solution 
= 33.3 -  30mls at 106.86Pa 
= 3.3mls at 106.86Pa
= 3.53mls at atmospheric pressure (sea level) and 31 OK (37°C) 
Volume of NO gas from NA solution 
= 33.3 - 31.7mls at 106.86Pa 
= 1.6mlsat 106.86Pa
183
= 1.7mls at atmospheric pressure (sea level) and 31 OK (37°C)
Predicted NO gas generation
Dead space of tubing prior to reaching glass chamber is 4 x 2.4mls (supply to 
each of the distal manometry ports).
Therefore, the volumes of active solution infused are 
Control: 33.3 -  (4 x 2.4) = 23.7mls 
NA: 31.7 - (4 X 2.4) = 22.1 mis 
NO: 30 -  (4 X 2.4) = 20.4mls
Assuming linear NO release over one hour (400mls infused) this could 
potentially generate 
= 3.53mls X (400/23.7)
= 59.5mls of NO gas over 1 hour from NO generating solution at 
atmospheric pressure (sea level) and 310K (37°C)
Potential NO from NA here 
= 1.7mlsx (400/22.1)
= 30.8mls of NO gas over 1 hour from NA solution at atmospheric 
pressure (sea level) and 31 OK (37*^C)
5.1.7 Discussion:
We have devised a system that allows the infusion solution to be 
captured In a sealed chamber. In doing so, and by use of a manometer, we
have been able to assess the amount of NO gas released by each of our
study solutions over a short duration. Performing linear extrapolation, we
have been able to estimate the potential volume of NO gas that may be
produced over the full hour infusion.
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5.1.8 Conclusion:
This experiment confirms the generation of NO gas from our study 
solutions. However, these are slightly confusing results, in that the NA 
solution produces almost 50% of the volume of gas as the NO solution. In 
order to investigate our concerns over the relatively low volumes of NO gas 
produced we decided to devise a further set of experiments. As stated, at 
37°C, if all of the NO were to come out of solution and assume gaseous form, 
the total amount (400jLimoles) could occupy 9.48 m^ at sea level.
We calculated that approximately 60mls of NO gas would be 
produced, which equates to 6x10 ®% of that expected. Also of concern was 
the amount of NO gas produced from the saturated NO solution, relative to 
the volume of NO gas produced by the NA solution (NO approximately 1% by 
concentration). When the chemical reaction was examined, we were able to 
postulate several possible explanations.
With NA, the low NO concentration means that the NO is more likely 
to remain as NO in solution. However, with the higher NO concentration in 
the NO generating solution, it has potential to react rapidly with the O2 in the 
HCI and head of air in the chamber. This will form nitrite, which the Vitamin C 
will convert back to NO. However, if this recycling depletes the Vitamin C, 
which will happen very quickly, then the NO will stay as nitrite, thus reducing 
the amount of NO gas formed.
Secondly, although the NO concentration is very high coming out of 
the catheter for the NO generating solution, once it enters the chamber it will 
be rapidly diluted by the large quantity of acid. This may, in theory, lower its 
concentration closer to that of the NA solution, reducing the tendency of the 
NO to preferentially leave solution. It is relatively important to know the
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answer to this, as it will reassure us as to whether the NO effects seen in our 
study, were pharmacological, physiological, physical, or a combination.
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5.2 In  v itro  assessment of dissolved oxygen in the recycling and 
formation of NO and nitrite.
5.2.1 Aim:
To see the impact of deoxygenating the artificial stomach on NO gas 
formation.
5.2.2 Method;
Using the same apparatus as before, the NO generating experiment 
was repeated with slight modifications. All solutions were prepared with 
argon deoxygenation. For extra thoroughness, all solutions had a head of 
argon placed above them before replacing the lid. This was achieved by 
suspending the gassing stone above the level of the solution for 
approximately 1 minute. Also, the pH 0,56 HCI in the artificial stomach 
(476mls) was deoxygenated with argon gassing. Also, an argon head was 
delivered to replace the air in the chamber, before placing the airtight cap.
The same starting volumes of acid and gas in the chamber were used. 
Again, it was lowered into a water bath at 37°C, and after a period of 
temperature equilibration, the NO generating infusion was commenced. The 
previous control experiments were used as the control comparison for this 
run. Gas volume calculation was performed as previously described.
5.2.3 Results:
Endpoint - duration of infusion to achieve manometer height of 0.7m 
NO (fully deoxygenated) = 4 minutes 30 seconds (30mls infusion)
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Control (non-deoxygenated) = 5 minutes (33.3mls infused)
NO gas generated in chamber
= 33.3mls -  30mls at 106.86Pa 
= 3.3mls at 106.86Pa
= 3.53mls at atmospheric pressure (sea level) and 31 OK (37®C)
5.2.4 Discussion:
As well as continuing to deoxygenate all test solutions prior to mixing 
and the dead-space distilled water, we have also removed the oxygen from 
the contents of the artificial stomach by pre-gassing with argon. We have 
used the same volume of acid in the artificial stomach as in the previous 
experiment. When the concentrated NO solution is infused into the 
submerged, sealed chamber, there is no change in the volume of NO gas 
produced.
5.2.5 Conclusion:
Deoxygenation of the HCI in the artificial stomach does not appear to 
have an impact on the production of NO gas from the concentrated NO 
solution. However, dilution of the NO solution from the catheter tip into the 
large volume of the chamber’s acid must be taken into account, and may 
explain our results. The next experiment was designed to address this.
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5.3 Assessment of concentrated NO solution dilution on its ability to 
produce NO gas in a deoxygenated environment
5.3.1 Aim:
To assess if NO gas production, in a deoxygenated environment, is 
more prolific from a concentrated NO solution.
5.3.2 Method:
Once again the same artificial stomach was used for this experiment. 
All solutions, Including the acid in the artificial stomach were deoxygenated. 
Heads of argon gas were placed in the chamber and also into the solutions' 
containers before they were mixed. A  smaller volume of acid was placed into 
the artificial stomach (78mls compared to 476mls previously) -  see Figure 
5.4. This was the lowest amount that would cover the lower end of the 
manometer column, and also not cause major issues with chamber 
buoyancy. Due to a lower volume of acid in the artificial stomach and a 
greater amount of gas, this meant that the chamber had to be forcibly held by 
clamps to the bottom of the water bath for the duration of the experiment.
Distilled water was used as a control run. All 4 syringe drivers were set 
at 99.9mls/hr/channel and delivered their infusion into the chamber until the 
manometer column had reached the target vertical limit as set before. The 
experiment was then repeated with the NO generating solution, and 
deoxygenated HCI in the chamber. As the fluid level in the chamber at the 
start of the experiment was lower than before, this meant that the change in 
height of the manometer fluid column would be greater than before. This 
height was measured and also the volume of fluid needed to achieve this.
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5.3.3 Results:
Total volume of artificial stomach = 540mls 
Initial ratio of 78mls acid and 462mls of Argon 
Height of manometer column at end of infusion = 76.5cm 
Volume of fluid to fill the manometer column = 27.5mls
Endpoint - duration of infusion to achieve manometer height of 0.765m 
Distilled water control = 9 minutes 39 seconds (64.3mis infused) 
NO generating solution = 9 minutes (60mls infused)
Volume of NO gas produced = 4.3mls after 9 minutes
Pressure acting on gas in chamber at 37°C:
= Atmospheric + column of manometer fluid
= 100 + (p X g X h)
= 100+ (1 X9.81 X 0.765)
= 107.7Pa
Volume of NO gas at atmospheric pressure and 37°C 
= 4.66mls
Volume of NO solution infused:
= 60 -  (4 X 2.4)
= 50.4mls
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Potential volume of NO gas generation, assuming linear production 
= 4.66 X (400/50.4)
= 37mls
Calculated concentration of NO in the artificial stomach after dilution
Original experiment with ‘full’ stomach 
= 1.1mmol/l X 30mls/(30mls + 476mls)
= 0.065mmol/l
Repeat experiment with ‘empty’ stomach 
= 1.1mmol/l X 60mls/(60mls + 78mls)
= 0.48 mmol/l
Ratio of end NO concentrations in chamber for each experiment 
= 0.48mmol/l / 0.065mmol/l 
= 7.36 fold difference
5.3.4 Discussion:
We have adapted the artificial stomach system from our original 
experiment. The oxygen has been completely removed from the system to 
the best of our ability, and also the starting volume of acid in the chamber 
has been reduced in order to minimise the dilution of the NO solution 
entering the chamber. Despite these measures there does not appear to be 
any dramatic increase in the volume of NO gas produced. Also, the predicted 
volume of NO gas from this last experiment is actually less than that of the 
original run. This implies that the release of NO from solution to form gas is 
not linear.
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There is a low O2 tension within both gastric juice and the stomach. 
The amount of vitamin C present is critical to the amount of NO produced. 
There does, however, not appear a great amount of NO gas generated, even 
under theoretically ideal conditions.
5.3.5 Conclusions:
Due to the variable availability of vitamin C at the cardia, and from our 
results with the artificial stomach, it is highly unlikely that a large volume or 
even small ‘blasts’ of NO gas would be formed. Certainly, there would not be 
a large enough volume to cause a physical distension of the proximal 
stomach, triggering TLOSRs.
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5.4 Assessment of gas volume head space on the ability of NO gas 
production from a concentrated NO solution.
5.4.1 Aim:
To assess if the pre-existing volume of gas in the artificial stomach’s 
head space plays a role on the amount of NO gas generated from the 
concentrated NO solution.
5.4.2 Method:
The same artificial stomach set up was used as before. The initial 
volume of acid in the stomach was again 78mls prior to the start of the 
infusion. This had been pre-gassed with argon to remove the oxygen. A head 
of argon gas was also added to the chamber before closure. Added to the 
glass chamber was a known volume amount of glass marbles (Figures 5.5 &
5.6). This inert occupation of space would allow for a reduction in the volume 
of gas in the chamber and thereby reduce the gas/liquid volume ratio. The 
potential concentration of NO in solution will be dictated by the volume of 
acid into which the concentrated NO solution is infused -  see Table 5.4.
The volume occupied by the marbles was calculated by their 
displacement of water in a measuring cylinder. Two different volumes of 
marbles were used, so that, including the marble-free run already performed, 
we would have 3 points from which a relationship or trend could be observed. 
Once lowered into the water bath and temperature equilibration had taken 
place, the NO generating solution (Table 3.3) was infused at the standard 
rate (99.9mls/hr/channel). The initial volume of gas in the chamber was 
calculated by subtraction of the marbles volume from 462mls. Volume of NO
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generated was calculated as before, using the time to reach a set rise in the 
manometer height as the endpoint.
5.4.3 Resuits: (summarised in Table 5.3)
Run 1 with control:
Volume of marbles added to chamber = 105mls 
Volume of acid in chamber = 78mls 
Volume of Argon in chamber = 357mls 
Time taken for infusion to reach end-point:
NO generating solution = 7 minutes 51 seconds 
Distilled water = 8 minutes 5 seconds 
Infusion volumes:
NO generating solution = 52.3mls
Distilled water = 53.8mls
Volume of NO gas generated = 1.5mls
Volume of fluid to fill manometer column to end-point = 26.5mls 
Vertical height of manometer to reach end-point = 81cm 
Pressure from column = (p x g x h)
= 1 X 9.8 X 0.81 
= 7.94 Pa
Volume of gas at 1 atmosphere (100 Pa)
= 1.6mls
Potential volume of NO gas from total infusion 
= (400/52.3) X 1.6 
= 15mls
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Run 2 with control:
Volume of marbles added to chamber = 205mls 
Volume of acid in chamber = 78mls 
Volume of Argon in chamber = 257mls 
Time taken for infusion to reach end-point:
NO generating solution = 6 minutes 15 seconds 
Distilled water = 6 minutes 39 seconds 
Infusion volumes:
NO generating solution = 41.6mls 
Distilled water = 44.3mls 
Volume of gas generated = 2.7mls
Volume of fluid to fill manometer column to end-point = 26.5m!s 
Vertical height of manometer to reach end-point = 81cm 
Pressure from column = (p x g x h)
= 1 X 9.8x0.81 
= 7.94 Pa
Volume of gas at 1 atmosphere (100 Pa)
= 2.9 mis
Potential volume of NO gas from total infusion 
= (400/32) X 2.9 
= 36.25mls
Volume of NO generating solution entering chamber excluding dead-space: 
105mls of marbles = 42.7mls 
205ml of marbles = 32mls
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5.4.4 Discussion:
This set of studies reveals a little more about the manner in which NO 
comes out of solution. It gives some insight into the effects of the liquid:gas 
ratio on NO gas release. It also shows the effect of different [NO], caused by 
solution dilution in the chamber, on gas production in a similar environment. 
There are several factors that need to be taken into account to interpret this 
data. We know that the release of NO gas from solution is unlikely to be 
linear. Our endpoints are when a similar pressure column has been attained.
As there are different volumes of the same NO study solution being 
infused, and the volume of acid in the chamber stays the same, the potential 
concentration of NO in the chamber liquid is different for each. In the run with 
no marbles the calculated concentration of NO is 0.40mmol/l. For the 105mls 
of marbles run the NO concentration is calculated at 0.36mmol/l, and the 
205mls of marbles run at 0.29mmol/l.
Therefore, the amount of gas produced in each of these runs is going 
to be multifactorial ie: based upon the concentration of NO in the chamber 
and also the ratio of volume of liquid and gas existing in the chamber. This is 
clear to us, as the amount of gas potentially produced from the marbleless 
chamber is 37mls. This is similar to the 205mls of marbles run (36.3mls), but 
higher than the 105mls of marbles run (15mls). This is despite the 
concentration of NO in the chamber liquid decreasing in concentration with 
each experiment. There are also possibly some errors which have not been 
taken into account.
As our gas to liquid ratio is probably still a little high even for the 
205mls of marbles run (78mls of acid and 257mls of Argon), this would imply 
that in a post-meal stomach, the amount of NO gas generated may be even
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higher than we have predicted. Even so, the level is unlikely to be anything 
like that required to cause marked distension of the proximal stomach 
triggering TLOSRs.
5.4.5 Conclusions:
The 3 points do not form a linear relationship as initially one might 
expect. This Indicates several points. Firstly, NO is not behaving as an ideal 
gas. This is mainly as there is a gas liquid interface and Boyle’s law 
(Pressure x Volume = Constant) does not therefore hold. Also, the change in 
surface area of the acid and NO solution may play a role in this equilibrium. 
Finally, the ratio of acid to chamber gas also appears to play a key role in the 
movement of NO between the gas and liquid phases.
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Table 5.1: List of the constituents of the control solution for the ‘meal’ study.
Gastric channels Oesophageal channels
Control study day
Thiocyanate -  1mM 
Hydrochloric acid -  pH 1.0 
E D T A -Im M  
Ascorbic Acid -  5mM
Thiocyanate -  ImM
Key: ‘Gastric’ channels refers to the distal 2 manometry channels and ‘Oesophageal’ 
channels to the 2 channels proximal to this.
Table 5.2: Summary of solution concentrations and catheter tip
concentrations. N A - nitrous acid, NO -  nitric oxide.
Solution [N itrite] in syringe I mmol
[NO] at catheter tip  / 
mmol
NA 1.6 0.012
NO 1.6 1.1
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Table 5.3; Summary of NO production with altered starting chamber Argon 
volume and calculated end [NO] in the chamber.
Volume
occupied
by
marbles
(ml)
Vol of NO 
solution 
added 
(ml)
[NO] in 
stomach 
(mmol/l)
Vol of NO 
gas 
produced 
(ml)
Pressure
from
column
(Pa)
Calculated 
volume of 
NO over 1 
hour (ml)
0 50.4 0.40 4.66 107.7 37.0
105 42.7 0.36 1.6 107.9 15.0
205 32 0.29 2.9 107.9 36.3
Table 5.4: Illustration of how volume of infused acid and container acid 
volume will affect final NO solution concentration.
Final [NO]
In chamber =
NO concentration 
at catheter tip (1.1 mM)
Volume of NO solution added
Starting volume + Dead space + NO solution 
of acid in chamber volume in tubing volume infused
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Figure 5.1 : Cap of stomach chamber with manometry tube secured.
Key: A: Epoxy resin seals, B: Manometry catheter, C: Manometer column for 
stomach, D; Glass cap for stomach, E: Top aperture for manometer 
extension.
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Figure 5.2: Artificial stomach with large acid volume.
Key: A: Oxygenated hydrochloric acid (pH 0.56) (476mls), B: Air in head 
space (64mls), C: Securing metal clip, D: Manometry column, E: Joint sealed 
with high vacuum grease, F: Glass feet
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Figure 5.3: Submerged artificial stomach.
Key: A: Securing plastic clip, B: Water at 37°C, C: Thermometer, D: Heater 
plate, E: Magnetic stirrer
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Figure 5.4: Artificial stomach with small acid volume.
Key: A: De-oxygenated hydrochloric acid (pH 0.56) (78mls), B: Argon in 
head space (462mls)
r
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Figure 5.5: Artificial stomach with inert occupation by small volume of 
marbles.
Key: A: De-oxygenated hydrochloric acid (pH 0.56) (78mls), B: Argon in 
head-space (357mls), C: Marbles in chamber (105mls).
T: i
%
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Figure 5.6: Artificial stomach with inert occupation by large volume of 
marbles.
Key: A: De-oxygenated hydrochloric acid (pH 0.56) (78mls), B: Argon in 
head-space (257mls), C: Marbles in chamber (205mls).
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The influence of luminal nitric oxide and 
nitrous acid on human LOS pressure and 
oesophageal pH, in the post prandial state.
Chapter 6
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Chapter aims:
This chapter examines the physiological effects of the nitric oxide and 
nitrous acid solutions delivered to the cardia region of the human upper 
gastrointestinal tract. As there was no effect seen in the fasting study, this 
study is carried out following a meal, when the upper gastrointestinal tract is 
under more direct stress and both TLOSRs and reflux are known to be more 
common. Higher doses of the luminal chemicals are used to model the 
increased levels present in saliva, as would be expected following a meal. 
The primary end-point of the study will be to look at the effects of the 
solutions on LOS pressure. Other secondary end-points, such as post­
prandial TLOSR rates and intra-oesophageat pH will also be addressed.
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6.1 Background:
Gastro-oesophageal reflux disease is caused by excessive acid 
exposure of the oesophagus. Luminal acid is neutralised by secreted 
mucosal bicarbonate and the delivery of saliva. This is carried into the 
stomach by both a wave of peristalsis, and gravity when in the upright 
posture. TLOSRs are the major mechanism of reflux events in both healthy 
subjects and also those with reflux disease. Nitric oxide antagonists have 
been shown to inhibit the triggering of TLOSRs by gastric distension. The 
physiological effects of luminaliy generated NO, in the proximal 
gastrointestinal tract of humans, is not known.
Human saliva has a high concentration of nitrite, which is derived from 
the enterosalivary recirculation of nitrate (232). Approximately 25% of the 
nitrate absorbed from the small Intestine, and produced endogenously, is 
taken up by the salivary glands and secreted into the mouth (233). 10-90% of 
the nitrate in saliva is reduced to nitrite by bacteria on the dorsum of the 
tongue (234).
When saliva is swallowed and encounters the acidic pH of the cardia, 
the nitrite within it is immediately converted to varying proportions of NA and 
NO (235). If ascorbic acid or other reducing agents are present in adequate 
amounts in the acidic gastric juice then all the nitrite is converted to NO in a 
1:1 molar ratio. In the absence of reducing agents the nitrite is converted to 
nitrous acid and only 1% to NO (236). The NA will also react with available 
thiols to form nitrosothiols (196).
Nitric oxide plays an important role in the physiological regulation of 
gastro-oesophageal motility. Neuronally released NO and NO donors such as 
nitrosothiols relax the body of the oesophagus, the LOS (196) and also the
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body of the stomach (141). This is mediated by NO increasing activity of 
cGMP (179). Increased local availability of NO could explain several of the 
pathophysiological features of GORD, including transient relaxations of the 
muscularis externa in the LOS, reduced sphincter tone and impaired 
oesophageal clearance.
The fact that substantial amounts of NO and nitrosothiol chemicals are 
generated when saliva meets gastric acid raises the possibility that this 
luminal chemistry might affect gastro-oesophageal motility and potentially 
contribute to the pathogenesis of reflux disease. Such an effect would 
depend upon the ability of these chemicals generated within the lumen to 
exert an effect on the musculature within the adjacent mucosa.
6.2 Aim:
The aim of this study was to determine whether luminaliy administered 
NO and/or NA could influence the generation of TLOSRs following a meal. 
Data on IGP, oesophageal acid exposure and peristalsis would also be 
collected during the study.
6.3 Study population:
15 healthy volunteers were recruited for this study. All were found to 
be H. pylori negative by urea breath test. We defined a healthy volunteer as 
someone with no upper gastrointestinal symptoms and no past history of 
upper gastrointestinal surgery. None were taking any form of acid 
suppression medication or antacids. We examined 8 males, average age 31 
years (range 23-43) and 7 females, average age 41 years (range 31-58). 
Body mass index was slightly higher in the females, mean 26.7 (range 21.2-
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30,5) and 25 for the males (range 19.3-29.8). Smokers were allowed to 
participate in the study but did not smoke on the day of their investigation.
6.4 Method:
6.4.1 Overall protocol:
Studies of the effect of luminal NO and NA on gastro-oesophageal 
function were performed after eating, as this is the time when the salivary 
delivery of these chemicals is maximal. It is also the time when TLOSRs 
characteristically occur with subsequent acid reflux (237). Each patient had 
SMPT manometry of their LOS performed (49), before and after a meal to 
identify the HPZ. Following the meal, test solutions were infused for one hour 
into the cardia region of the stomach. Throughout the infusions static 
manometry recordings of both the HPZ and oesophageal body was 
performed, as well as pH recordings of the oesophagus. Post-infusion SMPT 
manometry of the HPZ was also performed. Each subject attended for 3 
study days, receiving on each day in a double-blind randomised order, one of 
the following infusions; Hydrochloric acid (control), hydrochloric acid plus 
nitrite (nitrous acid), or hydrochloric acid plus nitrite plus ascorbic add (NO 
generating solution) - (Table 6.1 & Figure 6.1).
6.4.2a Details of protocol:
All participants were instructed regarding measures to reduce their 
endogenous salivary nitrite content over the 48 hours prior to each test. This 
included avoiding high-nitrate containing foods i.e.: salads, green leafy 
vegetables, potatoes, beetroot and gargling with 15mls of chlorhexidine 
gluconate mouthwash 0.12% w/v (Chlorohex 1200, Colgate) twice a day, to 
reduce bacterial reduction of salivary nitrate to nitrite (163).
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Subjects attended fasted on the day of each study. While seated 
upright the manometry/pH probe assembly was introduced into the nasal 
airway and swallowed until at least 65cm had been passed. Even without 
active manometry perfusion, but with static columns of water in the 
manometry catheter, passage into the stomach could be confirmed 
manometrically by both deep Inspiration and also by the significant drop in 
pH as recorded by the pH probes.
The patient was then given 15 minutes to get used to the sensation of 
the apparatus before recording began. At this stage, no solutions were 
running through the manometry catheter. A 1 cm-interval station pull-through, 
at 1 minute time intervals, was performed to locate the pH-step-up point, 
which in the fasting state, is just distal to the SCJ (23).
The apparatus was then passed back into the stomach and all 8 
pressure channels were perfused with de-oxygenated distilled water at the 
flow-rates described in the manometry section (6.4.2b). With the subject 
reclined at 20° to the horizontal a SMPT was performed (Catheter Puller, 
Medtronic Functional Diagnostics A/S, Denmark), using a withdrawal rate of 
1 mm/second. This was done during normal respiration and outwith any 
swallowing events. This gave a fasting baseline profile of the LOS, from 
which we could calculate a) the total length of the high pressure zone and its 
position relative to the nares, b) the RIP and therefore the length of the 
abdominal component of the sphincter c) the MEEP relative to the gastric 
baseline pressure and d) the position of the pH step-up/SCJ relative to the 
HPZ.
The distal four pressure channels only were used to assess these 
parameters, and all channels were withdrawn from the stomach into the
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oesophageal body. Proximal oesophageal channels were also perfused with 
distilled water at the same time to detect peristalsis, as all HPZ analyses 
needed to be performed outwith swallowing events. The syringes used to 
supply the distilled H2O were different to the ones used for the test solutions 
in the later experiments.
Following the SMPT the manometry perfusion was stopped and the 
apparatus passed back into the stomach. The patient sat up and was given a 
standard battered fish and chip meal with a glass of water to drink. Acid 
buffering within the stomach could be observed with the pH probes in situ. 
One to two minutes after ingestion of the meal the patient lay flat and the 
SMPT was repeated with deoxygenated distilled water running through all 
channels. This allowed us to see the degree of shortening of the sphincter 
caused by the meal and also any coincidental changes related to pressure, 
again using the fasting gastric baseline pressure as a reference value.
The patient then sat upright and the apparatus was passed back into 
the stomach. It was withdrawn to the point where the most distal channel was 
recording gastric pressure, and according to the pressure pull-through profile, 
the channel proximal to this was recording pressure in the lower part of the 
sphincter. The manometry and pH assembly was then taped to the nose for 
the one-hour recording period -  see Figure 6.2.
With the assembly positioned, perfusion of the test solutions was 
commenced through the lower 4 manometry channels and distilled water 
through the oesophageal channels. Each of the syringes contained SOmIs of 
solution running at 100ml/hour. Therefore, each syringe needed to be 
changed halfway through the recording process, creating a brief hiatus for 
data acquisition. It is important to note that we were using the perfusion
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system for a dual purpose, to deliver test solutions and to monitor pressure. 
Subjects were not allowed to speak or drink during the recording period to 
avoid unnecessary activation of the swallow sensor.
After the 60 minute perfusion period the manometry assembly was 
reinserted into the stomach, the subject lay flat, and a final SMPT performed, 
again using deoxygenated distilled water as the perfusate through all 8 
manometry channels. This pull-through was performed several minutes after 
the infusion had stopped and was, therefore, no longer bathing the cardia 
region.
6.4.2b Manometry:
A Muiscientific water perfused manometry pump was used (PIP-4-8, 
Muiscientific, Canada). Recordings were transferred through pressure 
transducers (Mediplus, 203216, High Wycombe, UK) via a 12 channel 
Polygraf (Medtronic Functional Diagnostics A/S, Denmark) to a personal 
computer and assessed using the Polygram Net software package (Version 
4.01.525.45, Medtronic A/S, Denmark). A 3.8 millimetre eight lumen 
manometry catheter was used (2282, Mediplus, UK). This catheter was made 
from medicat-grade PVC. With 5 centimetres of distal dead-space, moving 
proximally, the port intervals were 1cm, 1cm, 1cm, 2cm, 5cm, 5cm and 5cm. 
The 4 most proximal catheter ports were perfused with deoxygenated 
distilled water from the manometry chamber at a pressure of 15Kpa, giving a 
flow rate of 0.45mls/minute/channel.
The 4 lower catheter channels were supplied by individual syringe 
pumps (Perfusor, Braun, Berlin, Germany) connected to the efferent pressure 
transducer port by 1mm internal-diameter PVC tubing (1155.10, Vygon, 
Cirencester, UK). Lectrocaths were used in place of standard capillary tubing,
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as the resistance generated was too great for the syringe drivers to 
overcome at an acceptable flow rate. As larger calibre tubing was in use, all 4 
syringe pumps were placed below the level of the manometry catheter ports 
to prevent siphoning. The syringes delivered solutions at their maximum flow- 
rate of 1.67mls/min for each individual channel. The solution delivered by 
each pump is described below. All manometry channels were calibrated, 
whilst running at their experimental flow-rates, in a 2-point fashion at zero 
and 680mmHzO (equivalent to 50mmHg).
6.4.2c pH:
A 2-channel antimony crystal paediatric pH probe (26270, Mediplus, 
UK) was used to assess pH and reflux events during this study. The probe 
was 1.5mm in diameter, with an external reference electrode, and the 2 
sensors positioned 7cm apart. The 2 sensors and reference electrode 
underwent a 2-point calibration in Phosphate-free buffer at pH 1.07 and pH
7.01 (Medtronic A/S, Denmark). The pH probe was attached to the 
manometry catheter with thin strips of adhesive tape (Mefix, Tendra, 
Sweden) so that the lower recording sensor was 6 cm proximal to the distal 
manometry port - see Figure 6.2.
6.4.2d Swallow sensor:
A small balloon swallow sensor was taped over the cricoid cartilage to 
assess co-ordination of oesophageal peristalsis (RespSponse™ Transducer, 
Medtronic A/S, Denmark). Pressure recordings from this were relayed via the 
Polygraf.
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6.4.3 Solutions:
The 2 distal manometry channels were called the ‘gastric’ channels as 
these would contain hydrochloric acid during the observation period. The 2 
channels proximal to this were called the ‘oesophageal’ channels as these 
would be non-acid containing. This dictated the constituents of the 50ml 
syringes. Three separate study days were undertaken. One acted as a 
control, one had NA and the last had a NO-generating solution contained in 
it. A summary of the syringe contents can be seen in Table 6.1.
6.5 Bench-top studies:
We performed bench-top studies to confirm the concentrations and 
amount of NA and NO delivered by the 3 test solutions through the ports of 
the apparatus. This was performed at 37°C. NO concentration was measured 
by a NO probe (World Precision Instruments, Florida, USA) and NA by 
Greiss reagent. We also assessed the amount of gaseous NO which could 
be produced in vitro by each infusion under physiological conditions.
6.6 Data analysis:
6.6.1 Transient lower oesophageal sphincter relaxations:
TLOSRs were identified from the tracings as prolonged relaxation of 
the LOS as per Holloway’s criteria. TLOSRS are not associated with 
swallowing either 4 seconds before or 2 seconds after the event. The LOS 
relaxation is rapid (>1 mmHg/sec) and decreases to IGP giving a ‘common 
cavity’ event with the oesophagus (nadir pressure <2mmHg). Time to 
complete relaxation is < 10secs. LOS relaxation is longer than that following
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swallow-induced relaxation and is often followed by a marked after­
contraction (112). Frequency, duration and timing during the infusion of 
TLOSRs were documented.
6.6.2 intragastric pressure:
Post-prandial IGP, in the upright position, was measured prior to the 
start of the infusions. Changes in IGP relative to this were analysed at 15 
minute intervals throughout the 3 infusions. To do this, a short section 
(approximately 30 seconds) of the tracing, during proximal stomach inactivity, 
was taken and analysed as a guide of IGP. This was repeated approximately 
15 minutes later on the tracing, or as close to this as possible, as long as 
there was no obvious contractile activity present.
6.6.3 pH:
The number of pH events with a pH less than 4 were recorded, and 
also the duration of each event (time taken for pH to rise above 4). This 
allowed us to calculate a percentage time exposure of pH<4, the average 
time per reflux episode and also the total number of reflux episodes for each 
probe under each study condition.
6.6.4 Manometry:
Parameters of the HPZ were made by calculating the mean value from 
the 4 distal manometry channels. The lower border of the HPZ was identified 
as the point where the end expiratory pressure remains above that of gastric 
baseline pressure throughout the full respiratory cycle. The upper border of 
the HPZ was identified as the point where the pressure drops below
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oesophageal baseline pressure in end expiration. The RIP was identified as 
the point where the pressure deflection decreased in expiration. The MEEP 
was used as the marker of overall HPZ pressure. This was taken in the 
trough phase of respiration and calculated relative to the fasting gastric 
baseline pressure.
Subtracting the mean of the 4 HPZ upper border positions from the 
mean of the 4 HPZ lower border positions gave a mean total HPZ length for 
each subject. Subtracting the mean of the 4 RIP values from the previously 
calculated mean lower border of the HPZ gave a mean length for the 
abdominal length (AL) of the HPZ for each subject.
6.6.5 Swallowing:
The frequency of swallowing events during the infusions was 
assessed. Each infusion was divided into the four time quartiles to see if 
there was any trend between each solution in the pattern of swallowing.
6.6.6 Peristalsis:
To further investigate the acid reflux and clearance data collected, 
data from the oesophageal manometry ports was collected. The three 
channels represented the proximal, mid and distal oesophagus. Pressure 
amplitude of contraction, peristaltic wave velocity and peristaltic wave 
duration were calculated. Wave velocity was only calculated for the mid and 
distal oesophagus. All swallows were 'dry' and the data should be interpreted 
accordingly.
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6.7 Statistics:
As each subject was used as his or her own control the following were 
analysed using a 2-sided paired t-test. Total number of TLOSRs, mean 
duration of TLOSRs, percentage time pH<4 and total number of reflux 
events. Pooled data of all reflux events to assess the mean time per reflux 
episode was analysed using a 2-sided unpaired t-test. AN OVA was also used 
to examine the changes in IGP during the infusion.
6.8 Blinding:
All studies were carried out in a double-blinded randomised-controlled 
fashion. Analyses were performed before unblinding of the data took place.
6.9 Ethics:
This study was approved by North Glasgow University NHS Trust 
Ethics Committee and all subjects gave written informed consent.
6.10 Results:
6.10.1 Manometry:
6.10.1a TLOSRs:
The mean number of TLOSRs per infusion was similar in both the 
control, mean 3.5 (SD 1.7), and NA groups, mean 3.2 (SD 2.1), but 
significantly greater in the NO group, mean 5.2 (SD 2.1), (p<0.01 & p<0.0001 
respectively) -  see Figure 6.3. The mean duration per TLOSR was similar in 
each group, being 20.6 seconds (SD 3.5) for the control, 21.3 seconds (SD
4.7) for NA and 22.9 seconds (SD 4.4) for NO generating -  see Figure 6.4.
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6.10.1b Temporal relationship of reflux events to TLOSRs:
On no occasion did the pH rise during a TLOSR. There was, however, 
no change in pH following 29 of the 177 TLOSRs. 6 occurred during the 
control runs, in 3 separate patients. Of these 6, 2 happened with a pH less 
than 4 (mean pH 1.7). 3 occurred during the NA runs, in 2 different patients. 
2 occurred with a pH less than 4 (mean pH 2.25). 20 occurred in the NO 
runs, in 7 different patients. 19 of these events had a pH less than 4 (mean 
pH 1.4). A total of 52 TLOSRs occurred during the 15 control studies. For 
15% of these the distal pH sensor was at a pH less than 4 prior to the 
TLOSR. This is not different to the NA arm (21%), (p<0.46), but less than that 
seen for the NO arm (46%), (p<0.0001 vs control, p<0.003 vs NA).
6.10.1c Quartile assessment of TLOSR frequency:
Dividing the hour infusion into 15-minute sections allows us to took for 
trends of TLOSRs between the infusions. The NO group had a significantly 
higher frequency of TLOSRs than the control group in the first and last 
quarters (p<0.03 for both). The levels were higher yet again in the middle 2 
quarters, but did not reach significance, possibly due to underpowering of the 
study. Also there was an obvious trend that the frequency of TLOSRs was 
maintained throughout the infusion. This differed to both the control and NA 
groups, which showed a trend towards a reduction in TLOSR frequency as 
time progressed -  see Figure 6.5.
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6.10.2 Intragastric pressure:
Following complete ingestion of the meat (n=45), IGP was increased 
by 4.9mmHg (SD 1.3mmHg), (p<0.00001). The rise in IGP caused by the 
meal, measured in the supine position, was assessed for each study day 
group in turn. The control group had a mean rise of 5.6mmHg (SD 
2.3mmHg), which was not different to the NA group (mean 4.9mmHg, SD 
2.1mmHg), but was significantly greater than the NO group (mean 4.1mmHg, 
SD 0.91 mmHg), (p<0.02). The NA group was not different to the NO group -  
see Figure 6.6.
Using the immediate post-meal IGP as a reference point, the control 
group and the NO group showed an increase in IGP over the hour infusion of 
I.SmmHg (SD 2.6mmHg), (p<0.Q2) and 3.4mmHg (SD 3.7mmHg), (p<0.005) 
respectively. In contrast the NA group showed a small decrease in IGP (- 
1.7mmHg, SD 4.6mmHg, p<0.16). The NA group was significantly different to 
the control group at the 30-45 minute period (p<0.02 by t-test & p<0.006 by 
AN OVA) and to both the control (p<0.03) and NO groups (p<0.008) for the 
45-60 minute period -  (Figure 6.7). Scatter plots of the individual points for 
the 3^  ^ and 4^  ^quarters relative to the post-meal IGP can be seen in Figures
6.8 & 6.9. A summary of the mean and SD for each IGP arm relative to the 
post-meal pressure can be seen in Table 6.2. Less compelling data are seen 
when the IGP relative to the fasting values are used -  Table 6.3, Figures 
6 .1 0 & 6 .11.
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6.10.3 Effect of the meal (on single time-point pressure pull-through), 
(n=45):
Following ingestion of the meal and prior to commencing any test 
infusions, the total HPZ length (n=45) was 3.48cm (SD 0.63cm) compared to 
4.94cm (SD 0.76cm) before the meal (p<0.0001). This was mainly due to 
shortening of the abdominal component of the sphincter from 2.87cm (SD 
0.62cm) to 1.80cm (SD 0.59cm) (p<0.0001) with less marked shortening of 
the thoracic component from 2.1cm (SD 0.79cm) to 1.7cm (SD 0.34cm), 
(p<0.0001) (Figure 6.12). The lower border of the HPZ elevated from 
47.63cm (SD 2.63cm) to 45.98cm (SD 2.76cm) following the meal 
(p<0.0001), but there was no significant change in the upper border. The RIP 
elevated from 44.76cm (SD 2.53cm) to 44.17cm (SD 2.49cm), (p<0.0001), 
presumably reflecting slight elevation of the diaphragm by the distended 
stomach. The meal also produced a fall in the MEEP of the HPZ from 
24.5mmHg (SD 9.4mmHg) to 21.2mmHg (SD 8.1 mmHg), (p<0.04), (Figure 
6.13). All of these pressures used fasting IGP as a baseline. A diagram 
depicting the change in the shape of the HPZ can be seen in Figure 6.14 and 
a summary in Table 6.4.
6.10.4 Effect of the infusions following meal (on single time-point 
pressure pull-through), (n=15): 
6.10.4a Total LOS length:
Following the control infusion mean LOS length was 4.3cm (SD 
0.65cm), which was shorter than the fasting LOS, (mean 5.0cm, SD 0.63cm) 
(p<0.002), but longer than the immediate postprandial LOS values (mean
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3.5cm, SD 0.79cm) (p<0.002). There was no difference in the post-infusion 
LOS comparing control v NA (p<0.15), control v NO generating (p<0.11) and 
NA V NO generating (p<0.83). See Figure 6.15.
6.10.4b Abdominal sphincter length (AL) (n=15):
Following the control infusion mean AL was 2.2cm (SD 0.56cm). This 
was shorter than the fasting AL (mean 3.0cm, SD 0.56cm) (p<0.00001) and 
longer than the postprandial AL (mean 1.8cm, SD 0.70cm) (p<0.03). There 
was no difference in the post-infusion AL comparing control v NA (p<0.45), 
control V NO generating (p<0.62) and NA v NO generating (p<0.22). See 
Figure 6.16.
6.10.4c Maximum end expiratory pressure (n=15):
When the pre and post-meal LOS pressures were analysed within 
their respective study groups (n=15), the results are less compelling 
compared to the pooled data (n=45). Post-infusion MEEPs can be compared 
directly. There is no difference between the MEEPs of the three groups 
(n=15) fasting. The MEEP was 25.8mmHg (SD Q.ImmHg) after the control 
solution compared to 20.2mmHg (SD 10.4mmHg) after the NA series 
(p<0.03). MEEP was 23.7mmHg (SD II.SmmHg) after NO and not different 
to the control (p<0.31).
Making comparisons between the post-meal MEEPs and the post­
infusion MEEPs reveals no significant differences between any of the three 
groups. A summary of post-infusion LOS data can be seen in Table 6.5.
222
6.10.5 pH step-up point relative to HPZ:
A total of 90 fasting pH pull-throughs were performed, using the 2 
sequential pH probes, followed by 45 fasting LOS slow-motorised manometry 
pull-throughs. Plotting the lower and upper borders for each sphincter, the 
mean position of the pH step-up point in the sphincter can be located and its 
position relative to the RIP. The mean fasting position of the RIP was 
44.76cm + 0.4cm and the mean position of the pH step-up was at 44.97cm + 
0.5cm. The mean upper border position of the LOS was 42.7cm and the 
mean lower border of the LOS was 47.6cm. This shows that the fasting pH 
step-up point was contained well within the high-pressure zone of the LOS 
and that it was positioned in the abdominal portion of the sphincter - (Figure 
6.17). No post-prandial pH pull-through was performed.
6.10.6 Position of the distal pH probe relative to the upper border of the 
HPZ:
Postprandial HPZ lengths vary from subject to subject. With the distal 
manometry channel located in the proximal stomach, the distance between 
the upper border of the HPZ and distal pH probe will also vary. Not only will 
this vary between each subject but perhaps slightly between study days. The 
mean distance above the upper border of the HPZ of the distal pH probe was 
2.2cm (SD 1.03cm) for the control run, 1.8cm (SD 0.72cm) for the NA run 
and 2.2cm (SD 0.77cm) for the NO generating arm. Using a 2-sided paired 
sample t-test there was no significant difference comparing control v NA 
(p<0.11), control V NO generating (p<0.97) and NA v NO generating (p<0.08) 
-  see Figure 6.18.
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6.10.7 Assessment o f reflux:
6.10.7a Proximal probe:
There was no significant difference in mean oesophageal acid 
exposure of the proximal pH probe, being 26.5% (SD 25.5%) for control, 29% 
(SD 27.4%) for NA and 43.4% (SD 39.7%) for NO generating. The frequency 
of reflux episodes was also similar. However, the duration for each reflux 
episode was greater in the NO group, mean 387.6 seconds (SD 544.1 
seconds), compared to both NA, mean 107.9 seconds (SD 102.3 seconds), 
(p<0.049) and control, mean 84.1 seconds (SD 71.2 seconds), (p<0.04). 
Scatter plots can be seen for the proximal probe data in Figures 6.19, 6.20 & 
6.21.
6.10.7b Distal probe:
The control solution produced a mean oesophageal acid exposure of 
37.5% (SD 27.9%), NA 36.6% (SD 26.1%) and NO generating 62.2% (SD 
33.5%). Control was not different to NA (p<0.90), but NO gave a significantly 
greater acid exposure compared to both control (p<0.03) and NA (p<0.002). 
There was no significant difference in the mean number of reflux episodes 
between the groups, but there was prolongation of reflux in the NO group. 
The mean duration in the NO group was 574.6 seconds (SD 920.1 seconds), 
which was almost significantly longer than both the NA, mean 108.4 seconds 
(SD 104 seconds), (p<0.054) and the control group, mean 122.5 seconds 
(SD 127.6 seconds), (p<0.08). Scatter plots can be seen for the distal probe 
data in Figures 6.22, 6.23 & 6.24. A summary of all pH data and statistics can 
be seen in Tables 6.6 & 6.7 respectively.
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6.10.8 Swallowing:
There is no difference between the total number of swallowing events 
and the three test solutions, either for the whole infusion or individual 
quartiles. See Tables 6.8a-d.
6.10.9 Peristalsis:
6.10.9a Peristaltic pressure amplitude -
As expected, the peristaltic pressure amplitude, was less in the 
proximal oesophagus (mean 43mmHg, SD 13.3) compared to both the mid 
(mean 77mmHg, SD 41.3) and distal oesophagus (mean 91.4mmHg, SD 
45.7), for the control solution. This was the same for both test solutions. 
There were no significant differences between solutions for either overall 
average pressure amplitude, or each individual quartile. This is true 
especially for the distal oesophagus, where the reflux was occurring. See 
tables 6.9a-c, 6.10a-c, 6.11 a-c and 6.12.
6.10.9b Peristaltic velocity -
With the first manometry recording channel in the proximal 
oesophagus, the peristaltic velocity can only be calculated for the mid and 
distal oesophageal segments. Overall, there was no effect on peristaltic 
velocity between the three solutions, in either the mid or distal oesophagus. 
This included analysis of both the entire infusion duration and also each 
individual quartile. Some of the velocities were calculated as being negative 
values. This was true for all 3 solutions in the mid oesophagus and the NO 
group proximally. See Tables 6.13a-c, 6.14a-c and 6.15. This is presumably
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due to the way in which the software automatically calculates the velocity and 
partly due to some incoordination caused by dry swallowing.
6.10.9c Peristaltic duration -
Analysing the infusions as a whole, there was no significant effect on 
the peristaltic duration between each, for any oesophageal segment. There 
was a significant prolongation of the duration between Control (5.5 secs) 
compared to NO (7.2 secs), (p<0.02), in the third quartile. However, as there 
was no significant difference in the fourth quartile, this is of doubtful 
importance. See Tables 6.16a-c, 6.17a-c, 6.18a-c and 6.19.
6.10.10 Bench-top in v itro  NO studies:
A calibrated NO probe indicated that the concentration of NO at the 
catheter tip at 37°C, following dilution of the solution by the distilled water 
from the proximal catheter ports was 6pmol/l for the NA solution and
0.86mmol/l for the NO generating solution. This allowed us to calculate the 
dose of NO and NA given in each study as shown in Table 6.20. We also 
calculated that the volume of NO gas formed from the NO generating solution 
was approximately 60mls during the hour infusion and 30mls from the NA 
solution. See Chapter 5.
6.11 Discussion:
Our studies indicate that upper gastrointestinal physiology may be 
influenced by the intraluminal administration of NO and NA, both of which are 
generated when saliva is acidified in the proximal stomach. The situation is 
complex in that the effects of the two chemicals are different.
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The design of our study involved modifying the manometry system to 
allow us to administer the test solutions within the manometry perfusion 
solution. As the study involved each subject ingesting a meal we were able to 
validate the ability of our modified manometry system to detect physiological 
changes in sphincter morphology induced by the meal. The meal caused 
shortening of the abdominal portion of the sphincter and a reduction in 
MEEP. The abdominal portion shortening can be explained by a rise in the 
intragastric pressure overcoming the pressure of the distal sphincter. 
However, as the MEEP is referred back to fasting IGP this reflects a true 
reduction in the MEEP. In addition the RIP was slightly elevated after the 
meal, probably due to the distended stomach displacing the diaphragm 
upwards. The rise seen in IGP following the meal (4.9mmHg) is similar to that 
seen by Kahrilas' group (4mmHg) which was needed to trigger TLOSRs 
(123).
Our pilot studies and positive control experiments (section 2.4.1) were 
able to demonstrate a reduction in LOS MEEP. These reductions are 
recorded at approximately 15 minutes, which is long after the pull-through in 
this study. We would normally expect a greater LOS relaxation post-meal. 
This would suggest that LOS relaxation is likely to be hormonally mediated in 
part, possibly via cholecystokinin (238). Also, the variability in one-off LOS 
pressure measurements has already been discussed. The reason for not 
delaying the pull-though in our studies was to maximise the time of the meal 
in the stomach and thereby increase the chance of observing TLOSRs.
The luminal administration of the NO generating solution and NA 
without ascorbic acid, influenced the function of the distal oesophagus and 
GOJ. Compared to the Control, NO caused a significantly increased acid
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exposure of the lower oesophagus. In the proximal oesophagus, the duration 
of each reflux episode was increased significantly by the NO solution. There 
was no increase in the total number of reflux episodes in either part of the 
oesophagus. There was no increase in the number of reflux episodes despite 
there being an increase in the number of TLOSRs. The intra-oesophageal pH 
was more commonly less than 4 from a previous reflux episode, before a 
TLOSR, in the NO arm. This may indicate an overlap of reflux episodes. 
However, as there is no hard evidence of dysmotility in the lower 
oesophagus, impaired clearance cannot be blamed directly. A previous study 
showed that if NO effectiveness was increased, by inhibiting 
phosphodiesterase V, which degrades cyclic-GMP, lower oesophageal 
motility and subsequently acid clearance were impaired (179).
We assessed oesophageal motility by looking at the intermittent 
oesophageal peristalsis during the studies. Although difficult to compare, as it 
was mainly ‘dry’ swallows during the tests, there was no obvious difference 
between the 3 study arms. However, there was a significant increase in the 
number of TLOSRs following NO. It must be observed that the acid exposure 
was extremely high, even for the Control arm. This is likely to be due to both 
the volume of the acidic solution infused and also the presence of the 
instrumentation within the lumen.
Autonomic upset leading to impaired salivary function was excluded 
by blood pressure and heart rate monitoring. Perhaps there are other 
mechanisms involved in clearance. The function of the muscularis mucosa in 
the oesophagus is little understood and consequently often overlooked. 
Relaxation of the muscularis mucosae by NO could theoretically cause an 
impairment of acid clearance, at a level that is not recordable by standard
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manometry. Certainly, on the IGP scatter data, the NO data appears to have 
a bimodal distribution. This identifies either a group more susceptible to the 
effects of NO, or conversely, a group more resistant. However, on 
subanalysis of the data that we collected, these 2 populations did not appear 
to be at different ends of the ‘reflux spectrum', for healthy volunteers.
The level of acid exposure at the pH probes is higher than would be 
expected, even for the control arm of the study. There are several 
explanations for this. Preventative features of acid reflux rely on the presence 
of a competent sphincter. Splinting of the LOS with a manometry catheter 
may have some effect on it’s ability to perform. In a similar way, the presence 
of a 4mm manometry catheter/pH assembly through the length of the 
oesophagus, possibly impairs the mechanisms that perform acid clearance 
from the lumen. A single pH catheter in the oesophagus, and indeed even 
across the LOS, has been shown not to affect LOS function or acid clearance 
(239). This aside, the catheter is present, and therefore controlled for, in each 
of our experimental arms.
Taping 2 instruments together raises the potential for capillary action 
where their lengths make contact. This could give ref luxate the opportunity to 
travel vertically and independent of oesophageal motility. Although it is 
almost impossible to measure and assess this, with an identical apparatus 
and meal being used for each experimental arm, this can also be considered 
controlled for. We have not seen any effect on standard parameters of 
oesophageal motility ie; peristaltic amplitude, wave velocity and duration, by 
any of the solutions, indicating that the increased acid exposure seen in the 
NO arm of the study may be caused by more subtle mechanisms.
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Finally, the volume of gastric acid secreted is known to increase after 
a meal, in response to the release of gastrin (240). Submaximal stimulation 
of gastric acid secretion with intravenous pentagastrin (0.05mcg/kg/hr), in H. 
pylori negative subjects will increase the basal volume from 40-80mls/hour, 
to between 160-300 mIs/hour. This will be secreted relatively uniformly by the 
acid secreting mucosa, which extends down through the body of the 
stomach. During our experiment, we can safely assume that the stomach 
secretes it’s own acid, in addition to the 400mls that is infused into the 
proximal stomach. This extra volume may explain the slight increase in IGP 
seen in the Control and NO arms during the study.
Our research group has previously shown the presence of an 
unbuffered acid pocket in the proximal stomach following a meal (23). It Is 
likely that a modest proportion of the infused acid runs off to the distal 
stomach. However, we are also likely to be exaggerating the acid pocket for 
each study arm. The amount of ascorbic acid is certainly higher than we 
would normally expect to find at the cardia (fasting mean in healthy 
volunteers 13.0pmol/l -  SEM 6.1pmol/l) (241). What would normally be a 
limited exhaustive supply, with higher fasting levels in the gastric body and 
distal stomach than at the cardia, is now present in excess.
There was a much greater number of reflux events than TLOSRs. 
Cumulative data shows 177 reflux events for the 15 subjects during the 
control studies compared to 52 TLOSRs. There were 190 cumulative reflux 
events for the 15 subjects in the NA studies compared to 47 TLOSRs. There 
were 184 cumulative reflux events documented for the 15 subjects in the NO 
studies compared to 78 TLOSRs. 19 of these 78 TLOSRs could not have a 
reflux event documented against them as the pH was already less than 4 and
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did not reduce any further. This also means that many reflux events occurred 
outwith a TLOSR. It is possible that they occurred due to loss of sphincter 
tone or episodes that did not meet the criteria of a TLOSR. Without a 
manometry sleeve device across the LOS it would be difficult to say with total 
certainty whether or not this was the case.
Despite the increased frequency of TLOSRs and oesophageal acid 
exposure we did not observe any changes in the LOS pressure. However, 
the latter was measured only at a single time point and several minutes after 
discontinuing the NO infusion. It is of note that the abnormalities detected,
i.e. TLOSRs and acid exposure, were detected by continuous monitoring 
during the infusion. It is therefore possible that changes in sphincter pressure 
have been missed due to the technical impossibilities of monitoring this 
during NO administration. NO relaxes the LOS during peristalsis and this is a 
transient phenomenon (137).
It is important to remember that TLOSRs require relaxation of both the 
LOS and the crural diaphragm. It is highly unlikely that luminal NO would be 
able to permeate and have a direct effect on the diaphragmatic musculature. 
We have already considered the possibility that the NO containing solution 
might trigger TLOSRs due to the gas coming out of solution and causing 
gastric distension. However, our extensive benchtop studies, simulating our 
intragastric infusions, demonstrated that only approximately 60mls of gas are 
produced by the NO generating solution and 30mls by the NA solution 
throughout the one hour infusion period. Considering that each swallow 
introduces ISmIs of air into the stomach (13), it seems unlikely that the small 
amount of gas produced through the one hour infusion will have exerted any 
significant effect. It is possible that NO is triggering TLOSRs by altering the
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motility and morphology of the cardia region and possibly affecting the 
muscularis mucosae, which will be the smooth muscle closest to the 
luminally generated NO. The muscularis mucosae has been shown to relax 
in response to micromolar concentrations of NO in vitro (102).
It is also possible that locally high concentrations of NO may be able 
to cross through the mucosa of the proximal stomach and exert some effect 
on afferent receptors involved in TLOSR co-ordination. We have shown that 
NO can cross through the thickness of a rat’s stomach in vitro (unpublished 
laboratory work). Two weakness of this in vitro study are the absence of 
tissue blood flow and also surface mucous secretion. There are many 
perforating blood vessels present in the submucosa of the GOJ (38) and 
certainly the potential for this to 'mop-up' any absorbed NO, particularly by 
haemoglobin, could be one factor in reducing any local effect on the major 
muscle bulk of the LOS. This may explain the lack of effect seen on the 
MEEP within the NO arm. Nitric oxide at these high concentrations must 
somehow be making conditions more favourable in the proximal stomach 
either with regards to stretch or tone in the stomach wall or perhaps by 
interacting with a population of NO receptors that trigger the TLOSR 
cascade.
The NA solution did not cause increased oesophageal acid exposure 
but caused a significant reduction in IGP during the post-prandial period, 
compared to the control arm. As previously stated, NA solution reacts with 
thiols to form nitrosothiols (197). The latter are relatively stable and long- 
lived, and act as NO donors (242). The reduced IGP following the NA may be 
due to these nitrosothiols exerting an effect on the tone of the gastric wall.
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NO will have a much shorter half-life and its effect may be limited to the 
muscularis mucosae which is much closer to the luminal surface.
In some of the data (Figure 6.8), the scatter plots suggest a ‘dual 
effect' for the NO group, with a mild bi-modal population. We also know that 
NA exists as approximately 1% NO under these conditions. If there is a NO 
effect produced in the NA arm, by the proportion expected from a NA 
solution, it is either too small to see or abolished by the other component of 
NA’s action.
6.12 Clinical significance:
The pressure differential in IGP between Control and NA during the 
infusions is 3.5mmHg. This is a very important finding. Intragastric pressure 
directly acts on the abdominal portion of the sphincter. It is this lower 
pressure that may potentially allow the cardia to ‘reassemble’. This degree of 
gastric relaxation would allow a SMPT to ‘detect’ the abdominal sphincter 
sooner than if the IGP were higher. Whether the underlying mechanism be 
one of gastric relaxation, there is no doubt that this in fact may be a 
protective mechanism against reflux disease. If retaining food within the 
stomach, by gastric relaxation, NA may in fact be protective against reflux 
disease by prolonging food buffering of secreted gastric acid.
It is further borne out looking at the frequency of TLOSRs. Gastric 
relaxation, with subsequent changes to the abdominal sphincter may 
generate less afferent stimulation to trigger TLOSRs. Sphincter parameters 
post-infusion (Table 6.5 & Figure 6.15) showed that the NA studies have 
more significant gains in abdominal sphincter length compared to both 
Control and NO. Could it be a drop in IGP that allows this to occur?
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It is important to relate the concentration and amount of chemicals 
administered in our study with those occurring physiologically with swallowing 
saliva. In the fasting state the concentration of nitrite in saliva varies from 
approximately 50-600pmoles/litre and rises several fold following ingestion of 
nitrate in the diet. The concentration of nitrite administered in this study is 
therefore at the upper limit of the range occurring in swallowed saliva after a 
nitrate-rich meal. The amount of nitrate ingested each day in food is up to 2 
millimoles (243) with approximately 25% of this (500p,moles) being secreted 
in saliva in the post-prandial period (167). The amount of nitrate reduced to 
nitrite by buccal bacteria is highly variable, ranging between 5% and 90%. 
Based on these calculations, the amount of nitrite administered during our 
one-hour infusion approximates to the upper limit of the amount delivered 
during a days' post-prandial period.
Our studies indicated that the presence of ascorbic acid, which 
converts the NA to NO, influenced the effects of the solution on both gastric 
and oesophageal function, within healthy subjects, it is therefore important to 
consider factors that determine intragastric ascorbic acid availability. 
Ascorbic acid is actively secreted in gastric juice (244). It’s median 
intragastric value in subjects with a healthy stomach is 250pmol/l and is 
substantially lower in subjects with H.pylori infection (245), atrophic gastritis 
(216) and those of black ethnicity (246). Eating will considerably enhance the 
concentration of ascorbic acid as it is present in substantial concentrations in 
many foodstuffs. Ingesting a diet rich in both nitrates and also anti-oxidants 
may enhance any effects of physiological reflux and indeed predispose to 
inflammation, Barrett’s and cancer.
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There is some evidence that H.pylori may play a protective role 
against reflux disease (247;248). Carditis and intestinal metaplasia at the 
GOJ is more common in H.pylori positives than negatives (249), but this 
trend may be changing. This could have the effect of reducing the amount of 
acid-secreting mucosa available in a post-prandial ‘acid-pocket’. As this is 
assumed to be the area from which oesophageal acid reflux is generated, it 
is clearly important. Also, there is an association of reduced levels of 
ascorbic acid in plasma of patients of lower socio-economic class (250).
These can be linked in two ways. Firstly, the lower incidences of reflux 
disease and GOJ cancer in lower social classes mirrors their reduced ability 
to secrete ascorbic acid. They are also more likely to be H.pylori positive 
(251) with a greater predisposition to developing gastric cancer, probably 
related to an atrophic gastritis (252).
Another piece of evidence that picks out ascorbic acid as playing a 
key role in acid reflux is the association between black skin colour and low 
levels of gastric ascorbic acid (246). This correlates to a low prevalence of 
both GORD and oesophageal adenocarcinoma. Clearly, in these situations 
where there is less ascorbic acid there is likely to be more NA at the cardia. 
This in itself may be a protective mechanism against GORD. One previous 
study investigated the effect of oral nitrate supplements on oesophageal 
function in H.pylori negative healthy volunteers and GORD patients. Fasting 
basal LOS pressure measured using a sleeve did not appear to be affected 
in either group by the addition of nitrate to the diet (159).
TLOSR provocation was performed by rapid injection of 750mls of air 
into the gastric body. Therefore, the majority of the intragastric volume could 
be expelled with belching, which differs to our meal. It is difficult to comment
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on whether salivary nitrite levels were recorded at the appropriate time after a 
dose or not. It is also likely that the GORD patients in this study had intact 
oesophageal mucosa due to their prior therapy, and there is also no 
comment on the proportion with columnar-lined oesophagus. These are two 
important sub-sets of patients that require further evaluation.
Our current studies serve as a proof of the concept, that the chemicals 
generated when nitrite-rich saliva encounters gastric acid can influence 
gastro-oesophageal function. We have generated post-prandial luminal NO, 
in the correct location, probably at it's physiological upper limit. The question 
now remains as to where the threshold lies for such effects to take place. 
Does it vary between healthy volunteers and those with upper GI disease?
Amongst this group, do patients with a hiatus hernia differ to those 
without a hernia but with oesophagitis? Also, what is the effect on acid 
clearance in those with Barrett's oesophagus? Does luminal NO have a 
different effect, or different threshold for its effect, in the presence of a 
columnar-lined oesophagus? Also, does NA have a protective role in healthy 
volunteers, which is lost in GORD sufferers? It is now important to investigate 
whether this luminal chemistry contributes to disordered motility of the 
stomach and GOJ. The information from this study may allow us to target 
various areas of this pathway, including the amount of ingested nitrate and 
eliminating buccal bacteria.
6.13 Grant support;
This work was funded in part by a North Glasgow University Hospitals 
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Table 6.1: Concentration of chemicals in syringes on the different study day.
Gastric channels Oesophageal channels
Control study day
Thiocyanate -  1 mM Thiocyanate -  ImM
Hydrochloric acid -  pH 1.0
EDTA " ImM
Ascorbic Acid -  5Mm
Nitrous Acid study day
Thiocyanate -  ImM Thiocyanate -  ImM
Hydrochloric acid -  pH 1.0 Nitrite -  1.6mM
EDTA -  ImM
Nitrite -  1.6mM
NO-generating study day
Thiocyanate - 1  mM Thiocyanate -  1 mM
Hydrochloric acid -  pH 1.0 Nitrite -  1.6mM
EDTA - ImM
Nitrite -  1.6mM
Ascorbic Acid -  5mM
Table 6.2: Mean pressure changes in IGP during the infusions, relative to the
immediate post-meal IGP. Pressure in mmHg with standard deviation. NA -
nitrous acid, NO -  nitric oxide.
2"^ Quarter 3'^  ^Quarter 4*^  Quarter
Control 1.5 (2.1) 1.5 (2.9) 1.8 (2.6)
Acidified Nitrite 0.26 (2.5) -1.7 (4.6) -1.2 (5.0)
NO 1.4 (4.4) 0.9 (4.1) 3.4 (3.7)
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Table 6.3: Changes in IGP caused by the meal and during the infusions. All 
values are relative to fasting IGP. Pressure in mmHg with standard deviation.
Post-meal 2"^ Quarter 3"^  ^Quarter 4^ *^  Quarter
Control 5.6 (2.3) 7.1 (3.8) 7.1 (4.1) 7.4 (4.3)
Acidified
Nitrite 4.9 (2.1) 5.2 (2.7) 3.6 (2.6) 4.2 (2.2)
NO 4.1 (0.9) 5.6 (4.5) 5.4 (3.6) 7.6 (4.0)
Table 6.4: Effect of meal ingestion on the parameters of the LOS compared
to the fasting state, (n=45).
LOS parameter Fasted 
Mean (SD)
Post-meal 
Mean (SD)
P value <
Total LOS length 
/ cm 4.94 (0.76) 3.48 (0.63) 0.0001
Upper border / 
cm 42.69 (2.36) 42.50 (2.43) 0.18
Respiratory 
inversion point / 
cm
44.76 (2.53) 44.17(2.49) 0.0001
Lower border / 
cm 47.63 (2.61) 45.98 (2.76) 0.0001
Thoracic length 
LOS / cm 2.1 (0.79) 1.7(0.34) 0.0001
Abdominal length 
LOS / cm 2.87 (0.62) 1.80 (0.59) 0.0001
Maximum end 
expiratory 
pressure / mmHg 24.5 (9.4) 21.2(8.1) 0.04
Intragastric 
pressure / mmHg 0 4.9 (1.3) 0.00001
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Table 6.5: Summary of high pressure zone (HPZ) morphology.
Total HPZ length / cm Abdominal sphincter 
length / cm
Maximum end expiratory 
pressure / mmHg
Control NA NO Control NA NO Control NA NO
Fasted 5.0
(0.63)
4.9
(0.76)
4.9
(0.91)
3.0
(0.56)
2.9
(0.61)
2.8
(0.7)
23.0
(8.3)
26.3
(11.0)
24.3
(9.1)
Post­
meal
3.5
(0.79)
3.5
(0.48)
3.4
(0.65)
1.8
(0.70)
1.8
(0.42)
1.8
(0.64)
21.7
(9.1)
21.4
(8.2)
20.5
(7.5)
Post-
infusion
4.3
(0.65)
4.0
(0.82)
4.0
(0.66)
2.2
(0.56)
2.3
(0.63)
2.1
(0.43)
25.8
(9.1)
20.2
(10.4)
23.7
(11.8)
(n=15 for all categories). Data displayed as mean values with standard deviation in brackets. 
NA = Nitrous Acid, NO -  Nitric Oxide generating
Table 6.6: Summary of pH data (n=15 for all categories).
Percentage time pH<4 Total number of reflux 
episodes
Duration per reflux 
episode / seconds
pH
probe
Control NA NO Contro1 NA NO Control NA NO
Proximal 26.5
(25.5)
29.0
(27.4)
43.4
(39.7)
7.3
(7.1)
8.1
(7.2)
8.0
(7.6)
84.1
(71.2)
107.9
(102.3)
387.6
(544.1)
Distal 37.5^7.9)
36.6
(26.1)
62.2
(33.5)
11.8
(5.5)
12.7
(5.1)
12.3
(10.8)
122.5
(127.6)
108.4
(104)
574.6
(920.1)
Data displayed as mean values. Standard deviation in brackets. 
NA = Nitrous Acid, NO = Nitric Oxide generating
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Table 6.7: Paired t-test statistics for reflux data displayed in Table 6.6.
Percentage time 
pH<4 / 
p value <
Total number of 
reflux episodes / 
p value <
Duration per 
reflux episode / 
p value <
Cv NA 0.66 0.78 0.31
Proximal C v NO 0.07 0.81 0.04
NO vNA 0.08 0.98 0.049
C v NA 0.90 0.66 0.73
Distal C V NO 0.03 0.88 0.08
NOvNA 0.002 0.90 0.054
C = Control, NA = Nitrous acid, NO : 
Table 6.8a: Comparison of
= Nitric Oxide
the number of swallowing events for each
solution over the length of the infusion, and each quartile in turn (n=15).
Quarter of infusion /
Mean number of swallows
2nd 3rd 4th Mean / Total Range SD
Control 13.5 12.4 11.4 11.4 48.7 32-92 16.0
Nitrous
Acid 13.3 12.7 11.4 10.4 47.8 29-64 12.9
Nitric
Oxide 12.8 12.1 13.2 11.1 49.1 31-87 17.7
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Table 6.8b: Comparison of total number of swallows (paired t-tests, n=15).
t-test P value
Control V Nitrous Acid 0.69
Control V Nitric Oxide 0.70
Nitrous Acid v Nitric Oxide 0.41
Table 6.8c: Inter-quartile comparison of swallowing frequency for each 
solution (paired t-tests, n=15).
Q1vQ2 Q1vQ3 Q1vQ4 Q2vQ3 Q2vQ4 Q3vQ4
Control 0.18 0.046 0.04 0.37 0.36 1.0
Nitrous
Acid 0.53 0.08 0.02 0.04 0.02 0.16
Nitric
Oxide 0.33 0.76 0.15 0.30 0.32 0.04
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Table 6.8d: Comparison of the number of swallows for each quartile between
solutions (paired t-tests, n=15).
P value
t-te s t Q1 Q2 Q3 Q4
Control V 
Nitrous Acid 0.82 0.77 0.85 0.39
Control V Nitric 
Oxide 0.72 0.40 0.93 0.57
Nitrous Acid v 0.73 0.68 0.18 0.63Nitric Oxide
Table 6.9a: Comparison of the peristaltic pressure amplitude for the proximal 
oesophageal segment, for each solution and quartile in turn (n=15).
Proximal oesophagus:
Quarter of infusion / mean 
pressure amplitude (mmHg)
1"* 2nd 3rd 4th Mean / Total Range SD
Control 44.2 42.9 42.8 46.4 43.0 32-57 13.3
Nitrous
Acid 45.5 54.9 38.5 42.8 45.4 32-66 11.2
Nitric
Oxide 47.6 44.7 47.1 47.1 46.7 26-57 9.4
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Table 6.9b: Comparison of the peristaltic pressure amplitude between
quartiles for each solution (paired t-tests, n=15).
Q1vQ2 Q1vQ3 Q1vQ4 02vQ3 02v04 03v04
Control 0.83 0.99 0.95 0.85 0.79 0.96
0.22 0.63 0.003 0.06 0.27
S '. 0.90 0.93 0.66 0.62 0.99
Table 6.9c: Comparison of the peristaltic pressure amplitude for each
corresponding quartile, between solutions (paired t-tests, n=15).
p value
t-test 01 02 03 04
Control V 
Nitrous Acid 0.70 0.11 0.45 0.76
Control V Nitric 
Oxide 0.65 0.89 0.51 0.45
Nitrous Acid v 
Nitric Oxide 0.09 0.06 0.24 0.56
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Table 6.10a: Comparison of the peristaltic pressure amplitude In the mid-
oesophageal segment, for each solution and quartile in turn (n=15).
Mid-oesophagus:
Quarter of infusion / mean 
pressure amplitude (mmHg)
2nd 3rd 4**^ Mean / Total Range SD
Control 80.3 74.9 85.5 81.2 77.0 20-175 41.3
Nitrous
Acid 78.9 83.3 71.6 71.9 76.4 45-140 27.7
Nitric
Oxide 66.0 75.7 77.8 72.0 72.9 28-137 30.8
Table 6.10b: Comparison of the peristaltic pressure amplitude between
quartiles for each solution (paired t-tests, n=15).
Q1vQ2 Q1vQ3 Q1vQ4 Q2vQ3 Q2vQ4 Q3vQ4
Control 0.19 0.95 0.50 0.11 0.40 0.61
Nitrous
Acid 0.62 0.36 0.31 0.29 0.29 0.96
Nitric
Oxide 0.26 0.23 0.44 0.59 0.61 0.38
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Table 6.10c: Comparison of the peristaltic pressure amplitude for each
corresponding quartile, between solutions (paired t-tests, n=15).
p value
t-test Q1 Q2 Q3 Q4
Control V 
Nitrous Acid 0.92 0.14 0.56 0.53
Control V Nitric 
Oxide 0.04 0.72 0.77 0.57
Nitrous Acid v 
Nitric Oxide 0.07 0.63 0.83 0.93
Table 6.11a: Comparison of the peristaltic pressure amplitude for the distal
oesophageal segment, for each solution and quartile in turn (n=15).
Distal oesophagus:
Quarter of infusion / mean 
pressure amplitude (mmHg)
ist 2nd 3rd 4th Mean / Total Range SD
Control 52.4 46.4 57.4 47.7 91.4 21-170 45.7"sr «  » 103.4 91.9 83.4 90.7 61-134 29.6
oS 87.7 98.3 84.6 87.1 45-155 38.5
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Table 6.11b: Comparison of the peristaltic pressure amplitude between
quartiles for each solution (paired t-tests, n=15).
Q1vQ2 Q1vQ3 Q1vQ4 02v03 02v04 03v04
Control 0  1 4 0.21 0.60 0.49 0.20 0.27
0.21 0.92 0.18 0.07 0.15
S 'ï 0.05 0.46 0.07 0.62 0.06
Table 6.11c: Comparison of the peristaltic pressure amplitude for each
corresponding quartile, between solutions (paired t-tests, n=15).
P value
t-test 01 02 03 04
Control V 
Nitrous Acid 0.88 0.40 0.94 0.73
Control V Nitric 
Oxide 0.25 0.17 0.96 0.53
Nitrous Acid v 
Nitric Oxide 0.60 0.12 0.86 1.0
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Table 6.12: Overall comparison of peristaltic pressure amplitudes between
solutions (paired t-tests, n=15).
p value
Proximal Mid­ Distal
oesophagus oesophagus oesophagus
Control V 
Nitrous Acid 0.56 0.89 0.90
Control V Nitric 0.52 0.58 0.59Oxide
Nitrous Acid v 
Nitric Oxide 0.47 0.42 0.40
Table 6.13a: Comparison of the peristaltic velocity for the mid-oesophageal 
segment, for each solution and quartile in turn (n=15).
Mid-oesophagus:
Quarter of infusion / mean 
peristaltic velocity (cm/sec)
1st 2nd 3rd 4^^ Mean / Total Range SD
Control 1.8 5.8 6.0 3.3 4.0 -0.4-11.7 3.5
Nitrous
Acid 4.3 0.6 9.5 1.1 3.9 -3.2-10.4 4.6
Nitric
Oxide 0.9 1.9 5.0 5.0 3.2 -0.8-9.6 2.6
247
Table 6.13b: Comparison of the peristaltic velocity for each quartile, of each
solution, in turn (paired t-tests, n=15).
Q1vQ2 Q1vQ3 Q1vQ4 Q2vQ3 02v04 03v04
Control 0.07 0.40 0.49 0.94 0.09 0.47
Nitrous p. 
Acid 0.38 0.20 0.15 0.87 0.27
0 “ 0.09 0.23 0.13 0.16 0.99
Table 6.13c: Comparison of the peristaltic velocity comparison for each
corresponding quartile, between solutions (paired t-tests, n=15).
p value
t“test 01 02 03 04
Control V 
Nitrous Acid 0.24 0.003 0.50 0.49
Control V Nitric 
Oxide 0.65 0.02 0.54 0.21
Nitrous Acid v 
Nitric Oxide 0.19 0.32 0.87 0.38
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Table 6.14a: Comparison of the peristaltic velocity for the distal oesophageal
segment, for each solution and quartile in turn (n=15).
Distal oesophagus:
Quarter of infusion / mean 
peristaltic velocity (cm/sec)
1st 2nd 3rd 4"' Mean / Total Range SD
Control 4.4 7.1 4.3 4.1 4.4 2.6-7.9 2.1
Nitrous 6.6 9.5 6.0 4.4 6.6 2.1-29.1 6.6
Acid
Nitric 5.2 4.1 4.6 9.5 5.8 -7.4-25.6 9.8
Oxide
Table 6.14b: Comparison of the peristaltic velocity for each quartile, of each
solution, in turn (n=15).
Q1vQ2 QlvQS Q1vQ4 Q2vQ3 Q2vQ4 Q3vQ4
Control 0.37 0.75 0.05 0.38 0.06 0.19
Nitrous
Acid 0.59 0.79 0.07 0.36 0.34 0.34
Nitric
Oxide 0.90 0.79 0.44 0.96 0.57 0.43
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Table 6.14c: Comparison of the peristaltic velocity comparison for each
corresponding quartile, between solutions (paired t-tests, n=15).
p value
t-test Qi 02 03 04
Control V  
Nitrous Acid ^ 0.19 0.46 0.10
Control V  Nitric ^ 
Oxide 0.88 0.42 0.26
Nitrous Acid v « 
Nitric Oxide ^ 0.69 0.44 0.44
Table 6.15: Overall comparison 
solutions (paired t-tests, n=15).
of peristaltic wave velocity, between
p value
Mid-oesophagus Distal oesophagus
Control V Nitrous Acid 0.93 0.26
Control V Nitric Oxide 0.32 0.82
Nitrous Acid v Nitric 
Oxide 0.82 0.70
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Table 6.16a: Comparison of the peristaltic duration for the proximal
oesophageal segment, for each solution and quartile in turn (n=15).
Proximal oesophagus:
Quarter of infusion I  mean 
duration of peristalsis (secs)
ist 2nd 3rd 4th Mean / Total Range SD
Control 3.9 4.2 5.2 5.3 4.2 0.4-6.7 1.7
Nitrous 4.3 5.2 4.4 4.3 4.6 2.9-59 1.3
Acid
Nitric 5.5 4.2 5.2 5.1 5.0 28-7.8 1.8
Oxide
Table 6.16b: Comparison of the peristaltic duration between quartiles, for
each solution in turn (paired t-tests, n=15).
Q1vQ2 Q1vQ3 Q1vQ4 Q2vQ3 Q2vQ4 Q3vQ4
Control 0.44 0.04 0.79 0.25 0.60 0.08
Nitrous
Acid 0.39 0.87 0.97 0.39 0.31 0.83
Nitric
Oxide 0.20 0.76 0.60 0.02 0.17 0.88
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Table 6.16c: Comparison of the peristaltic duration between solutions for
each quartile in turn (paired t-tests, n=15).
p value
t-tes t QI Q2 Q3 Q4
Control V 
Nitrous Acid 0.37 0.31 0.46 0.44
Control V Nitric 
Oxide 0.11 0.84 0.90 0.02
Nitrous Acid v 
Nitric Oxide 0.31 0.32 0.42 0.43
Table 6.17a: Comparison of the peristaltic duration for the mid-oesophageal
segment, for each solution and quartile in turn (n= 15).
Mid-oesophagus:
Quarter of infusion / mean
duration of peristalsis (secs)
ist 2nd 3rd 4th Mean / Total Range SD
Control 4.8 5.0 5.6 5.4 4.8 2.3-83 1.6
Nitrous 5.0 5.0 4.9 4.7 4.9 3.6-64 0.8
Acid
Nitric 5.4 4.8 5.2 5.0 5.1 3.1-6.8 1.4
Oxide
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Table 6.17b: Comparison of the peristaltic duration between quartiles, for
each solution in turn (paired t-tests, n=15).
Q1vQ2 Q1vQ3 Q1vQ4 Q2vQ3 Q2vQ4 Q3vQ4
Control 0.92 0.09 0.24 0.13 0.32 0.02
T T  » »= 0.88 0.51 0.85 0.41 0.72
0.67 0.41 0.14 0.51 0.71
Table 6.17c: Comparison of the peristaltic duration between solutions for
each quartile in turn (paired t-tests. n=15).
p value
t-tes t Q I Q2 Q3 Q4
Control V 
Nitrous Acid 0.72 0.40 0.58 0.42
Control V Nitric 
Oxide 0.49 0.93 0.90 0.17
Nitrous Acid v 
Nitric Oxide 0.47 0.39 0.94 0.80
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Table 6.18a: Comparison of the peristaltic duration for the distal
oesophageal segment, for each solution and quartile in turn (n=15).
Distal oesophagus:
Quarter of infusion / mean 
duration of peristalsis (secs)
1st 2nd 3rd 4th Mean / Total Range SD
Control 5.6 5.4 5.5 7.4 5.7 2.9-75 1.5
Nitrous 4.9 6.5 5.8 5.4 5.6 2.7-8.6 1.4
Acid
Nitric 6.5 6.0 7^ » &7 6.6 34-8.9 1.7
Oxide
Table 6.18b: Comparison of the peristaltic duration between quartiles, for
each solution in turn (paired t-tests, n=15).
Q1vQ2 Q1vQ3 Q1vQ4 Q2vQ3 Q2vQ4 Q3vQ4
Control 0.92 0.79 0.33 0.74 0.32 (X38
Nitrous
Acid 0.06 0.14 0.27 0.57 0.25 0.35
Nitric
Oxide 0.52 0.35 0.77 0.06 0.23 0.29
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Table 6.18c: Comparison of the peristaltic duration between solutions for
each quartile in turn (paired t-tests, n=15).
p value
t-test Q I Q2 Q3 Q4
Control V  
Nitrous Acid 0.14 0.48 0.94 0.95
Control V  Nitric 
Oxide 0.51 0.55 0.02 0.12
Nitrous Acid v 
Nitric Oxide 0.08 0.42 0.18 0.11
Table 6.19: Overall comparison of peristaltic duration between the solutions 
(paired t-tests, n=15).
p value
Proximal
oesophagus Mid-oesophagus
Distal
oesophagus
Control V  
Nitrous Acid 0.37 0.78 0.96
Control V Nitric 
Oxide 0.15 0.57 0.07
Nitrous Acid v 
Nitric Oxide 0.58 0.85 0.16
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Table 6.20: Calculation of NO delivery over one hour from the test solutions. 
Catheter concentration of NO was performed by the Greiss reaction and 
takes into account dilution from proximal channel distilled water.
Volume NO NO load Nitrous Acid Nitrous Acid
Test solution delivered concentration millimoles/hour concentration load
litres millimoles/litre millimoles/litre millimoles/hour
NO
generating 0.4 0.86 0.344 0 0
Nitrous Acid 0.4 0.006 0.0024 1.6 0.64
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Figure 6.2: Location of the pH sensors in relation to the manometry catheter 
ports.
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Figure 6.3: Frequency of TLOSRs during the infusion period. Bars indicate 
median values. Lines join each individual Subject’s results.
C o n t r o l  N i t r o u s  A c id  N i t r ic  O x id e
Control V Nitrous Acid p<0.35, Control v Nitric Oxide p<0.01, Nitrous Acid v Nitric Oxide p<0.0001
Figure 6.4: Mean duration of TLOSRs for each subject with each infusion. 
Bars indicate mean values.
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Figure 6.5: Demonstration of TLOSR frequency for each quarter of the three 
experimental infusions. Error bars indicate standard deviation of the sample, 
p values represent Control v NO, paired t-tests, n=15.
2.5
1.5
0.5
p<0.03
p<0.03
1 st quarter 2nd quarter 3rd quarter
m
4th quarter
□ Control ■ Nitrous Acid □ Nitric Oxide
Figure 6.6: Rise in intragastric pressure (mmHg) caused by meal ingestion, 
for each of the three study days. Bars indicate mean values.
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Control V Nitrous Acid p<0.39, Control v NO p<0.02, Nitrous Acid v NO p<0.18
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Figure 6.7: Changes in intra-gastric post-meai pressure throughout the 
infusions. Time on X-axis. Points are mean values (n=15).
Patient sat 
upright -  Gastric 
baseline zeroed
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X - Nitrous Acid — Control Nitric Oxide
Figure 6.8: Intragastric pressure relative to immediate post-meal value 
during the third quarter of the infusion -  AN OVA p<0.0Q6. Bars indicate 
mean values.
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Figure 6.9: Comparison of IGP relative to immediate post-meal IGP during
the fourth quarter of the infusion. Bars indicate mean values.
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Figure 6.10: Comparison of IGP relative to fasting IGP during the third 
quarter of the infusion. Bars indicate mean values.
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Figure 6.11: Comparison of IGP relative to fasting IGP during the fourth
quarter of the infusion. Bars indicate mean values.
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Figure 6.12: Length of the high pressure zone (HPZ) and abdominal 
sphincter length (AL) fasting and immediately following a meal. Bars indicate 
mean values.
p<0.0001p<Q.OOQl
§
• •
• • •
#  $
Post-meai HPZ Post-meal AL
263
Figure 6.13: Maximum end expiratory pressure (MEEP) fasting and
immediately following a meal. Bars indicate mean values.
p<0.04
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Figure 6.14: Mean positions of the upper and lower borders of the high 
pressure zone (HPZ) and the respiratory inversion point (RIP), (n=45).
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Figure 6.15: Comparison of each solution on LOS total length. Bars indicate 
mean values.
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Figure 6.16: Comparison of each solution on LOS abdominal length. Bars
indicate mean values.
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Figure 6.17: Location of the pH step-up point relative to the fasting high 
pressure zone (HPZ) and respiratory inversion point (RIP), (n=45).
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Figure 6.18: Position of distal pH probe relative to upper border of HPZ. Bars 
indicate mean values.
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Figure 6.19: Proximal pH probe -  % time pH<4. Bars indicate mean values.
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Figure 6.20: Proximal pH probe -  total number of reflux episodes. Bars 
indicate mean values.
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Figure 6.21: Proximal pH probe -  mean duration per reflux event. Bars
indicate mean values.
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Figure 6.22; Distal pH probe - % time pH<4. Bars indicate mean values.
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Figure 6.23: Distal pH probe -  total number of reflux episodes. Bars indicate
mean values.
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Figure 6.24: Distal pH probe -  mean duration per reflux event. Bars indicate
mean values.
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7.1 Discussion:
This series of studies and experiments gives more insight into the 
potential physiological roles of dietary nitrate and salivary nitrite. GORD and 
the relatively overlooked phenomenon of short-segment reflux are clearly 
multi-factorial processes. This can lead to difficulty in deciphering the exact 
contribution of dietary nitrate and salivary nitrite to each condition. From this 
set of experiments it Is plausible to assume that salivary nitrite could 
contribute to both long and short-segment reflux.
GORD is traditionally associated with long-segment reflux into the 
oesophagus. Refluxed luminal contents are poorly neutralised and clearance 
of luminal acid is reduced. However, lower LOS resting pressures are also 
contributory, but not a necessity. Short-segment reflux disease is one of the 
hypotheses for the generation of intestinal metaplasia at the gastric cardia, 
and perhaps even the distal squamous mucosa. Whether this is the 
precursor to short-segment Barrett’s and perhaps even adenocarcinoma of 
the gastric cardia, is not clear.
These findings do tend to link together with the luminal chemistry. 
Clearly the most information from this work has been yielded from the 'meal' 
related studies (Chapter 6). Physiologically, reflux occurs even in healthy 
volunteers. However, the innate mechanisms, such as secretion of luminal 
bicarbonate, swallowing of saliva and clearance by secondary peristalsis, 
prevent both perception of reflux and damage from occurring. There is also, 
perhaps, a range of severity of physiological reflux. This may put healthy 
subjects at risk of transferring to a more GORD-like state if the luminal 
chemistry of the refluxate is able to dictate, in some capacity, whether
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mucosal damage will occur. A healthy subject is unlikely to be aware of this 
as the majority of reflux events in healthy subjects are asymptomatic.
Our control arm of the reflux studies did show a variation in the degree 
of physiological reflux between our 15 subjects. All were asymptomatic and 
may even have had DeMeester scores considered to be pathological on 
formal 24-hour pH testing. This, however, was not performed. The silastic 
tube experiments appeared to back up the reflux data in the 2 subjects that 
we studied. This was by showing different oesophageal exposures to NO, the 
solution of which was delivered to the distal LOS, and which could be used 
as a surrogate marker of evidence of reflux.
The NO arm of the meal study demonstrated that high amounts of 
luminal NO appear to significantly impair oesophageal clearance, which as 
already discussed, is a major characteristic of GORD. This must be 
approached with a little caution, as must all of our results, due to us 
modelling the physiological mechanisms, rather than using them directly. 
That is to say, NO was delivered to the physiological site, with blockade of 
patient NO generation by avoidance of nitrate containing foods and 
eradication of buccal bacteria, rather than being intrinsically generated from 
swallowed salivary nitrite in the lumen. This was important to do for several 
reasons. Compliance of low nitrate ingestion can be problematical. Also, the 
conversion of nitrate to nitrite by the bacteria on the dorsum of the tongue is 
outwith our control.
in order to make everything level, subjects were dosed with the same 
amount of nitrite at their LOS. This was after all, a pilot study, attempting to 
prove a concept. Delivery of the nitrite in the test solution, was also non- 
physiological. Saliva is swallowed as boluses and delivered to the distal
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oesophagus and LOS in this fashion, not as a continuous infusion. It is 
difficult to design flawless in vivo studies of this nature. It is important to have 
as few variables as possible, particularly if the physiological change that is 
being looked for is potentially very small indeed.
In addition, the viscosity of the carrier fluid, which was distilled water, 
is less than saliva, so the ability of the fluid to remain at the cardia region is 
reduced. Volume of fluid perfused is also questionable. Normal gastric 
secretion totals 1.5-2.0 litres per day. The majority of this occurs during meal 
times following gastrin release. We infused 400mls of test solution into the 
LOS region over the course of an hour. This again, is not entirely 
physiological. The reasons for needing to infuse such a large volume was 
down to the NO arm of the study. If the concentration of nitrite was any 
greater in the solution, which would have allowed volume reduction, then NO 
would have come out of solution in an obvious fashion. This would have filled 
the manometry system with NO gas bubbles, greatly affecting the 
performance of the pressure sensors and also effectively visually unblinding 
the study arm.
So, it was with a little reluctance that this volume was used, but it was 
at the time, the only plausible way that we could deliver such a high amount 
of NO. Delivering nitrous acid and ascorbic acid separately to the cardia 
would also have given unpredictable NO generation. The particular 
manometry catheter used (2282, Mediplus, UK) was also selected for several 
reasons. It gave the ability to deliver solutions to the lumen of the LOS due to 
the location of the distal ports. A sleeve system would have given accurate 
LOS measurements, but the solutions would have run-off distal to the LOS 
rather than within it. Also, the silicone rubber material from which a Dent
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sleeve catheter is manufactured is very effective at letting NO pass through. 
Therefore, any NO generated in the syringe, even at high flow-rates, will pass 
out into the atmosphere before reaching the subject. The Mediplus catheter 
is made from medical grade PVC and retains the majority of NO within the 
system allowing adequate delivery within the subject.
Analysis of all healthy subject data in this thesis indicates that the 
important areas where statistically significant data have been obtained, 
occurred during the times of continuous monitoring, rather than single time 
points. These include the effects on oesophageal acid exposure, IGP and 
TLOSRs. In the earlier fasting study (Chapter 6), no effect was seen on 
resting MEEP following luminal NO. However, this does not definitely exclude 
an effect on the MEEP with NO. It may be that the protocol is not correctly 
designed to detect it. This may be relevant with the T1/2 of NO being merely 
seconds. Also, subtle effects may be occurring at the LOS, in all of our 
studies, which are limited to the mucosal area. Our in vivo protocol or 
equipment may not be sensitive enough to detect these changes.
Carditis and intestinal metaplasia of the gastric cardia are very likely to 
be associated with bathing of the mucosa by acid, pepsin, proteolytic juice 
and bile. Intestinal metaplasia of the cardia is becoming more common in H. 
pylori negative subjects (253), in whom there is a definite increased risk of 
junctional adenocarcinoma. Whether a H.pylori positive state protects by 
altering the ascorbic acid availability, is not clear. Due to its location, reflux to 
this area is normally asymptomatic and as such, adenocarcinoma of the GOJ 
is not as strongly associated with a history of reflux as distal oesophageal 
adenocarcinomas (254).
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7.2 Future work:
There are various avenues as to how this work could, and should, be 
taken forwards. It may be that on a population level, the prevention of 
disease (ie: primary prevention) in the future, will be of greater importance. 
Therefore, continuing work in healthy subjects, with attention to H.pylori 
status would be the way forward. In this asymptomatic group, disease at the 
SCJ is probably the most important. For patients with GORD, the best 
available medical therapy is acid suppression with proton pump inhibitors. 
There is also some expanding evidence for baclofen (129). Dietary 
modification is rarely followed and helps only approximately 20% of patients. 
However, there is some rationale for reducing meal size and increasing meal 
frequency. As the understanding of factors causing disease progression in 
GORD, and particularly those patients with Barret’s oesophagus, are poorly 
understood, it is equally correct to focus these studies on this population.
There are several reasons, in fact, why this may be more appropriate. 
As patients with existing upper Gi disease, they may be more sensitive to the 
effects of luminal nitrite chemistry. This may be related to either the differing 
properties of a columnar-lined oesophagus or the potentially more 
penetrating effects of the chemistry in the breached mucosa of oesophagitis. 
Penetration or diffusion of these luminal chemicals may even be important in 
the columnar-lined oesophagus, as the epithelium is only one layer thick, 
compared to the naturally occurring partially keratinised stratified squamous 
equivalent.
Permeation of NO or even refluxed nitroso-thiols into the lumen of the 
inflamed oesophagus, may cause relaxation of exposed or more susceptible 
muscularis mucosae. Physiological contraction of this thin muscular layer
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normally acts as a protective mechanism, following a breach of the mucosa. 
A similar event would be expected post-endoscopic biopsy or even around 
ulcerated tissue.
One way to pursue this work is in hiatus hernia patients, with 
oesophagitis, and preferably those with Barrett’s oesophagus. Hernia 
patients’ results could prove very enlightening due to their anatomy. Due to 
the separation of the diaphragmatic crura from the LOS, this would give a 
better indication of effects seen on sphincter morphology and pressure. For 
the reasons previously discussed regarding day-to-day variability of LOS 
pressure, this type of study may prove unachievable. The pressures found in 
the LOS of hernia patients are lower than normal. Taking into account the 
variability of resting LOS pressures and desire to pick up small changes, it 
may well be that any effects may be too small to ever define.
It would be ideal if accurate data could be collected to assess 
oesophageal acid clearance by both pH monitoring and impedance after a 
meal, with concurrent oesophageal body, LOS and gastric body motility 
recording. Subjects would need to be off all acid suppression according to a 
strict protocol and follow both a low-nitrate diet and mouthwash regime as 
previously described. Also, since this work was carried out, high-resolution 
manometry (255;256) has evolved as a readily available resource. ‘High 
resolution pH’ has also been prototyped In our unit (unpublished work at time 
of writing). These modalities would remove some of the complications 
presented by our study design as well as providing, previously unavailable 
information. The problem with over-complicating protocols is that excessive 
luminal instrumentation can interfere with normal physiological function, as 
can the introduction of large volumes of luminal chemicals. A simpler
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experiment would therefore be to examine the effect of swallowed nitrite on 
reflux and intra-oesophageal pH after a meal.
In order to assess the sensitivity of the NA mechanism, a dose- 
response effect, could be looked at in a randomised, double-blinded fashion. 
Only then will we have a better grasp of whether more day-to-day 
physiological levels of salivary nitrite can be implicated in the potentiation of 
upper GI disease. One problem with our healthy subject studies, and a 
reason for stressing their upper GI tract with so much NA and NO, was that it 
was unlikely that a big effect would be seen in this population. It was, 
however, interesting to see statistically significant data from a study size of 
n=15. Regardless, the maximum dose used, equivalent to 24 hours post­
prandial nitrate exposure over a one-hour period, was entirely appropriate.
The role of antioxidants in the diet has been discussed already 
(section 6.12). The most commonly available antioxidant available in the 
upper GI tract is ascorbic acid. This is due to both its secretion into the 
gastric juice and also because of its frequent ingestion in meals. The fasting 
profile of ascorbic acid in the stomach has been analysed (241). In the 
fasting state it showed that there is a gradient of 13.0jj.moles/litre (SEM 
0.1jLimoies/litre) at the cardia to 86pmoles/litre (SEM 29pmoles/litre) at the 
antrum. This may impact on luminal NO production. Boluses of nitrite are 
more likely to give higher levels of NO, with replenishment of ascorbic acid 
following its reduction. The time for proximal gastric ascorbic acid levels to 
replenish are not known. Post-prandial intragastric ascorbic acid levels, either 
related to gastric secretion or meal ingestion are also not known.
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Upper GI disease states such as Barrett’s oesophagus and 
adenocarcinoma can take decades to develop, perhaps in a small, step-wise 
fashion. This, theoretically, could be related to recurrent effects of luminal 
nitrite chemistry in the post-prandial setting. However, further negative results 
do not completely exclude nitrite as a co-factor in upper GI disease. If further 
effects were seen in hernia patients then removal of the acid, probably with 
proton pump inhibitors, to show the importance of acidifying the nitrite, could 
be taken further. The acid-pocket has been demonstrated as an unbuffered 
region of gastric acid-following a meal. The pH of this area appears to mirror 
that of the oesophageal refluxate. Similarly, for hiatus hernia patients, some 
work carried out in our Unit has shown that hiatus hernia patients have a 
larger unbuffered region of post-prandial acid, related to the hiatal sac (257). 
Therefore, targeting therapies at modifying acid secretion of the hiatal sac 
and proximal stomach may prove more beneficial in the long term.
Further work will be funded with a substantial grant awarded by the 
Scottish Office, December 2006.
278
References
(1) Pohl H, Welch HG. The rote of overdiagnosis and reclassification in the 
marked increase of esophageal adenocarcinoma incidence. Journal of 
the National Cancer Institute 97(2): 142-6, 2005.
(2) Haghighi P, Nasr K. Gastrointestinal cancer in Iran. Journal of Chronic 
Diseases 24(10):625-33, 1971.
(3) Derakhshan MH, Yazdanbod A, Sadjadi AR, Shokoohi B, McColl KE, 
Malekzadeh R. High incidence of adenocarcinoma arising from the right 
side of the gastric cardia in NW Iran. Gut 53(9): 1262-6, 2004.
(4) Moayyedi P, Axon AT. Review article: gastro-oesophageal reflux 
disease-the extent of the problem. Alimentary Pharmacology & 
Therapeutics 22 SuppI 1:11-9, 2005.
(5) Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic 
gastroesophageal reflux as a risk factor for esophageal 
adenocarcinoma. New England Journal of Medicine 340(11):825-31,
1999.
(6) Johnson DA, Fennerty MB. Heartburn severity underestimates erosive 
esophagitis severity in elderly patients with gastroesophageal reflux 
disease. Gastroenterology 126(3):660-4, 2004.
(7) Deane HW, Padykula HA. Alimentary Tract. Histology. Mc-Graw Hill, 
1996: 489-530.
(8) DeNardi FG, Riddell RH. The normal esophagus. American Journal of 
Surgical Pathology 15(3):296-309, 1991.
(9) Ross MH, Kaye GI, Pawlina W. Digestive System II: Esophagus and 
Gastrointestinal Tract. Histology: A text and atlas. Lippincott Williams & 
Wilkins, 2003.
(10) AI Yassin TM, Toner PG. Fine structure of squamous epithelium and 
submucosal glands of human oesophagus. Journal of Anatomy 123(Pt 
3):705-21, 1977.
(11) Kahrilas PJ. Anatomy and physiology of the gastroesophageal junction. 
Gastroenterology Clinics of North America 26(3):467-86, 1997.
(12) DeNardi FG, Riddell RH. The normal esophagus. American Journal of 
Surgical Pathology 15(3):296-309, 1991.
(13) Pouderoux P, Erg un GA, Lin S, Kahrilas PJ. Esophageal bolus transit 
imaged by ultrafast computerized tomography. Gastroenterology 
110(5): 1422-8, 1996.
279
(14) Chandrasoma P, Makarewicz K, Wickramasinghe K, Ma Y, Demeester 
T. A proposai for a new validated histological definition of the 
gastroesophageal junction. Human Pathology 37(1):40-7, 2006.
(15) Csendes A, Maluenda F, Braghetto I, Csendes P, Henriquez A, 
Quesada MS. Location of the lower oesophageal sphincter and the 
squamous columnar mucosal junction in 109 healthy controls and 778 
patients with different degrees of endoscopic oesophagitis. Gut 
34(1):21-7, 1993.
(16) Rhee PL, Liu J, Puckett JL, Mittal RK. Measuring esophageal distension 
by high-frequency intraluminal ultrasound probe. American Journal of 
Physiology - Gastrointestinal & Liver Physiology 283(4);G886-92, 2002.
(17) Pandolfino JE, Schreiner MA, Lee TJ, Zhang Q, Boniquit C, Kahrilas PJ. 
Comparison of the Bravo wireless and Digitrapper catheter-based pH 
monitoring systems for measuring esophageal acid exposure. American 
Journal of Gastroenterology 100(7): 1466-76, 2005.
(18) S if rim D, Castell D, Dent J, Kahrilas PJ. Gastro-oesophageal reflux 
monitoring: review and consensus report on detection and definitions of 
acid, non-acid, and gas reflux. Gut 2004; 53(7): 1024-1031.
(19) S if rim D, Holloway R, Silny J, Xin Z, Tack J, Lerut A et al. Acid, nonacid, 
and gas reflux in patients with gastroesophageal reflux disease during 
ambulatory 24-hour pH-impedance recordings. Gastroenterology 
120(7): 1588-98, 2001.
(20) Streets CG, DeMeester TR. Ambulatory 24-hour esophageal pH 
monitoring: why, when, and what to do. Journal of Clinical 
Gastroenterology 37(1): 14-22, 2003.
(21) Sifrim D, Silny J, Holloway RH, Janssens JJ. Patterns of gas and liquid 
reflux during transient lower oesophageal sphincter relaxation: a study 
using intraluminal electrical impedance.Gut 44(1):47-54, 1999.
(22) Freidin N, Mittal RK, McCailum RW. Does body posture affect the 
incidence and mechanism of gastro-oesophageal reflux? Gut 32(2): 133- 
6. 1991.
(23) Fletcher J, Wirz A, Young J, Vallance R, McColl KE. Unbuffered highly 
acidic gastric juice exists at the gastroesophageal junction after a meal. 
Gastroenterology 2001; 121(4):775-783.
(24) Oberg S, Peters JH, DeMeester TR, Chandrasoma P, Hagen JA, 
Ireland AP et al. Inflammation and specialized intestinal metaplasia of 
cardiac mucosa is a manifestation of gastroesophageal reflux disease. 
Ann Surg 1997; 226(4):522-530.
(25) Fletcher J, Gillen D, Wirz A, McColl KE. Barrett's esophagus evokes a 
quantitatively and qualitatively altered response to both acid and
280
hypertonie solutions. American Journal of Gastroenterology 98(7): 1480- 
6, 2003.
(26) Wajed SA, Streets CG, Bremner CG, DeMeester TR. Elevated body 
mass disrupts the barrier to gastroesophageal reflux; discussion 1018-9. 
Archives of Surgery 136(9): 1014-8, 2001.
(27) Jacobson BC, Somers SC, Fuchs CS, Kelly CP, Camargo CA, Jr. Body- 
mass index and symptoms of gastroesophageal reflux in women. New 
England Journal of Medicine 354(22):2340-8, 2006.
(28) Lagergren J, Bergstrom R, Nyren O. No relation between body mass 
and gastro-oesophageal reflux symptoms in a Swedish population 
based study. Gut 47(1):26-9, 2000.
(29) Barak N, Ehrenpreis ED, Harrison JR, Sitrin MD. Gastro-oesophageal 
reflux disease in obesity: pathophysiological and therapeutic 
considerations. Obesity Reviews 3(1):9-15, 2002.
(30) Liebermann-Meffert D, Allgower M, Schmid P, Blum AL. Muscular 
equivalent of the lower esophageal sphincter. Gastroenterology 
76(1):31-8, 1979.
(31) Kahrilas PJ, Lin S, Chen J, Manka M. The effect of hiatus hernia on 
gastro-oesophageal junction pressure. Gut 44(4):476-82, 1999.
(32) Liu J, Parashar VK, Mittal RK. Asymmetry of lower esophageal 
sphincter pressure: is it related to the muscle thickness or its shape? 
American Journal of Physiology 272(6 Pt 1):G1509-17, 1997.
(33) Cooke HJ. Neurobiology of the intestinal mucosa. Gastroenterology 
90(4):1057-81, 1986.
(34) Martin CJ, Dodds WJ, Liem HH, Dantas RO, layman RD, Dent J. 
Diaphragmatic contribution to gastroesophageal competence and reflux 
in dogs. Am J Physiol 1992; 263(4 Pt 1):G551-G557.
(35) Cohn R, Magladry Jr WG. The affect of alterations of the mucosa of the 
gastroesophageal junction upon gastric reflux into the oesophagus. 
American Journal of Surgery 1956; 92:189-193.
(36) Meiss JH, Grindlay JH, Eliis Jr FH. The gastroesophageal sphincter 
II.Further experimental studies in the dog. J Thoracic Surg 1958; 
36(2): 156-165.
(37) Muller Botha GS. Mucosal folds at the cardia as a component of the 
gastro-oesophageal closing mechanism. Br J Surg 1958; 45(194):569- 
580.
(38) Vianna A, Hayes PC, Moscoso G, Driver M, Portmann B, Westaby D et 
al. Normal venous circulation of the gastroesophageal junction. A route 
to understanding varices. Gastroenterology 93(4):876-89, 1987.
281
(39) Hill LD, Kozarek RA, Kraemer SJ, Aye RW, Mercer CD, Low DE et al. 
The gastroesophageal flap valve: in vitro and in vivo observations. 
Gastrointestinal Endoscopy 44(5):541-7, 1996.
(40) Nauta J. The closing mechanism of the cardia. Arch Chir Neerl 1956; 
8:280-291.
(41) Hill LD, Kozarek RA. The gastroesophageal flap valve. Journal of 
Clinical Gastroenterology 1999; 28(3): 194-197.
(42) Kahrilas PJ, Gupta RR. Mechanisms of acid reflux associated with 
cigarette smoking. Gut 31(1):4-10, 1990.
(43) Csendes A, Oster M, Brandsborg O, Moller JT, Overgaard H, 
Brandsborg M et al. The effect of vagotomy on human 
gastroesophageal sphincter pressure in the resting state and following 
increases in intra-abdominal pressure. Surgery 85(4):419-24, 1979.
(44) Smid SD, Dent J, Blackshaw LA. In vitro function of the human lower 
oesophageal sphincter (LOS) in Barretts oesophagus. Journal of 
Gastroenterology & Hepatology 1998; 13(supplement):pA156.
(45) Kahrilas PJ, Lin S, Chen J, Manka M. The effect of hiatus hernia on 
gastro-oesophageal junction pressure. Gut 44(4):476-82, 1999.
(46) Patti MG, Goldberg HI, Arcerito M, Bortolasi L, Tong J, Way LW. Hiatal 
hernia size affects lower esophageal sphincter function, esophageal 
acid exposure, and the degree of mucosal injury. American Journal of 
Surgery 171(1): 182-6, 1996.
(47) Kasapidis P, Vassilakis JS, Tzovaras G, Chrysos E, Xynos E. Effect of 
hiatal hernia on esophageal manometry and pH-metry in 
gastroesophageal reflux disease. Dig Dis Sci 1995; 40(12):2724-2730.
(48) Welch RW, Gray JE. Influence of respiration on recordings of lower 
esophageal sphincter pressure in humans. Gastroenterology 83(3):590- 
4, 1982.
(49) Campos GM, Oberg S, Gastal O, Theisen J, Nigro JJ, Hagen JA et al. 
Manometry of the lower esophageal sphincter: inter- and intraindividual 
variability of slow motorized pull-through versus station pull-through 
manometry. Digestive Diseases & Sciences 2003; 48(6): 1057-1061.
(50) Kuipers EJ, Uyterlinde AM, Pena AS, Roosendaal R, Pals G, Nelis GF 
et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 
345(8964): 1525-8, 1995.
(51) Kuipers EJ, Nelis GF, Klinkenberg-Knol EC, Snel P, Goldfain D, 
Kolkman JJ et al. Cure of Helicobacter pylori infection in patients with 
reflux oesophagitis treated with long term omeprazole reverses gastritis 
without exacerbation of reflux disease: results of a randomised 
controlled trial. Gut 53(1): 12-20, 2004.
282
(52) Orlando RC. Review article: oesophageal mucosal resistance. 
Alimentary Pharmacology & Therapeutics 12(3):191-7, 1998.
(53) Orlando RC, Esophageal epithelial resistance. In: Castell DO, Wu WC, 
Ott DJ, editors. Gastroesophageal reflux disease: Pathogenesis, 
Diagnosis, Therapy. Mount Cisco, NY.: Future., 1985: 55-79.
(54) De Backer A, Haentjens P, Willems G. Hydrochloric acid. A trigger of 
cell proliferation in the esophagus of dogs. Digestive Diseases & 
Sciences 30(9):884-90, 1985.
(55) Bass BL, Schweitzer EJ, Harmon JW, Kraimer J. H+ back diffusion 
interferes with intrinsic reactive regulation of esophageal mucosal blood 
flow. Surgery 96(2):404-13, 1984.
(56) Hollwarth ME, Smith M, Kvietys PR, Granger DN. Esophageal blood 
flow in the cat. Normal distribution and effects of acid perfusion. 
Gastroenterology 90(3):622-7, 1986.
(57) Babka JC, Castell DO. On the genesis of heartburn. The effects of 
specific foods on the lower esophageal sphincter. American Journal of 
Digestive Diseases 18(5):391-7, 1973.
(58) Castell DO, Levine SM. Lower esophageal sphincter response to gastric 
alkalinization. A  new mechanism for treatment of heartburn with 
antacids. Annals of Internal Medicine 74(2):223-7, 1971.
(59) Crookes PF, Hamoui N, Thiesen J, Johannson J, Lord RV, Gastal O et 
al. Response of lower esophageal sphincter to ingestion of carbonated 
beverages. Gastroenterology 1999; 116(4):A140:G0608.
(60) Pouderoux P, Lin S, Kahrilas PJ. Timing, propagation, coordination, and 
effect of esophageal shortening during peristalsis. Gastroenterology 
112(4): 1147-54, 1997.
(61) Kahrilas PJ, Wu S, Lin S, Pouderoux P. Attenuation of esophageal 
shortening during peristalsis with hiatus hernia. Gastroenterology 1995; 
109(6): 1818-1825.
(62) Bhalla V, Liu J, Puckett JL, Mittal RK. Symptom hypersensitivity to acid 
infusion is associated with hypersensitivity of esophageal contractility. 
American Journal of Physiology - Gastrointestinal & Liver Physiology 
287(1 ):G65-71, 2004.
(63) Pehlivanov N, Liu J, Mittal RK. Sustained esophageal contraction: a 
motor correlate of heartburn symptom. American Journal of Physiology - 
Gastrointestinal & Liver Physiology 281(3):G743-51, 2001.
(64) Farkkila MA, Ertama L, Katila H, Kuusi K, Paavolainen M, Varis K. 
Globus pharyngis, commonly associated with esophageal motility 
disorders. American Journal of Gastroenterology 89(4):503-8, 1994.
283
(65) Howard PJ, Maher L, Pryde A, Heading RC. Symptomatic gastro- 
oesophageal reflux, abnormal oesophageal acid exposure, and mucosal 
acid sensitivity are three separate, though related, aspects of gastro- 
oesophageal reflux disease. Gut 32(2): 128-32, 1991.
(66) Zollei E, Paprika D, Wittmann T, Rosztoczy A, Roka R, Gingl Z et al. 
Oesophageal acid stimulation in humans: does it alter baroreflex 
function? Acta Physiologica Hungarica 90(2): 109-14, 2003.
(67) Wani M, Hishon S. ECG record during changes in oesophageal pH. Gut 
31 (2): 127-8, 1990.
(68) Zentilin P, Conio M, Mele MR, Mansi C, Pandolfo N, Dulbecco P et al. 
Comparison of the main oesophageal pathophysiological characteristics 
between short- and long-segment Barrett's oesophagus. Alimentary 
Pharmacology & Therapeutics 16(5):893-8, 2002.
(69) Christensen J, Lund GF. Esophageal responses to distension and 
electrical stimulation. Journal of Clinical Investigation 48(2):408-19, 
1969.
(70) Winship DH, Zboralske FF. The esophageal propulsive force: 
esophageal response to acute obstruction. Journal of Clinical 
Investigation 46(9): 1391-401, 1967.
(71) Kusano M, Hogan WJ, Lang IM, Bonnevier JL, Massey BT, Shaker R. 
Initiation of esophageal secondary peristalsis by slow fluid infusion in 
the opossum: effect of hydrochloric acid. American Journal of 
Physiology 270(6 Pt 1):G927-31, 1996.
(72) White RJ, Zhang Y, Morris GP, Paterson WG. Esophagitis-related 
esophageal shortening in opossum is associated with longitudinal 
muscle hyperresponsiveness. American Journal of Physiology - 
Gastrointestinal & Liver Physiology 280(3):G463-9, 2001.
(73) Paterson WG, Kolyn DM. Esophageal shortening induced by short-term 
intraluminal acid perfusion in opossum: a cause for hiatus hernia? 
Gastroenterology 1994; 107(6): 1736-1740.
(74) Aksglaede K, Funch-Jensen P, Thommesen P. Intra-esophageal pH 
probe movement during eating and talking. A videoradiographic study. 
Acta Radiologica 44(2): 131-5, 2003.
(75) Shi G, Pandolfino JE, Zhang Q, Hirano 1, Joehl RJ, Kahrilas PJ. 
Deglutitive inhibition affects both esophageal peristaltic amplitude and 
shortening. American Journal of Physiology - Gastrointestinal & Liver 
Physiology 284(4):G575-82, 2003.
(76) Paterson WG. Role of mast cell-derived mediators in acid-induced 
shortening of the esophagus. American Journal of Physiology 274(2 Pt 
1):G385-8, 1998.
284
(77) Stanciu C. The general pattern of duodenal motility: 24 hour recordings 
in normal subjects. Rev Med Chir Soc Med Nat Iasi 1975; 79:31-36.
(78) Meyer JH, Thomson JB, Cohen MB, Shadchehr A, Mandiola SA. 
Sieving of solid food by the canine stomach and sieving after gastric 
surgery. Gastroenterology 76(4):804-13, 1979.
(79) Sun WM, Andrews JM, Hebbard GS, Malbert CH, Horowitz M, Dent J. 
The rate of gastric emptying is inversely related to the frequency of 
isolated pyloric pressure waves. Journal of Gastroenterology & 
Hepatology 1997; 12(Supplement):A127.
(80) Vaezi MF, Richter JE. Role of acid and duodenogastroesophageal 
reflux in gastroesophageal reflux disease. Gastroenterology 
111(5): 1192-9, 1996.
(81) Galmiche JP, Brandstatter G, Evreux M, Hentschel E, Kerstan E, 
Kratochvil P et al. Combined therapy with cisapride and cimetidine in 
severe reflux oesophagitis: a double blind controlled trial. Gut 29(5):675- 
81, 1988.
(82) Collen MJ, Johnson DA, Sheridan MJ. Basal acid output and gastric 
acid hypersecretion in gastroesophageal reflux disease. Correlation with 
ranitidine therapy. Digestive Diseases & Sciences 39(2):410-7, 1994.
(83) Wienbeck M. Does a motor stimulating agent improve the therapeutic 
effect of H-2 blockers in reflux esophagitis? Gastroenterology 1986; 
90(5):1691 (part 2).
(84) Helm JF, Dodds WJ, Hogan WJ, Soergel KH, Egide MS, Wood CM. 
Acid neutralizing capacity of human saliva. Gastroenterology 83(1 Pt 
1):69-74, 1982.
(85) Kahrilas PJ. The role of hiatus hernia in GERD. Yale Journal of Biology 
& Medicine 72(2-3): 101-11, 1999;-Jun.
(86) Byrnes CK, Pisko-Dubienski ZA. An anatomical sphincter of the 
oesophago-gastric junction. Bulletin de la Société Internationale de 
Chirurgie 1963; 1:62-67.
(87) Ohkawa H. Mechanical activity of the smooth muscle of the muscularis 
mucosa of the guinea pig esophagus and drug actions. Japanese 
Journal of Physiology 30(2): 161-77, 1980.
(88) Lawson HH. The lamina muscularis mucosa. South African Journal of 
Surgery 15(4): 179-83, 1977.
(89) Shaük A, Doss S, Asaad S, Ali YA. Rectosigmoid junction: anatomical, 
histological, and radiological studies with special reference to a 
sphincteric function. International Journal of Colorectal Disease 14(4- 
5):237-44, 1999.
285
(90) Clements JL, Jr., Abernathy J, Weens HS. Corrugated mucosal pattern 
in the esophagus associated with progressive systemic sclerosis. 
Gastrointestinal Radiology 3(2): 119-21, 1978.
(91) Williams SM, Harned RK, Kaplan P, Consigny PM. Work in progress: 
transverse striations of the esophagus: association with 
gastroesophageal reflux. Radiology 146(1):25-7, 1983.
(92) Cho KC, Gold BM, Printz DA. Multiple transverse folds in the gastric 
antrum. Radiology 164(2):339-41, 1987.
(93) Forsell G. Studies of the mechanism of movement of the mucous 
membrane of the digestive tract. The American Journal of Roenterology 
and Radium Therapy 1923; 10(2):87-103.
(94) Seymour EQ, Meredith HC. Antral and esophageal rimple: a normal 
variation. Gastrointestinal Radiology 3(2): 147-9, 1978.
(95) Arakawa M, Masuzaki T, Okuda K. Pathomorphology of esophageal 
and gastric varices. Seminars in Liver Disease 22(1):73-82, 2002.
(96) Kahrilas PJ, Lin S, Chen J, Manka M. The effect of hiatus hernia on 
gastro-oesophageal junction pressure. Gut 44(4):476-82, 1999.
(97) Palmer ED. An attempt to localize the normal esophagogastric junction. 
Radiology 1953; 60:825-831.
(98) Daniel EE, Jury J, Bowker P. Muscarinic receptors on nerves and 
muscles in opossum esophagus muscularis mucosa. Canadian Journal 
of Physiology & Pharmacology 65(9): 1903-7, 1987.
(99) Domoto T, Jury J, Berezin I, Fox JE, Daniel EE. Does substance P 
comediate with acetylcholine in nerves of opossum esophageal 
muscularis mucosa? American Journal of Physiology 245(1 ):G19-28,
1983.
(100) Daniel EE, Jury J, Robotham KH. Receptors for neurotransmitters in 
opossum oesophagus muscularis mucosa. British Journal of 
Pharmacology 88(3):707-14, 1986.
(101) Hughes FB. The muscularis mucosae of the oesophagus of the cat, 
rabbit and rat. Journal of Physiology 1955; 130:123-130.
(102) Percy WH, Miller AJ, Brunz JT. Pharmacologic characteristics of rabbit 
esophageal muscularis mucosae in vitro. Digestive Diseases & 
Sciences 42(12):2537-46, 1997.
(103) Tansy MF, Martin JS, Landin WE, Kendall FM. Discrete motor effects 
of neurohumoral and hormonal stimuli on the canine small intestine. 
Surgery, Gynecology & Obstetrics 150(6):827-38, 1980.
286
(104) Tansy MF, Martin JS, Landin WE, Kendall FM. Species difference in 
GI motor response to somatostatin. Journal of Pharmaceutical Sciences 
68(9); 1107-13, 1979.
(105) Tansy MF, Martin JS, Landin WE, Kendall FM. Evidence of reflexive 
beta adrenergic motor stimulation in the canine stomach and small 
intestine. Surgery, Gynecology & Obstetrics 148(6):905-12, 1979.
(106) King CE, Glass LG, Townsend SE. The circular components of the 
muscularis mucosae of the small intestine of the dog. American Journal 
of Physiology 1947; 148:667-674.
(107) Walder DN. The muscularis mucosae of the human stomach. Journal 
of Physiology 1953; 120:365-372.
(108) Dent J, Dodds WJ, Friedman RH, Sekiguchi T, Hogan WJ, Arndorfer 
RC et al. Mechanism of gastroesophageal reflux in recumbent 
asymptomatic human subjects. Journal of Clinical Investigation 
65(2):256-67, 1980.
(109) Mittal RK, Holloway RH, Penagini R, Blackshaw LA, Dent J. Transient 
lower esophageal sphincter relaxation. Gastroenterology 109(2):601-10,
1995.
(110) Monges H, Salducci J, Naudy B. Dissociation between the electrical 
activity of the diaphragmatic dome and crura muscular fibers during 
esophageal distension, vomiting and eructation. An electromyographic 
study in the dog. Journal de Physiologie 74(6):541-54, 1978.
(111) Altschuler SM, Boyle JT, Nixon TE, Pack Al, Cohen S. Simultaneous 
reflex inhibition of lower esophageal sphincter and crural diaphragm in 
cats. American Journal of Physiology 249(5 Pt 1):G586-91, 1985.
(112) Holloway RH, Penagini R, Ireland AC. Criteria for objective definition 
of transient lower esophageal sphincter relaxation. American Journal of 
Physiology 268(1 Pt 1):G128-33, 1995.
(113) Straathof JW, Ringers J, La mers CB, Masclee AA. Provocation of 
transient lower esophageal sphincter relaxations by gastric distension 
with air. American Journal of Gastroenterology 96(8):2317-23, 2001.
(114) Wyman JB, Dent J, Heddle R, Dodds WJ, Toouli J, Downton J. 
Control of belching by the lower oesophageal sphincter. Gut 31(6):639- 
46, 1990.
(115) Ireland AC, Dent J, Holloway RH. Preservation of postural control of 
transient lower oesophageal sphincter relaxations in patients with reflux 
oesophagitis. Gut 44(3):313-6, 1999.
(116) Mason RJ, DeMeester TR, Lund RJ, Peters JH, Crookes P, Ritter M et 
al. Nissen fundoplication prevents shortening of the sphincter during 
gastric distention. Archives of Surgery 1997; 132(7):719-724.
287
(117) Curry J, Shi G, Pandolfino JE, Joehl RJ. Mechanical characteristics of 
the EGJ after fundoplication compared to normal subjects and GERD 
patients. Gastroenterology 2001; 20:604,A112.
(118) Ireland AC, Holloway RH, Toouli J, Dent J. Mechanisms underlying 
the anti reflux action of fundoplication. Gut 34(3):303-8, 1993.
(119) Johnsson F, Ireland AC, Jamieson GG, Dent J, Holloway RH. Effect of 
intraoperative manipulation and anaesthesia on lower oesophageal 
sphincter function during fundoplication. British Journal of Surgery 
81(6):866-8, 1994.
(120) Penagini R, Carmagnola S, Cantu P, Allocca M, Bianchi PA. 
Mechanoreceptors of the proximal stomach: Role in triggering transient 
lower esophageal sphincter relaxation. Gastroenterology 126(1):49-56, 
2004.
(121) Johnsson F, Holloway RH, Ireland AC, Jamieson GG, Dent J. Effect of 
fundoplication on transient lower oesophageal sphincter relaxation and 
gas reflux. British Journal of Surgery 84(5):686-9, 1997.
(122) Dodds WJ, Dent J, Hogan WJ, Helm JF, Hauser R, Pate! GK et al. 
Mechanisms of gastroesophageal reflux in patients with reflux 
esophagitis. N Engl J Med 1982; 307(25): 1547-1552.
(123) Kahrilas PJ, Shi G, Manka M, Joehl RJ. Increased frequency of 
transient lower esophageal sphincter relaxation induced by gastric 
distention in reflux patients with hiatal hernia. Gastroenterology 2000; 
118(4):688-695.
(124) Holloway RH, Hongo M, Berger K, McCallum RW. Gastric distention: a 
mechanism for postprandial gastroesophageal reflux. Gastroenterology 
89(4):779-84, 1985.
(125) Kahrilas PJ, Lin S, Chen J, Manka M. The effect of hiatus hernia on 
gastro-oesophageal junction pressure. Gut 44(4):476-82, 1999.
(126) Penagini R, Hebbard G, Horowitz M, Dent J, Bermingham H, Jones K 
et al. Motor function of the proximal stomach and visceral perception in 
gastro-oesophageal reflux disease. Gut 42(2):251-7, 1998.
(127) Penagini R, Holloway RH, Hebbard GS, Bermingham H, Horowitz M, 
Dent J. Fasting compliance and postprandial relaxation of the proximal 
stomach in gastroesophageal reflux disease. Journal of 
Gastroenterology & Hepatology 1996; 11(10 (supplement)):A93.
(128) Lidums I, Lehmann A, Checklin H, Dent J, Holloway RH. The GABA-B 
agonist baclofen inhibits transient lower oesophageal sphincter 
relaxations and gastro-oesophageal reflux in normal human subjects. 
Journal of Gastroenterology & Hepatology 1999; 14(Supplement):A203.
288
(129) Ciccaglione AF, Marzio L. Effect of acute and chronic administration of 
the GABA B agonist baclofen on 24 hour pH metry and symptoms in 
control subjects and in patients with gastro-oesophageal reflux disease. 
Gut 52(4):464-70, 2003.
(130) Vela MF, Camacho-Lobato L, Srinivasan R, Tutuian R, Katz PO, 
Castell DO. Simultaneous intraesophageal impedance and pH 
measurement of acid and nonacid gastroesophageal reflux: effect of 
omeprazole. Gastroenterology 120(7): 1599-606, 2001.
(131) Zhang Q, Lehmann A, Rigda R, Dent J, Holloway RH. Control of 
transient lower oesophageal sphincter relaxations and reflux by the 
GABA(B) agonist baclofen in patients with gastro-oesophageal reflux 
disease. Gut 50(1): 19-24, 2002.
(132) Richter J. Do we know the cause of reflux disease? Eur J 
Gastroenterol Hepatol 1999; 11 SuppI 1:S3-9.:S3-S9.
(133) Martin CJ, Patrikios J, Dent J. Abolition of gas reflux and transient 
lower esophageal sphincter relaxation by vagal blockade in the dog. 
Gastroenterology 1986; 91(4):890-896.
(134) Mittal RK, Holloway R, Dent J. Effect of atropine on the frequency of 
reflux and transient lower esophageal sphincter relaxation in normal 
subjects. Gastroenterology 109(5): 1547-54, 1995.
(135) Carvalho PJPC, Miidia I, Donahue PE, Vaz O, Sugitani A, Nyhus LM. 
A noninvasive model of gastroesophageal reflux in dogs. Digestive 
Surgery 1992; 9:89-94.
(136) Scheffer RC, Akkermans LM, Bais JE, Roelofs JM, Smout AJ, 
Gooszen HG. Elicitation of transient lower oesophageal sphincter 
relaxations in response to gastric distension and meal ingestion. 
Neurogastroenterology & Motility 14(6):647-55, 2002.
(137) Boeckxstaens GE, Hirsch DP, Fakhry N, Holloway RH, D'Amato M, 
Tytgat GN. Involvement of cholecystokininA receptors in transient lower 
esophageal sphincter relaxations triggered by gastric distension. 
American Journal of Gastroenterology 93(10): 1823-8, 1998.
(138) Penagini R, Bianchi PA. Effect of morphine on gastroesophageal 
reflux and transient lower esophageal sphincter relaxation. 
Gastroenterology 113(2):409-14, 1997.
(139) Cange L, Johnsson E, Rydholm H, Lehmann A, Finizia C, Lundell L et 
al. Baclofen-mediated gastro-oesophageal acid reflux control in patients 
with established reflux disease. Alimentary Pharmacology & 
Therapeutics 16(5):869-73, 2002.
(140) Hirsch DP, Holloway RH, Tytgat GN, Boeckxstaens GE. Involvement 
of nitric oxide in human transient lower esophageal sphincter relaxations
289
and esophageal primary peristalsis. Gastroenterology 115(6): 1374-80,
1998.
(141) Hirsch DP, Tiel-Van Buul MM, Tytgat GN, Boeckxstaens GE. Effect of 
L-NMMA on postprandial transient lower esophageal sphincter 
relaxations in healthy volunteers. Digestive Diseases & Sciences 
45(10):2069-75, 2000.
(142) Zerbib F, Bruley D, V, Scarpignato C, Leray V, D'Amato M, Roze C et 
al. Endogenous cholecystokinin in postprandial lower esophageal 
sphincter function and fundic tone in humans. American Journal of 
Physiology 275(6 Pt 1):G1266-73, 1998.
(143) Boulant J, Fioramonti J, Dapoigny M, Bommelaer G, Bueno L. 
Cholecystokinin and nitric oxide in transient lower esophageal sphincter 
relaxation to gastric distention in dogs. Gastroenterology 107(4): 1059- 
66, 1994.
(144) Holloway RH, Lyrenas E, Ireland A, Dent J. Effect of intraduodenal fat 
on lower oesophageal sphincter function and gastro-oesophageal reflux. 
Gut 40(4):449-53, 1997.
(145) Pehl C, Waizenhoefer A, Wend! B, Schmidt T, Schepp W, Pfeiffer A. 
Effect of low and high fat meals on lower esophageal sphincter motility 
and gastroesophageal reflux in healthy subjects. American Journal of 
Gastroenterology 94(5): 1192-6, 1999.
(146) Iwakiri K, Kobayashi M, Kotoyori M, Yamada H, Sugiura T, Nakagawa 
Y. Relationship between postprandial esophageal acid exposure and 
meal volume and fat content. Digestive Diseases & Sciences 41 (5):926- 
30, 1996.
(147) Penagini R, Mangano M, Bianchi PA. Effect of increasing the fat 
content but not the energy load of a meal on gastro-oesophageal reflux 
and lower oesophageal sphincter motor function. Gut 1998; 42(3);330- 
333.
(148) Corley DA, Katz P, Wo JM, Stefan A, Patti M, Rothstein R et al. 
Improvement of gastroesophageal reflux symptoms after radiofrequency 
energy: a randomized, sham-controlled trial. Gastroenterology 
125(3):668-76, 2003.
(149) Kahrilas PJ. Radiofrequency energy treatment of GERD. 
Gastroenterology 125(3):970-3, 2003.
(150) Korn O, Csendes A, Burdiles P, Braghetto I, Stein HJ. Anatomic 
dilatation of the cardia and competence of the lower esophageal 
sphincter: a clinical and experimental study. Journal of Gastrointestinal 
Surgery 4(4):398-406, 2000;-Aug.
290
(151) McGouran RC, Galloway JM. A laser-induced scar at the cardia 
increases the yield pressure of the lower esophageal sphincter. 
Gastrointestinal Endoscopy 36(5):439-43, 1990;-Oct.
(152) Chuttani R. Endoscopic full-thickness plication: the device, technique, 
pre-clinical and early clinical experience. Gastrointestinal Endoscopy 
Clinics of North America 13(1): 109-16, ix-x, 2003.
(153) Pandolfino JE, Shi G, Trueworthy B, Kahrilas PJ. Esophagogastric 
junction opening during relaxation distinguishes nonhernia reflux 
patients, hernia patients, and normal subjects. Gastroenterology 2003; 
125(4): 1018-1024.
(154) Richter T, Spurling C, Cordova M, Mercer CD, Castell D. Effects of the 
oral calcium antagonist, diltiazem, on esophageal contractions in normal 
human volunteers. Gastroenterology 1982; 82(5 (supplement)): 1161.
(155) Danielides 1C, Basioukas P, Pouggouras P. Effects of nifedipine on 
primary esophageal motility disorders. Gastroenterology 1984; 86(5 
pt2):1056.
(156) Schuurkes JA, Van Nueten JM, Van Daele PG, Reyntjens AJ, 
Janssen PA. Motor-stimulating properties of cisapride on isolated 
gastrointestinal preparations of the guinea pig. J Pharmacol Exp Ther 
1985; 234:775-783.
(157) Finizia C, Lundell L, Cange L, Ruth M. The effect of cisapride on 
oesophageal motility and lower sphincter function in patients with 
gastro-oesophageal reflux disease. European Journal of 
Gastroenterology & Hepatology 14(1):9-14, 2002.
(158) Weihrauch TR, Forster CF, Kohler H, Ewe K, Krieglstein J. Effect of 
intravenous diazepam on human lower oesophageal sphincter pressure 
under controlled double blind crossover conditions. Gut 1920;(1):64-67.
(159) Bove M, Lundell L, Ny L, Casselbrant A, Fandriks L, Pettersson A et 
al. Effects of dietary nitrate on oesophageal motor function and gastro- 
oesophageal acid exposure in healthy volunteers and reflux patients. 
Digestion 68(1):49-56, 2003.
(160) Coss A, Cantor KP, Reif JS, Lynch CF, Ward MH. Pancreatic cancer 
and drinking water and dietary sources of nitrate and nitrite. American 
Journal of Epidemiology 159(7):693-701, 2004.
(161) Choi NW, Miller AB, Fodor JG, Jain M, Howe GR, Risch HA et al. 
Consumption of precursors of N-nitroso compounds and human gastric 
cancer. lARC Scientific Publications (84):492-6, 1987.
(162) lijima K, Henry E, Moriya A, Wirz A, Kelman AW, McColl KE. Dietary 
nitrate generates potentially mutagenic concentrations of nitric oxide at 
the gastroesophageal junction. Gastroenterology 122(5): 1248-57, 2002.
291
(163) van Maanen JM, van Geel AA, Kteinjans JC. Modulation of nitrate- 
nitrite conversion in the oral cavity. Cancer Detection & Prevention 
1996;(6):590-596.
(164) Navarro M, Pichini S, Farre M, Ortuno J, Roset PN, Segura J et al. 
Usefulness of saliva for measurement of 3,4- 
methylenedioxymethamphetamine and its metabolites: correlation with 
plasma drug concentrations and effect of salivary pH. Clinical Chemistry 
47(10): 1788-95, 2001.
(165) Butler AR, Ridd JH. Formation of nitric oxide from nitrous acid in 
ischemic tissue and skin. Nitric Oxide 10(1):20-4, 2004.
(166) Suzuki H, lijima K, Scobie G, Fyfe V, McColl KE. Nitrate and 
nitrosative chemistry within Barrett's oesophagus during acid reflux. Gut 
54(11): 1527-35, 2005.
(167) Mowat C, Carswell A, Wirz A, McColl KE. Omeprazole and dietary 
nitrate independently affect levels of vitamin C and nitrite in gastric 
juice.[erratum appears in Gastroenterology 1999 Jun;116(6): 1507]. 
Gastroenterology 116(4):813-22, 1999.
(168) Cassel brant A, Pettersson A, Ruth M, Bove M, Lundell L, Fandriks L. 
Sources of intra-oesophageal nitric oxide production following 
intraluminal acid exposure. Scandinavian Journal of Gastroenterology
37(6):631-7, 2002.
(169) Hill MJ. Bacterial N-nitrosation and gastric carcinogenesis in humans. 
Italian Journal of Gastroenterology 23(1):17-23, 1991.
(170) Correa P. A human model of gastric carcinogenesis. Cancer Research 
48(13):3554-60, 1988.
(171) MacMicking J, Xie Q, Nathan C. Nitric oxide and macrophage function. 
Annual Review of Immunology 1997; 15:323-350.
(172) Holm M, Olbe L, Fandriks L. Intragastric C02 and nitric oxide 
participate in the regulation of peptone-induced gastrin release in 
humans. Scandinavian Journal of Gastroenterology 35(12): 1260-5, 
2000.
(173) Gillespie JS, Sheng H. Influence of haemoglobin and erythrocytes on 
the effects of EDRF, a smooth muscle inhibitory factor, and nitric oxide 
on vascular and non-vascular smooth muscle. British Journal of 
Pharmacology 95(4): 1151-6, 1988.
(174) Bowman A, Gillespie JS, Soares-da-Silva P. A comparison of the 
action of the endothelium-derived relaxant factor and the inhibitory 
factor from the bovine retractor penis on rabbit aortic smooth muscle. 
British Journal of Pharmacology 87(1):175-81, 1986.
292
(175) Barahona MV, Sanchez-Fortun S, San Andres MD, Rodriguez C, San 
Andres M. Involvement of cyclic GMP-dependent mechanism in the 
nitrergic relaxation of the bovine oesophageal groove. Journal of 
Autonomic Pharmacology 1999;(1):39-47.
(176) Ghofrani HA, Wiedemann R, Rose F, Schermuly RT, Olschewski H, 
Weissmann N et ai. Sildenafil for treatment of lung fibrosis and 
pulmonary hypertension: a randomised controlled trial. Lancet 
360(9337):895-900, 2002.
(177) Dweik RA. Pulmonary hypertension and the search for the selective 
pulmonary vasodilator. Lancet 360(9337):886-7, 2002.
(178) Simren M, Silny J, Holloway R, Tack J, Janssens J, Sifrim D. 
Relevance of ineffective oesophageal motility during oesophageal acid 
clearance. Gut 52(6):784-90, 2003.
(179) Eherer AJ, Schwetz I, Hammer HF, Petnehazy T, ScheidI SJ, Weber K 
et al. Effect of sildenafil on oesophageal motor function in healthy 
subjects and patients with oesophageal motor disorders. Gut 50(6):758- 
64, 2002.
(180) Bove M, Vieth M, Casselbrant A, Ny L, Lundell L, Ruth M. Acid 
challenge to the esophageal mucosa: effects on local nitric oxide 
formation and its relation to epithelial functions. Digestive Diseases & 
Sciences 50(4):640-8, 2005.
(181) Sun WM, Doran S, Lingenfeiser T, Hebbard GS, Morley JE, Dent J et 
al. Effects of glyceryl trinitrate on the pyloric motor response to 
intraduodenal triglyceride infusion in humans. European Journal of 
Clinical Investigation 26(8):657-64, 1996.
(182) Pique JM, Esplugues JV, Whittle BJ. Endogenous nitric oxide as a 
mediator of gastric mucosal vasodilatation during acid secretion. 
Gastroenterology 102(1): 168-74, 1992.
(183) Desai KM, Sessa WC, Vane JR. Involvement of nitric oxide in the 
reflex relaxation of the stomach to accommodate food or fluid. Nature 
351(6326):477-9, 1991.
(184) Sun WM, Doran S, Lingenfeiser T, Hebbard GS, Morley JE, Dent J et 
al. Effects of glyceryl trinitrate on the pyloric motor response to 
intraduodenal triglyceride infusion in humans. European Journal of 
Clinical Investigation 26(8):657-64, 1996.
(185) Konturek J, Thor P, Domschke W. Effects of nitric oxide on antral 
motility and gastric emptying in humans. Eur J Gastroenterol Hepatol 
1995; 7:97-102.
(186) Vergara P, Woskowska Z, Cipris S, Fox-Threlkeld JE, Daniel EE. 
Mechanisms of action of cholecystokinin in the canine gastrointestinal
293
tract: role of vasoactive intestinal peptide and nitric oxide. Journal of 
Pharmacology & Experimental Therapeutics 279(1):306-16, 1996.
(187) Sifrim D, Lefebvre R. Role of nitric oxide during swallow-induced 
esophageal shortening in cats. Digestive Diseases & Sciences 
46(4):822-30, 2001.
(188) Snygg J, Casselbrant A, Pettersson A, Holm M, Fandriks L, Aneman 
A. Tonometric assessment of jejunal mucosal nitric oxide formation in 
anaesthetized pigs. Acta Physiologica Scandinavica 169(1):39~45,
2000.
(189) Cooper CE. Nitric oxide and iron proteins. Biochimica et Biophysica 
Acta 1411(2-3):290-309, 1999.
(190) Henry Y, Ducrocq C, Drapier JC, Servent D, Pellat C, Guissani A. 
Nitric oxide, a biological effector. Electron paramagnetic resonance 
detection of nitrosyl-iron-protein complexes in whole cells. European 
Biophysics Journal 1991;(1):1-15.
(191) Moncada S, Erusalimsky JD. Does nitric oxide modulate mitochondrial 
energy generation and apoptosis?. Nature Reviews Molecular Cell 
Biology 3(3):214-20, 2002.
(192) Cooper CE. Nitric oxide and cytochrome oxidase: substrate, inhibitor 
or effector?. Trends in Biochemical Sciences 27(1):33~9, 2002.
(193) Brown GC. Nitric oxide and mitochondrial respiration. Biochimica et 
Biophysica Acta 1411(2-3):351-69, 1999.
(194) Cooper CE, Davies NA, Psychoulis M, Canevari L, Bates TE, Dobbie 
MS et al. Nitric oxide and peroxynitrite cause irreversible increases in 
the K(m) for oxygen of mitochondrial cytochrome oxidase: in vitro and in 
vivo studies. Biochimica et Biophysica Acta 1607(1 ):27-34, 2003.
(195) Pearce LL, Pitt BR, Peterson J. The peroxynitrite reductase activity of 
cytochrome c oxidase involves a two-electron redox reaction at the 
heme a(3)-Cu(B) site. Journal of Biological Chemistry 274(50):35763-7, 
1999.
(196) Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz 
PJ et al. Mechanism of vascular smooth muscle relaxation by organic 
nitrates, nitrites, nitroprusside and nitric oxide: evidence for the 
involvement of S-nitrosothiols as active intermediates. Journal of 
Pharmacology & Experimental Therapeutics 218(3):739-49, 1981.
(197) De Man JG, De Winter BY, Boeckxstaens GE, Herman AG, 
Pelckmans PA. Effect of thiol modulators and Cu/Zn superoxide 
dismutase inhibition on nitrergic relaxations in the rat gastric fundus. 
British Journal of Pharmacology 119(5): 1022-8, 1996.
294
(198) Hogg N. Biological chemistry and clinical potential of S-nitrosothiols. 
Free Radical Biology & Medicine 28(10): 1478-86, 2000.
(199) Clancy RM, Levartovsky D, Leszczynska-Piziak J, Yegudin J, 
Abramson SB. Nitric oxide reacts with intracellular glutathione and 
activates the hexose monophosphate shunt in human neutrophils: 
evidence for S-nitrosoglutathione as a bioactive intermediary. 
Proceedings of the National Academy of Sciences of the United States 
of America 91 (9):3680-4, 1994.
(200) Butler AR, Flitney FW, Williams DL. NO, nitrosonium ions, nitroxide 
ions, nitrosothiols and iron-nitrosyls in biology: a chemist's perspective. 
Trends in Pharmacological Sciences 16(1): 18-22, 1995.
(201) Akaike T. Mechanisms of biological S-nitrosation and its 
measurement. Free Radical Research 33(5):461-9, 2000.
(202) Wexler EM, Stanton PK, Nawy S. Nitric oxide depresses GABAA 
receptor function via coactivation of cGMP-dependent kinase and 
phosphodiesterase. Journal of Neuroscience 18(7):2342-9, 1998.
(203) Wink DA, Nims RW, Derbyshire JF, Christodoulou D, Hanbauer 1, Cox 
GW et al. Reaction kinetics for nitrosation of cysteine and glutathione in 
aerobic nitric oxide solutions at neutral pH. Insights into the fate and 
physiological effects of intermediates generated in the N 0/02  reaction. 
Chemical Research in Toxicology 7(4):519-25, 1994;-Aug.
(204) Kashiba-lwatsuki M, Yamaguchi M, Inoue M. Role of ascorbic acid in 
the metabolism of S-nitroso-glutathione. FEBS Letters 389(2): 149-52,
1996.
(205) Marley R, Feelisch M, Holt S, Moore K. A chemiluminescense-based 
assay for S-nitrosoalbumin and other plasma S-nitrosothiols. Free 
Radical Research 32(1): 1-9, 2000.
(206) Holmes AJ, Williams LH. Reaction of ascorbic acid with 8- 
nitrosothiols: clear evidence for two distinct reaction pathways. J Chem 
Soc 2000; 2:1639-1644.
(207) Pohl H, Welch HG. The role of overdiagnosis and reclassification in 
the marked increase of esophageal adenocarcinoma incidence. Journal 
of the National Cancer Institute 97(2): 142-6, 2005.
(208) Butler AR, Flitney FW, Williams DL. NO, nitrosonium ions, nitroxide 
ions, nitrosothiols and iron-nitrosyls in biology: a chemist's perspective. 
Trends in Pharmacological Sciences 16(1): 18-22, 1995.
(209) Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic 
gastroesophageal reflux as a risk factor for esophageal 
adenocarcinoma. New England Journal of Medicine 340(11):825-31, 
1999.
295
(210) Walker R. Nitrates, nitrites and N-nitrosocompounds: a review of the 
occurrence in food and diet and the toxicological implications. Food 
Additives & Contaminants 7(6):717-68, 1990;-Dec.
(211) Spiegelhalder B, Eisenbrand G, Preussmann R. Influence of dietary 
nitrate on nitrite content of human saliva: possible relevance to in vivo 
formation of N-nitroso compounds. Food & Cosmetics Toxicology 
14(6):545-8, 1976.
(212) McKnight GM, Smith LM, Drummond RS, Duncan CW, Golden M, 
Benjamin N. Chemical synthesis of nitric oxide in the stomach from 
dietary nitrate in humans. Gut 40(2):211-4, 1997.
(213) Mittal RK, Holloway RH, Penagini R, Blackshaw LA, Dent J. Transient 
lower esophageal sphincter relaxation. Gastroenterology 109(2):601-10, 
1995.
(214) Mowat C, Williams C, Gillen D, Hossack M, Gilmour D, Carswell A  et 
al. Omeprazole, Helicobacter pylori status, and alterations in the 
intragastric milieu facilitating bacterial N-nitrosation. Gastroenterology
119(2):339-47, 2000.
(215) World Precision Instruments I. ISO-NO Mark II. Isolated nitric oxide 
meter and sensors. Instruction Manual. 1st edition, ed. 1999.
(216) Sobala GM, Schorah CJ, Sanderson M, Dixon MF, Tompkins DS, 
Godwin P et al. Ascorbic acid in the human stomach. Gastroenterology 
97(2):357-63, 1989.
(217) Winter J, Paterson S, Scobie G, Wirz A, Preston T, McColl KEL. In- 
situ generation of N-nitroso compound from dietary nitrate via nitric 
oxide in the human proximal stomach. Gut 2005; 54(supplement 2, 
110):A30.
(218) Lundberg JO, Weitzberg E, Lundberg JM, Alving K. Intragastric nitric 
oxide production in humans: measurements in expelled air. Gut 
35(11): 1543-6, 1994.
(219) Souza RF, Spechler SJ. Concepts in the prevention of 
adenocarcinoma of the distal esophagus and proximal stomach. CA: a 
Cancer Journal for Clinicians 55(6):334-51, 2005;-Dec.
(220) Spechler SJ. Review article: what I do now to manage 
adenocarcinoma risk, and what I may be doing in 10 years' time. 
Alimentary Pharmacology & Therapeutics 2004; 105-110.
(221) McKnight GM, Smith LM, Drummond RS, Duncan CW, Golden M, 
Benjamin N. Chemical synthesis of nitric oxide in the stomach from 
dietary nitrate in humans. Gut 40(2):211-4, 1997.
(222) DeNardi FG, Riddell RH. The normal esophagus. American Journal of 
Surgical Pathology 15(3):296-309, 1991.
296
(223) Kahrilas PJ, Dodds WJ, Hogan WJ, Kern M, Arndorfer RC, Reece A. 
Esophageal peristaltic dysfunction in peptic esophagitis. 
Gastroenterology 91(4):897-904, 1986.
(224) Walker R. Nitrates, nitrites and N-nitrosocompounds: a review of the 
occurrence in food and diet and the toxicological implications. Food 
Additives & Contaminants 7(6):717-68, 1990.
(225) Lausier JM, Gerraughty RJ, Paruta AN. Efficient deoxygenation of 
water by gas permeation. Journal of Pharmaceutical Sciences 
60(12): 1906-7, 1971.
(226) Kahrilas PJ. Anatomy and physiology of the gastroesophageal 
junction. Gastroenterology Clinics of North America 26(3):467-86, 1997.
(227) Dent J, Dodds WJ, Sekiguchi T, Hogan WJ, Arndorfer RC. 
Interdigestive phasic contractions of the human lower esophageal 
sphincter. Gastroenterology 1983; 84:453-460.
(228) Fletcher J, Wirz A, Henry E, McColl KE. Studies of acid exposure 
immediately above the gastro-oesophageal squamocolumnar junction: 
evidence of short segment reflux. Gut 2004; 53(2): 168-173.
(229) Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's 
esophagus in asymptomatic individuals.Gastroenterology 123(2):461-7, 
2002.
(230) Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic 
gastroesophageal reflux as a risk factor for esophageal 
adenocarcinoma. New England Journal of Medicine 340(11):825-31, 
1999.
(231) Walker R. Nitrates, nitrites and N-nitrosocompounds: a review of the 
occurrence in food and diet and the toxicological implications. Food 
Additives & Contaminants 7(6):717-68, 1990;-Dec.
(232) Bartholomew B, Hill MJ. The pharmacology of dietary nitrate and the 
origin of urinary nitrate. Food & Chemical Toxicology 22(10):789-95,
1984.
(233) Tannenbaum SR, Weisman M, Fett D. The effect of nitrate intake on 
nitrite formation in human saliva. Food & Cosmetics Toxicology 
14(6):549-52, 1976.
(234) Bos PM, Van den Brandt PA, Wedel M, Ockhuizen T. The 
reproducibility of the conversion of nitrate to nitrite in human saliva after 
a nitrate load. Food & Chemical Toxicology 26(2):93-7, 1988.
(235) Leach S. Mechanisms of endogenous N-nitrosation. In: Hill J, editor. 
Nitrosamines: Toxicology and Microbiology. Ellis Holwood, 1988: 69-87.
297
(236) Moriya A, Grant J, Mowat C, Williams C, Carswell A, Preston T et al. 
In vitro studies indicate that acid catalysed generation of N- 
nitrosocompounds from dietary nitrate will be maximal at the gastro- 
oesophageal junction and cardia. Scandinavian Journal of 
Gastroenterology 37(3):253-61, 2002.
(237) Mittal RK, Holloway RH, Penagini R, Blackshaw LA, Dent J. Transient 
lower esophageal sphincter relaxation. Gastroenterology 109(2):601-10, 
1995.
(238) Ledeboer M, Masclee AA, Batstra MR, Jansen JB, Lamers CB. Effect 
of cholecystokinin on lower oesophageal sphincter pressure and 
transient lower oesophageal sphincter relaxations in humans.[see 
comment]. Gut 36(1):39-44, 1995.
(239) Decktor DL, Krawet SH, Rodriguez SL, Robinson M, Castell DO. Dual 
site ambulatory pH monitoring: a probe across the lower esophageal 
sphincter does not induce gastroesophageal reflux. Am J Gastroenterol 
1996; 91(6):1162-1166.
(240) Feldman M, Cryer B, Lee E. Effects of Helicobacter pylori gastritis on 
gastric secretion in healthy human beings. American Journal of 
Physiology 274(6 Pt 1):G1011-7, 1998.
(241) Suzuki H, lijima K, Moriya A, McElroy K, Scobie G, Fyfe V et al. 
Conditions for acid catalysed luminal nitrosation are maximal at the 
gastric cardia. Gut 52(8): 1095-101, 2003.
(242) Arnelle DR, Stamler JS. N0+, NO, and NO- donation by 8- 
nitrosothiols: implications for regulation of physiological functions by 8- 
nitrosylation and acceleration of disulfide formation. Archives of 
Biochemistry & Biophysics 318(2):279-85, 1995.
(243) Walker R. Nitrates, nitrites and N-nitrosocompounds: a review of the 
occurrence in food and diet and the toxicological implications. Food 
Additives & Contaminants 7(6):717-68, 1990;-Dec.
(244) Rood JC, Ruiz B, Fontham ET, Malcom GT, Hunter FM, Sobhan M et 
al. Helicobacter pylori-associated gastritis and the ascorbic acid 
concentration in gastric juice. Nutrition & Cancer 22(1):65-72, 1994.
(245) Banerjee 8, Hawksby C, Miller 8, Dahill 8, Beattie AD, McColl KE. 
Effect of Helicobacter pylori and its eradication on gastric juice ascorbic 
acid. Gut 35(3):317-22, 1994.
(246) Ruiz B, Correa P, Fontham ET, Rood JC, Malcom GT, Torrado J et al. 
Ascorbic acid, Helicobacter pylori and Lewis phenotype among blacks 
and whites in New Orleans. Cancer Letters 83(1-2):323-9, 1994.
(247) Katelaris PH, 8eow F, Lin BP, Napoli J, Ngu MC, Jones DB. Effect of 
age, Helicobacter pylori infection, and gastritis with atrophy on serum
298
gastrin and gastric acid secretion in healthy men. Gut 34(8): 1032-7, 
1993.
(248) McColl KE. When saliva meets acid: chemical warfare at the 
oesophagogastric junction. Gut 54(1): 1-3, 2005.
(249) Chen YY, Antonioli DA, Spechler SJ, Zeroogian JM, Goya I RK, Wang 
HH. Gastroesophageal reflux disease versus Helicobacter pylori 
infection as the cause of gastric carditis. Modern Pathology 11(10):950- 
6, 1998.
(250) Palli D, Decarli A, Russo A, Cipriani F, Giacosa A, Amadori D et al. 
Plasma levels of antioxidant vitamins and cholesterol in a large 
population sample in central-northern Italy. European Journal of 
Nutrition 38(2):90-8, 1999.
(251) Bener A, Uduman SA, Ameen A, Alwash R, Pasha MA, Usmani MA et 
al. Prevalence of Helicobacter pylori infection among low socio­
economic workers. Journal of Communicable Diseases 34(3): 179-84, 
2002.
(257) Clarke AT, Wirz AA, Manning JJ, Ballantyne S, Alcorn D, McColl KEL. 
Oesophagitis is associated with enlarged unbuffered postprandial acid 
pocket. Gut 2006; 55(Supplement No 2):A19.
299 , .J
(252) Zhang ZF, Kurtz RC, Klimstra DS, Yu GP, Sun M, Harlap S et al. 
Helicobacter pylori infection on the risk of stomach cancer and chronic 
atrophic gastritis. Cancer Detection & Prevention 23(5):357-67, 1999.
(253) Morini 8, Zullo A, Hassan C, Lorenzetti R, Stella F, Martini MT. Gastric 
cardia inflammation: role of Helicobacter pylori infection and symptoms 
of gastroesophageal reflux disease. American Journal of 
Gastroenterology 96(8):2337-40, 2001.
(254) Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic 
gastroesophageal reflux as a risk factor for esophageal 
adenocarcinoma. New England Journal of Medicine 340(11):825-31,
1999.
(255) Ghosh 8K, Pandolfino JE, Zhang Q, Jarosz A, Shah N, Kahrilas PJ. 
Quantifying esophageal peristalsis with high-resolution manometry: a 
study of 75 asymptomatic volunteers. American Journal of Physiology - 
Gastrointestinal & Liver Physiology 290(5):G988-97, 2006.
(256) Pandolfino JE, Ghosh SK, Zhang Q, Jarosz A, Shah N, Kahrilas PJ. 
Quantifying EGJ morphology and relaxation with high-resolution 
manometry: a study of 75 asymptomatic volunteers. American Journal 
of Physiology - Gastrointestinal & Liver Physiology 290(5):G1033-40, 
2006.
